Referenser

Referens140 sidor · PDF

Orange Book - Lists of Scheduling Actions, Controlled Substances, and Regulated Chemicals

Källa: https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf

Ett verk av en annan upphovsperson, återgivet här i sin helhet så att det går att läsa; originalet är den gällande versionen.

Ladda ner som PDF

Orange Book - Lists of Scheduling Actions, Controlled Substances, and Regulated Chemicals

U.S. Department of Justice

Drug Enforcement Administration Diversion Control Division Drug & Chemical Evaluation Section

Lists of:

Scheduling Actions Controlled Substances Regulated Chemicals

November 2026

Foreword

The first three sections of this booklet list the names of the substances which are described in the Code of Federal Regulations (CFR) as well as some of those which generate frequent inquiries. The substances are first arranged alphabetically, then by Drug Enforcement Administration (DEA) drug code number, and finally by Controlled Substances Act (21 U.S.C. §801 et seq.) (CSA) schedule. These lists describe the basic or parent chemical and do not describe the salts, isomers, salts of isomers, esters, ethers, and derivatives which may be controlled substances. These are not comprehensive lists so please note that a substance need not be listed as a controlled substance to be treated as a scheduled substance for criminal prosecution. The “Other Names” column, provides some examples of alternate names for certain compounds, and in some instances provides examples of “positional isomers”. If outside parties want to ensure that a compound is not considered a scheduled substance or listed chemical, they should write the DEA, Drug and Chemical Evaluation Section (DRE), Diversion Control Division, 8701 Morrissette Drive, Springfield, Virginia 22152, for an official determination. A substance (not included on these lists) may also be regulated as a controlled substance analogue. A controlled substance analogue is a substance which is intended for human consumption, is structurally substantially similar to a schedule I or schedule II substance, is pharmacologically substantially similar to a schedule I or schedule II substance, or is represented as being similar to a schedule I or schedule II substance and is not an approved medication in the United States. See 21 U.S.C. § 802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. § 813 for the schedule. The next two sections of this booklet list the Federal Register notices through which the DEA has directed substances to be added, deleted or transferred between schedules of the CSA. The scheduling changes are listed first in alphabetical order by substance and then in chronological order by effective date. With the exception of anabolic steroids, section 812 of the CSA lists only those substances which were controlled in 1970 when the law was enacted. Since then, numerous substances have been added, removed, or transferred from one schedule to another. The current official list of controlled substances can be found in section 1308 of the most recent issue of Title 21 Code of Federal Regulations Part 1300 to end (21 CFR § 1308) and the final rules which have been published in the Federal Register subsequent to the issuance of the CFR. The CFR and the Federal Register are available on the U.S. Government Printing Office web site at https://www.gpo.gov/fdsys/. This information is accessible, also, on the Diversion Control Division’s website at https://www.deadiversion.usdoj.gov/. The last section of this booklet identifies the “List I” and “List II” chemicals. Certain commercial transactions involving these chemicals are regulated by the CSA. See 21 CFR §§ 1309, 1310 and 1313 for details.

These lists are intended as general references and are not comprehensive listings of all controlled substances and

regulated chemicals.

Drug and Chemical Evaluation Section Diversion Control Division Drug Enforcement Administration

November 2026

Abbreviations

2C-B = 4-Bromo-2,5-dimethoxyphenethylamine 2C-T-7 = 2,5-Dimethoxy-4(n)-propylthiophenethylamine BZP = N-Benzylpiperazine DMT = Dimethyltryptamine

DOM= 4-Methyl-2,5-dimethoxyamphetamine
GBL= Gamma butyrolactone
GHB= Gamma hydroxybutyric acid, gamma hydroxybutyrate,

4-hydroxybutanoic acid, sodium oxybate LAAM = Levo-alphacetylmethadol LSD = Lysergic acid diethylamide, lysergide

MDA= 3,4-Methylenedioxyamphetamine
MDE= 3,4-Methylenedioxy-N-ethylamphetamine

MDMA = 3,4-Methylenedioxymethamphetamine MPPP = 1-Methyl-4-phenyl-4-propionoxypiperidine

P2P= Phenyl-2-propanone, phenylacetone
PCC= 1-Piperidinocyclohexanecarbonitrile
PCE= N-Ethyl-1-phenylcyclohexylamine
PCH= 1-Phenylcyclohexylamine
PCP= 1-(1-Phenylcyclohexyl)piperidine, phencyclidine

PEPAP = 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine

PHP= 1-(1-Phenylcyclohexyl)pyrrolidine
SPA= (-)-1-Dimethylamino-1,2-diphenylethane
TCP= 1-[1-(2-Thienyl)cyclohexyl]piperidine
TCPy= 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
THC= Tetrahydrocannabinols
THG= Tetrahydrogestrinone

Alphabetical OrderScheduling Actions

Scheduling Actions

- Alphabetical Order -

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (AM–1220)

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-16-19 84 FR 15505 4/16/2019 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) *

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 03-31-21 86 FR 16669 4/16/2021 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) **

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-07-22 87 FR 20318 4/7/2022 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144)

(1-(5-FLUOROPENTYL)-1H-INDOL-3-YL)(4- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLNAPHTHALEN-1-YL)METHANONE (MAM–2201)

(1-HEXYL-5-PHENYL-1H-PYRROL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–147)

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) *

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-15-15 80 FR 27854 5/15/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) **

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)

(2-IODOPHENYL)(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (AM–2233)

(2-METHYL-1-PENTYL-1H-INDOL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–007)

(4-ETHYLNAPHTHALEN-1-YL)(1-(5-FLUOROPENTYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (EAM–2201)

(4-ETHYLNAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–210)

(4-FLUORONAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–412)

(4-METHOXYNAPHTHALEN-1-YL)(2-METHYL-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (JWH–098)

(4-METHYLNAPHTHALEN-1-YL)(1-(2-MORPHOLINOETHYL)- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1H-INDOL-3-YL)METHANONE (JWH–193)

(5-(2-FLUOROPHENYL)-1-PENTYL-1H-PYRROL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (JWH–307)

(5-METHYL-3-(MORPHOLINOMETHYL)-2,3-DIHYDRO- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I [1,4]OXAZINO[2,3,4-HI]INDOL-6-YL)(NAPHTHALEN-1- YL)METHANONE (WIN 55,212– 2)

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 01-30-15 80 FR 5042 1/30/2015 I YL)METHANONE (THJ-2201) *

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 10-16-17 82 FR 47971 10/16/2017 I YL)METHANONE (THJ-2201)

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11) *

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-15-15 80 FR 27854 5/5/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11) **

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11)

[123I]IOFLUPANE06-03-1509-11-1580 FR 547159/11/2015II → NC
[18F]FP-CIT11-04-2111-21-2287 FR 7071512/21/2022 II → NC
1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3-03-01-2186 FR 118623/1/2021I

DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE) *

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-06-23 88 FR 13692 4/5/2023 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-5,6- 08-27-26 91 FR 55252 8/27/2026 I DICHLORO-1,3-DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6- DICHLORO BRORPHINE, SR–14968) *

1-(1,3-BENZODIOXOL-5-YL)-2-(DIMETHYLAMINO)PENTAN-1- 08-08-25 90 FR 38396 8/8/2025 I ONE (N,N-DIMETHYLPENTYLONE; DIPENTYLONE) (Prior control as a positional isomer of N-ETHYLPENTYLONE: See 90 FR 38396 08/31/2018)

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-31-18 83 FR 44474 8/31/2018 I ONE (N-ETHYLPENTYLONE; EPHYLONE) *

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-27-20 85 FR 52915 8/31/2020 I ONE (N-ETHYLPENTYLONE; EPHYLONE) **

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 06-14-21 86 FR 31427 6/14/2021 I ONE (N-ETHYLPENTYLONE; EPHYLONE)

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) *09-20-0267 FR 591619/20/2002I
1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) **09-10-0368 FR 532899/20/2003I
1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP)09-08-0303-18-0469 FR 127943/19/2004I → NC
1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H-07-10-1883 FR 318777/10/2018I

INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) *

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) **

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)

1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE (AM2201) 04-13-23 01-20-26 91 FR 2297 2/19/2026 I (Prior control under SDAPA: See 78 FR 664 01/04/2013)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-16-19 84 FR 15505 4/16/2019 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 03-31-21 86 FR 16669 4/16/2021 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-07-22 87 FR 20318 4/7/2022 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA)

1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE03-20-8907-06-8954 FR 284147/6/1989I
19-NOR-4,9(10)-ANDROSTADIENEDIONE (ESTRA-4,9(10)-04-25-0812-04-0974 FR 636031/4/2010III

DIENE-3,17-DIONE)

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(2-((2,3-DIHYDROBENZOFURAN-5-YL)METHYL)-5-NITRO- 10-15-25 90 FR 48259 10/15/2025 I 1H-BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (ETHYLENEOXYNITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-12-22 87 FR 21556 4/12/2022 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-11-24 89 FR 25517 4/12/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) **

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-25-24 89 FR 85047 10/25/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE)

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-12-22 87 FR 21556 4/12/2022 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE) *

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-11-24 89 FR 25514 4/11/2024 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE)

2-(2-(4-ETHOXYBENZYL)-5-METHYL-1H-BENZIMIDAZOL-1- 10-15-25 90 FR 48259 10/15/2025 I YL)-N,N-DIETHYLETHAN-1-AMINE (5-METHYL ETODESNITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N,N-DIMETHYLETHAN-1-AMINE (N,N-DIMETHYLAMINO ETONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N-ETHYLETHAN-1-AMINE (N-DESETHYL ETONITAZENE) *

2-(2-(BENZODIOXOL-5-YLMETHYL)-5-NITRO-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (METHYLENEDIOXYNITAZENE; 3′,4′- METHYLENEDIOXYNITAZENE) *

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLDECAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C9 HOMOLOG)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLHEPTAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C6 HOMOLOG)

2-(3-METHOXYPHENYL)-1-(1-PENTYL-1H-INDOL-3-YL)ETHAN-04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1-ONE (JWH–302)

2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25B-NBOMe) *

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25C-NBOMe) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1-YL)ETHYL)- 07-29-24 89 FR 60817 7/29/2024 I 1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1-YL)ETHYL)- 12-23-25 90 FR 59969 1/22/2026 I 1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-12-22 87 FR 21556 4/12/2022 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-11-24 89 FR 25514 4/11/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE)

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe) *

2-(4-ISOPROPOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 10-15-25 90 FR 48259 10/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ISOTONITAZENE) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE) *

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE)

2-(5-HYDROXY-2-(3-HYDROXYPROPYL)CYCLOHEXYL)-5-(2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLOCTAN-2-YL)PHENOL (CP–55,940)

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T- 09-20-02 67 FR 59163 9/20/2002 I 7) *

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T- 09-10-03 68 FR 53289 9/20/2003 I 7) **

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T-09-08-03 03-18-04 69 FR 12794 3/18/2004 I 7)

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC)04-11-2204-11-2287 FR 21069I
2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC)04-11-2208-29-2287 FR 52712I Withdrew

2022 proposed rule

2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET)10-30-8701-14-9358 FR 43162/16/1993I
2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI)04-11-2204-11-2287 FR 21069I
2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI)04-11-2208-29-2287 FR 52712I Withdrew

2022 proposed rule

2,5-DIMETHOXYAMPHETAMINE (DMA)05-31-7309-21-7338 FR 264479/21/1973I
2',5'-DIMETHOXYFENTANYL (N-(1-(2,5-12-07-2388 FR 8510412/7/2023I

DIMETHOXYPHENETHYL)PIPERIDINE-4-YL)-N- PHENYLPROPIONAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2'-FLUORO ORTHO-FLUOROFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2-FLUORODESCHLOROKETAMINE (2-(2-FLUOROPHENYL)-2- 05-22-26 91 FR 30204 5/22/2026 I (METHYLAMINO)CYCLOHEXAN-1-ONE; 2-FDCK) *

2-METHYL AP-237 (1-(2-METHYL-4-(3-PHENYLPROP-2-EN-1- 03-15-24 89 FR 18793 4/15/2024 I YL)PIPERAZIN-1-YL)BUTAN-1-ONE)

3-((4-METHYLNAPHTHALEN-1-YL)METHYL)-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOLE (JWH–184)

3-(3-(1-(1-(4-CHLOROPHENYL)ETHYL)PIPERIDIN-4-YL)-2- 08-27-26 91 FR 55252 8/27/2026 I OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-1- YL)PROPANENITRILE (N-PROPIONITRILE CHLORPHINE, CYCHLORPHINE) *

3,4-DICHLORO-N-[(1- 04-14-16 81 FR 22023 5/15/2016 I DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE (AH- 7921)

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 11-14-16 81 FR 79389 11/14/2016 I METHYLBENZAMIDE (U-47700) *

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 04-20-18 83 FR 17486 4/20/2018 I METHYLBENZAMIDE (U-47700)

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-15-87 52 FR 38225 10/15/1987 I MDEA) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-13-88 53 FR 40061 10/13/1988 I MDEA) **

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-14-88 04-13-89 54 FR 14797 4/13/1989 I MDEA)

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 76 FR 65371 10/21/2011 I (METHYLONE) *

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE)

3,4-METHYLENEDIOXYPYROVALERONE (MDPV) *10-21-1176 FR 6537110/21/2011I
3-CHLOROMETHCATHINONE (3-CMC; 1-(3-11-06-2691 FR 7000911/6/2026I

CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

3-FLUORO-N-METHYLCATHINONE (3-FMC) *03-07-1479 FR 129383/7/2014I
3-FLUORO-N-METHYLCATHINONE (3-FMC) **03-04-1681 FR 114293/4/2016I
3-FLUORO-N-METHYLCATHINONE (3-FMC)03-04-1603-01-1782 FR 121713/1/2017I
3-FURANYL FENTANYL (N-(1-PHENTHYLPIPERIDIN-4-YL)-N-12-07-2388 FR 8510412/7/2023I

PHENYLFURAN-3-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

3-METHOXYPHENCYCLIDINE (1-(1-(3- 03-23-26 91 FR 13733 4/22/2026 I METHOXYPHENYL)CYCLOHEXYL)PIPERIDINE; 3-MEO–PCP)

3-METHYLFENTANYL *03-25-8550 FR 116904/25/1985I
3-METHYLFENTANYL **04-24-8651 FR 154744/25/1986I
3-METHYLFENTANYL04-24-8609-22-8651 FR 335929/22/1986I
3-METHYLTHIOFENTANYL *10-29-8550 FR 4369811/29/1985I
3-METHYLTHIOFENTANYL **11-26-8651 FR 4283411/29/1986I
3-METHYLTHIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
3-MMC (2-(METHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1-12-13-2388 FR 8626612/13/2023I

ONE) (Prior control as a positional isomer of MEPHEDRONE: See 88 FR 86266 07/09/2012)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-26-23 88 FR 48112 7/26/2023 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) *

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 90 FR 35236 7/26/2025 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) **

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM)

4,4′-DIMETHYLAMINOREX (4,4′-DMAR; 4,5-DIHYDRO-4- 04-07-20 08-12-21 86 FR 44270 9/13/2021 I METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE)

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) *07-18-1984 FR 342917/18/2019I
4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) **07-18-2186 FR 376727/18/2021I
4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP)06-01-2287 FR 329966/1/2022I
4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP)04-09-0806-29-1075 FR 372968/30/2010II
4-BROMO-2,5-DIMETHOXYAMPHETAMINE07-02-7309-21-7338 FR 264479/21/1973I
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE *01-06-9459 FR 006711/6/1994I
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE **12-21-9459 FR 657101/6/1995I
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE12-20-9406-02-9560 FR 287186/2/1995I
4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4-07-18-1984 FR 342917/18/2019I

CHLORO-α-PVP) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 07-18-21 86 FR 37672 7/18/2021 I CHLORO-α-PVP) **

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 06-01-22 87 FR 32996 6/1/2022 I CHLORO-α-PVP)

4-CHLOROMETHCATHINONE (4-CMC, 1-(4- 11-17-25 90 FR 51102 12/17/2025 I CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

4-FLUOROAMPHETAMINE (4–FA, 1-(4- 06-03-25 01-15-26 91 FR 1692 2/17/2026 I FLUOROPHENYL)PROPAN-2-AMINE, PARA- FLUOROAMPHETAMINE)

4-FLUORO-N-METHYLCATHINONE (4-FMC) *03-07-1479 FR 129383/7/2014I
4-FLUORO-N-METHYLCATHINONE (4-FMC) **03-04-1681 FR 114293/4/2016I
4-FLUORO-N-METHYLCATHINONE (4-FMC)03-04-1603-01-1782 FR 121713/1/2017I
4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE-12-12-2388 FR 8604012/12/2023I

3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)01-14-2201-14-2287 FR 2376I
4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)01-14-2207-27-2287 FR 45076I Withdrew

2022 proposed rule

4-METHOXYAMPHETAMINE (PMA)07-02-7309-21-7338 FR 264479/21/1973I
4'-METHYL ACETYL FENTANYL (Prior control under Temporary04-27-2186 FR 221134/27/2021I

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-19 84 FR 34291 7/18/2019 I *

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-21 86 FR 37672 7/18/2021 I **

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP)06-01-2287 FR 329966/1/2022I
4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-03-07-1479 FR 129383/7/2014I

MePPP) *

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 81 FR 11429 3/4/2016 I MePPP) **

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 03-01-17 82 FR 12171 3/1/2017 I MePPP)

4-METHYLAMINOREX *10-15-8752 FR 3822510/15/1987I
4-METHYLAMINOREX **10-13-8853 FR 4006110/13/1988I
4-METHYLAMINOREX10-14-8804-13-8954 FR 147994/13/1989I
4-METHYL-N-ETHYLCATHINONE (4-MEC) *03-07-1479 FR 129383/7/2014I
4-METHYL-N-ETHYLCATHINONE (4-MEC) **03-04-1681 FR 114293/4/2016I
4-METHYL-N-ETHYLCATHINONE (4-MEC)03-04-1603-01-1782 FR 121713/1/2017I
4-METHYL-N-METHYLCATHINONE (MEPHEDRONE) *10-21-1176 FR 6537110/21/2011I
5,6-DICHLORO-1-(1-(4-CHLOROBENZYL)PIPERIDIN-4-YL)-1,3-08-27-2691 FR 552528/27/2026I

DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6-DICHLORO DESMETHYLCHLORPHINE,SR–17018) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-12-23 88 FR 86040 12/12/2023 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-16-25 90 FR 58149 12/12/2025 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT)01-14-2201-14-2287 FR 2376I
5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT)01-14-2207-27-2287 FR 45076I Withdrew

2022 proposed rule

5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET)01-14-2201-14-2287 FR 2376I
5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET)01-14-2207-27-2287 FR 45076I Withdrew

2022 proposed rule

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) *04-04-0368 FR 164274/4/2003I
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) **04-01-0469 FR 170344/1/2004I
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT)09-29-0469 FR 580509/29/2004I
5-METHOXY-N,N-DIMETHYLTRYPTAMINE08-21-0912-20-1075 FR 792961/19/2011I
5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-2201-14-2287 FR 2376I

MiPT)

5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-2207-27-2287 FR 45076I Withdrew
MiPT)2022

proposed rule

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE) *

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE)

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-12-23 88 FR 86040 12/12/2023 I 1-ONE (CUMYL-PEGACLONE, SGT-151) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 90 FR 57542 12/12/2025 I 1-ONE (CUMYL-PEGACLONE, SGT-151) **

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 05-13-26 91 FR 26913 5/13/2026 I 1-ONE (CUMYL-PEGACLONE, SGT-151)

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) *

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) **

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM)

6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,9,10,10A-HEXAHYDRO- 05-04-26 91 FR 23913 5/4/2026 I 6H-BENZO[C]CHROMEN-1-OL (HEXAHYDROCANNABINOL, HHC)

6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5- 01-24-20 85 FR 4215 1/24/2020 II → NC EPOXYMORPHINAN-3,6,14-TRIOL)

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-26-23 88 FR 48112 7/26/2023 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) *

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 90 FR 35236 7/26/2025 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) **

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM)

8-(1-(4-CHLOROPHENYL)ETHYL)-1-PHENYL-1,3,8- 08-27-26 91 FR 55252 8/27/2026 I TRIAZASPIRO[4.5]DECAN-4-ONE (SPIROCHLORPHINE, R–6890) *

8-BROMO-1-METHYL-6-PHENYL-4H- 03-16-26 91 FR 12504 3/16/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (BROMAZOLAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) **

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM)

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) *

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) **

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM)

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-17-15 80 FR 42381 7/17/2015 I PHENYLACETAMIDE) *

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 06-07-17 82 FR 26349 6/7/2017 I PHENYLACETAMIDE)

ACETYL-ALPHA-METHYLFENTANYL *10-29-8550 FR 4369811/29/1985I
ACETYL-ALPHA-METHYLFENTANYL **11-26-8651 FR 4283411/29/1986I
ACETYL-ALPHA-METHYLFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-07-14-1782 FR 324537/14/2017I

PHENYLACRYLAMIDE) *

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-29-18 83 FR 61320 11/29/2018 I PHENYLACRYLAMIDE)

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-12-23 88 FR 86040 12/12/2023 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) *

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-16-25 90 FR 58149 12/12/2025 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) **

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE)

ADB-BUTINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2- 12-13-23 88 FR 86266 12/13/2023 I YL)-1-BUTYL-1H-INDAZOLE-3-CARBOXAMIDE) (Prior control as a positional isomer of AB-PINACA: See 88 FR 86266 01/30/2015)

ALFAXALONE (5α-PREGNAN-3α-OL-11,20-DIONE)03-25-1302-27-1479 FR 109853/31/2014IV
ALFENTANIL06-25-8449 FR 258498/24/1984I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

ALFENTANIL04-17-8601-23-8752 FR 25161/23/1987I → II
ALPHA-ETHYLTRYPTAMINE *03-12-9358 FR 135333/12/1993I
ALPHA-ETHYLTRYPTAMINE **03-07-9459 FR 107203/12/1994I
ALPHA-ETHYLTRYPTAMINE03-07-9409-12-9459 FR 467579/12/1994I
ALPHA'-METHYL BUTYRYL FENTANYL (2-METHYL-N-(1-12-07-2388 FR 8510412/7/2023I

PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ALPHA-METHYLFENTANYL08-05-8109-22-8146 FR 467999/22/1981I
ALPHA-METHYLTHIOFENTANYL *10-29-8550 FR 4369811/29/1985I
ALPHA-METHYLTHIOFENTANYL **11-26-8651 FR 4283411/29/1986I
ALPHA-METHYLTHIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
ALPHA-METHYLTRYPTAMINE (AMT) *04-04-0368 FR 164274/4/2003I
ALPHA-METHYLTRYPTAMINE (AMT) **04-01-0469 FR 170344/1/2004I
ALPHA-METHYLTRYPTAMINE (AMT)09-29-0469 FR 580509/29/2004I
ALPHA-PIHP (4-METHYL-1-PHENYL-2-(PYRROLIDIN-1-12-13-2388 FR 8626612/13/2023I

YL)PENTAN-1-ONE) (Prior control as a positional isomer of A- PHP: See 88 FR 86266 07/18/2019)

ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) *03-07-1479 FR 129383/7/2014I
ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) **03-04-1681 FR 114293/4/2016I
ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP)03-04-1603-01-1782 FR 121713/1/2017I
ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) *07-18-1984 FR 342917/18/2019I
ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) **07-18-2186 FR 376727/18/2021I
ALPHA-PYRROLIDINOHEPTAPHENONE (PV8)06-01-2287 FR 329966/1/2022I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) *07-18-1984 FR 342917/18/2019I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) **07-18-2186 FR 376727/18/2021I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP)06-01-2287 FR 329966/1/2022I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) *03-07-1479 FR 129383/7/2014I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) **03-04-1681 FR 114293/4/2016I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP)03-04-1603-01-1782 FR 121713/1/2017I
ALPRAZOLAM04-29-8111-12-8146 FR 5568811/12/1981IV
AMINEPTINE (7-[(10,11-DIHYDRO-5H-07-22-2211-17-2287 FR 6889512/19/2022I

DIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO]HEPTANOIC ACID)

AMINOREX *09-21-9257 FR 433999/21/1992I
AMINOREX **08-24-9358 FR 446119/21/1993I
AMINOREX08-20-9303-18-9459 FR 128283/18/1994I
AMOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
AMPHETAMINE05-26-7107-07-7136 FR 127347/7/1971III → II
ANABOLIC STEROIDSPL 101-64702-13-9156 FR 57532/27/1991III
ANABOLIC STEROIDSPL 108-35812-16-0570 FR 746531/17/2006III
ANABOLIC STEROIDS (amended regulations consistent with08-01-2388 FR 500368/1/2023III

DASCA; updated and moved specific listing to 21 CFR 1308.13(f))

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

APOMORPHINE04-08-7606-28-7641 FR 265686/28/1976II → NC
APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD09-28-1883 FR 489539/28/2018V

AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 08-21-20 85 FR 51639 8/21/2020 V → NC AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

BENZPHETAMINE05-09-7306-15-7338 FR 157196/15/1973III
BENZYLFENTANYL*10-29-8550 FR 4369811/29/1985 I Expired

11/29/86

BETA-HYDROXY-3-METHYLFENTANYL *10-29-8550 FR 4369811/29/1985I
BETA-HYDROXY-3-METHYLFENTANYL **11-26-8651 FR 4283411/29/1986 I Expired

5/29/87

BETA-HYDROXY-3-METHYLFENTANYL11-28-8601-08-8853 FR 5001/8/1988I
BETA-HYDROXYFENTANYL *10-29-8550 FR 4369811/29/1985I
BETA-HYDROXYFENTANYL **11-26-8651 FR 4283411/29/1986I
BETA-HYDROXYFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
BETA-HYDROXYTHIOFENTANYL *05-12-1681 FR 294925/12/2016I
BETA-HYDROXYTHIOFENTANYL05-08-1984 FR 200235/8/2019I
BETA-METHYL FENTANYL (Prior control under Temporary04-27-2186 FR 221134/27/2021I

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 12-30-24 89 FR 106311 12/31/2024 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 09-18-25 90 FR 44979 9/18/2025 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA'-PHENYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BIPHETAMINE & BIPHETAMINE-T05-26-7107-23-7136 FR 136867/23/1971III → II
BOLDIONE (ANDROSTA-1,4-DIENE-3,17-DIONE)04-25-0812-04-0974 FR 636031/4/2010III
BREXANOLONE (3α-HYDROXY-5α-PREGNAN-20-ONE),06-17-1984 FR 279386/17/2019IV

ALLOPREGNANOLONE

BRIVARACETAM (BRV; UCB-34714; BRIVIACT)05-12-1681 FR 294875/12/2016V
BROMAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
BUPRENORPHINE09-20-8202-28-8550 FR 81044/1/1985II → V
BUPRENORPHINE03-21-0210-07-0267 FR 6235410/7/2002V → III
BUTORPHANOL07-10-9710-01-9762 FR 5137010/31/1997IV
BUTORPHANOL, THEBAINE DERIVED04-03-9207-14-9257 FR 311267/14/1992II → NC

Superseded 10/97

BUTYLONE *03-07-1479 FR 129383/7/2014I
BUTYLONE **03-04-1681 FR 114293/4/2016I
BUTYLONE03-04-1603-01-1782 FR 121713/1/2017I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

BUTYRYL FENTANYL*05-12-1681 FR 294925/12/2016I
CAMAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
CANNABIMIMETIC AGENTS (as defined in 21 CFR §04-13-2301-20-2691 FR 22972/19/2026I

1308.11(g))

CARFENTANIL01-12-8810-28-8853 FR 4368410/28/1988II
CARISOPRODOL11-17-0912-12-1176 FR 773301/11/2012IV
CATHINE10-30-8705-17-8853 FR 174596/16/1988IV
CATHINONE10-30-8701-14-9358 FR 43162/16/1993I
CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2-03-10-2085 FR 137413/10/2020V

YL)ETHYL]CARBAMATE

CENTANAFADINE10-30-2691 FR 6847010/30/2026III
CHLORDIAZEPOXIDE01-27-7506-04-7540 FR 239987/2/1975IV
CHLORPHENTERMINE05-09-7306-15-7338 FR 157196/15/1973III
CIPEPOFOL08-27-2691 FR 552598/27/2026IV
CLOBAZAM08-01-8410-05-8449 FR 3930711/5/1984IV
CLONAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
CLORAZEPATE01-27-7506-04-7540 FR 239987/2/1975IV
CLORTERMINE05-09-7306-15-7338 FR 157196/15/1973III
CLOTIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
CLOXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
CONCENTRATE OF POPPY STRAW12-20-7402-14-7540 FR 67792/14/1975II
CP-47,497 C8 HOMOLOGUE *03-01-1176 FR 110753/1/2011I
CP-47,497 C8 HOMOLOGUE **02-29-1277 FR 122012/29/2012I
CP-47,497 C8 HOMOLOGUE (Consolidated under04-13-2301-20-2691 FR 22972/19/2026I

"CANNABIMIMETIC AGENTS" as defined in 21 CFR § 1308.11(g))

CP-47,497 *03-01-1176 FR 110753/1/2011I
CP-47,497 **02-29-1277 FR 122012/29/2012I
CP-47,497 (Consolidated under "CANNABIMIMETIC AGENTS"04-13-2301-20-2691 FR 22972/19/2026I

as defined in 21 CFR § 1308.11(g))

CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4- 10-02-20 85 FR 62215 10/2/2020 I YL)-N-PHENYLBUT-2-ENAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 01-04-18 83 FR 469 1/4/2018 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) *

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)

DARIDOREXANT (QUVIVIQ)04-07-2287 FR 203134/7/2022IV
DELORAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
DESOXYMETHYLTESTOSTERONE (17α-METHYL-5α-04-25-0812-04-0974 FR 636031/4/2010III

ANDROST-2-EN-17-OL; MADOL)

DEXTROPROPOXYPHENE09-29-7602-11-7742 FR 86363/14/1977IV
DEXTROPROPOXYPHENE01-21-8006-24-8045 FR 422647/24/1980IV
DEXTROPROPOXYPHENE (BULK)07-22-8045 FR 488819/22/1980IV → II

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

DEXTRORPHAN04-19-7610-01-7641 FR 4340110/1/1976I → NC
DIAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
DICHLORALPHENAZONE (chloral hydrate compound)12-11-0008-16-0166 FR 429438/16/2001 clarification

of CIV control

DIETHYLPROPION05-10-7307-06-7338 FR 180137/6/1973IV
DIFENOXIN05-07-7540 FR 198136/1/1975I
DIFENOXIN 1 MG WITH ATROPINE06-26-7808-28-7843 FR 383829/27/1978I → IV
DIFENOXIN 1/2 MG WITH ATROPINE06-26-7808-28-7843 FR 383829/27/1978I → V
DIHYDROETORPHINE (thebaine derivative)11-17-0065 FR 6944211/17/2000 clarification

of CII control

DIPHENIDINE (1-(1,2-DIPHENYLETHYL)PIPERIDINE)05-26-2609-21-2691 FR 5969510/21/2026I
DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT03-23-1782 FR 148153/23/2017II

APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMINISTRATION

DRONABINOL PRODUCT (MARINOL)10-18-8505-13-8651 FR 174765/13/1986I → II
DRONABINOL PRODUCT (MARINOL)11-05-9807-02-9964 FR 359287/2/1999II → III
DROTEBANOL07-03-7338 FR 177178/6/1973I
ELUXADOLINE08-11-1511-12-1580 FR 6986112/17/2015IV
EMBUTRAMIDE07-29-0508-29-0671 FR 511159/28/2006III
ESKATROL05-26-7108-18-7136 FR 157448/18/1971III → II
ESTAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-04-16-1984 FR 155054/16/2019I

CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) *

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) **

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA)

ETHYL LOFLAZEPATE08-01-8410-05-8449 FR 3930711/5/1984IV
ETHYLONE (Prior control as a positional isomer of BUTYLONE:06-08-2085 FR 346076/8/2020I

See 85 FR 34967 03/07/2014)

ETHYLPHENIDATE (ETHYL 2-PHENYL-2-(PIPERIDIN-2- 09-22-23 10-22-24 89 FR 84281 11/21/2024 I YL)ACETATE)

ETORPHINE HYDROCHLORIDE11-23-7303-29-7439 FR 115354/19/1974I → II
EUTYLONE (1-(1,3-BENZODIOXOL-5-YL)-2-04-10-2388 FR 211014/10/2023I

(ETHYLAMINO)BUTAN-1-ONE) (Prior control as a positional isomer of PENTYLONE: See 88 FR 21101 03/07/2014)

EZOGABINE10-21-1112-15-1176 FR 7789512/15/2011V
FENCAMFAMIN10-30-8705-17-8853 FR 174596/16/1988IV
FENETHYLLINE05-01-8107-21-8146 FR 375038/20/1981I
FENFLURAMINE05-09-7306-15-7338 FR 157196/15/1973IV
FENFLURAMINE05-06-9705-06-9762 FR 24620IV → NC

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

FENFLURAMINE 05-06-97 05-15-03 68 FR 26247 IV Withdrew 97 proposed rule

FENFLURAMINE07-19-2212-23-2287 FR 7885712/23/2022 IV → NC
FENPROPOREX10-30-8705-17-8853 FR 174596/16/1988IV
FENTANYL CARBAMATE (Prior control under Temporary Order05-04-2186 FR 236025/4/2021I

for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 CFR 02-06-18 83 FR 5188 2/6/2018 I 1308.11(h)*

FETAMIN05-26-7107-23-7136 FR 136867/23/1971III → II
FLUDIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
FLUNITRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
FLURAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
FOSPROPOFOL07-23-0910-06-0974 FR 5123411/5/2009IV
FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4-11-03-1782 FR 5115411/3/2017I

FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) *

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 03-30-20 85 FR 17494 3/30/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE)

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 10-30-19 84 FR 58045 11/3/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) **

GAMMA HYDROXYBUTYRIC ACID (GHB)PL 106-17203-13-0065 FR 132353/13/2000I
GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drugPL 106-17203-13-0065 FR 132353/13/2000III

products

GANAXOLONE (3α-HYDROXY-3β-METHYL-5α-PREGNAN-20- 06-01-22 87 FR 32991 6/1/2022 V ONE)

GLUTETHIMIDE07-26-9003-21-9156 FR 119303/21/1991III → II
HALAZEPAM04-29-8110-29-8146 FR 5340710/29/1981IV
HALOXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
HYDROCODONE COMBINATION PRODUCTS02-27-1408-22-1479 FR 4966110/6/2014III → II
INDIPLON01-31-0801-31-081/31/2008IV
ISOTONITAZENE (N,N-DIETHYL-2-(2-(408-20-2085 FR 513428/20/2020I

ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE) *

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 11-04-21 86 FR 60761 12/6/2021 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE)

ISOVALERY FENTANYL (3-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

JWH–018 *03-01-1176 FR 110753/1/2011I
JWH–018 **02-29-1277 FR 122012/29/2012I
JWH–01801-04-1378 FR 6641/4/2013I
JWH–018 (Reclassified under 21 CFR § 1308.11(d))04-13-2301-20-2691 FR 22972/19/2026I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

JWH–073 *03-01-1176 FR 110753/1/2011I
JWH–073 **02-29-1277 FR 122012/29/2012I
JWH–073 (Consolidated under "CANNABIMIMETIC AGENTS"04-13-2301-20-2691 FR 22972/19/2026I

as defined in 21 CFR § 1308.11(g))

JWH–200 *03-01-1176 FR 110753/1/2011I
JWH–200 **02-29-1277 FR 122012/29/2012I
JWH–200 (Consolidated under "CANNABIMIMETIC AGENTS"04-13-2301-20-2691 FR 22972/19/2026I

as defined in 21 CFR § 1308.11(g))

KETAMINE04-09-9907-13-9964 FR 376738/12/1999III
KETAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
LACOSAMIDE03-10-0905-21-0974 FR 237896/22/2009V
LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE-01-31-2085 FR 55571/31/2020V

4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE]

LEMBOREXANT04-07-2085 FR 193874/7/2020IV
LEVO-ALPHACETYLMETHADOL (LAAM)04-28-9308-18-9358 FR 437958/18/1993I → II
LIBRAX06-05-7511-11-7540 FR 5260911/28/1975 Exempted

RX

LISDEXAMFETAMINE02-22-0705-03-0772 FR 245326/4/2007II
LOPERAMIDE07-29-7605-18-7742 FR 254986/17/1977V
LOPERAMIDE07-28-8211-03-8247 FR 4984011/3/1982V → NC
LOPRAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
LORAZEPAM06-28-7710-07-7742 FR 5454610/3/1977IV
LORCASERIN12-19-1205-08-1378 FR 267016/7/2013IV
LORMETAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
MARIJUANA EXTRACT, AS DEFINED IN 21 CFR04-28-2691 FR 227144/28/2026III

1308.11(D)(58), IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

MARIJUANA, AS DEFINED IN 21 U.S.C. 802(16), IN A U.S. 04-28-26 91 FR 22714 4/28/2026 III FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

MAZINDOL05-09-7306-15-7338 FR 157196/15/1973III
MAZINDOL04-17-8110-27-8146 FR 5233311/27/1981III → IV
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) *05-31-8550 FR 231187/1/1985I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) **06-17-8651 FR 219117/1/1986I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)07-27-8410-14-8651 FR 3655211/13/1986I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)01-27-8853 FR 22251/27/1988I → NC
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)02-22-8853 FR 51563/23/1988I
MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4-12-12-2388 FR 8604012/12/2023I

EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) *

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-11-25 90 FR 57356 12/12/2025 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) **

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 10-02-25 04-24-26 91 FR 21958 4/27/2026 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE)

MEBUTAMATE12-13-7401-30-7540 FR 44181/30/1975IV
MECLOQUALONE05-29-7507-08-7540 FR 286117/10/1975I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

MEDAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
MEFENOREX10-30-8705-17-8853 FR 174596/16/1988IV
MENRIUM06-05-7511-11-7540 FR 5260911/28/1975 Exempted

RX

MESOCARB (N-PHENYL-N'-(3-(1-PHENYLPROPAN-2-YL)- 08-11-21 11-22-22 87 FR 71247 12/22/2022 I 1,2,3-OXADIAZOL-3-IUM-5-YL)CARBAMIMIDATE)

META-FLUOROFENTANYL (N-(3-FLUORPHENYL)-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 12-30-24 89 FR 106311 12/31/2024 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2-CARBOXAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 09-18-25 90 FR 44979 9/18/2025 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2- CARBOXAMIDE (Prior control under Temporary Order Fentanyl- Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROISOBUTYRYL FENTANYL (N-(3- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

METHAMPHETAMINE05-26-7107-07-7136 FR 127347/7/1971III → II
METHAQUALONE04-11-7310-04-7338 FR 2751610/4/1973II
METHAQUALONE08-27-8449 FR 338708/27/1984II → I
METHASTERONE (2α,17α-DIMETHYL-5α-ANDROSTAN-17β-11-23-1107-30-1277 FR 444568/29/2012III

OL-3-ONE)

METHCATHINONE *05-01-9257 FR 188245/1/1992I
METHCATHINONE **04-29-9358 FR 259345/1/1993I
METHCATHINONE04-28-9310-15-9358 FR 5340410/15/1993I
METHIOPROPAMINE (N-METHYL-1-(THIOPHEN-2-09-02-2112-09-2287 FR 754701/9/2023I

YL)PROPANE-2-AMINE)

METHOXETAMINE12-07-2106-07-2287 FR 341667/6/2022I
METHOXYACETYL FENTANYL (2-METHOXY-N-(1-10-26-1782 FR 4950410/26/2017I

PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) *

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-25-19 84 FR 57323 10/25/2019 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

METHYL (E)-2-((1′S,6′S,7′S)-6′-ETHYL-4-METHOXY-3-OXO- 08-26-26 91 FR 54948 8/26/2026 I 3′,5′,6′,7′,8′,8A′-HEXAHYDRO-2′H-SPIRO[INDOLINE-2,1′- INDOLIZINE]-7′-YL)-3-METHOXYACRYLATE (MITRAGYNINE PSEUDOINDOXYL) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-7A- 08-26-26 91 FR 54948 8/26/2026 I HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–15, DIHYDRO-7- HYDROXYMITRAGYNINE) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-9-FLUORO- 08-26-26 91 FR 54948 8/26/2026 I 7A-HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–16) *

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB–FUBINACA) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA) **

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA)

METHYL 2-(1-(4-FLUOROBUTYL)-1H-INDAZOLE-3- 06-22-21 86 FR 32633 6/22/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (4F-MDMB- BINACA) (Prior control as a positional isomer of 5F-AMB: See 86 FR 32633 04/10/2017)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA)

METHYLPHENIDATE09-17-7110-28-7136 FR 2068610/28/1971III → II
MIDAZOLAM02-07-8603-25-8651 FR 101903/25/1986IV

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) *

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) **

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE)

MODAFINIL04-14-9801-27-9964 FR 40501/27/1999IV
MPPP *07-10-8550 FR 280988/12/1985I
MPPP **08-11-8651 FR 286958/12/1986I
MPPP08-11-8601-23-8752 FR 25151/23/1987I
MT-45 (1-CYCLOHEXYL-4-(1,2-12-13-1782 FR 585571/12/2018I

DIPHENYLETHYL)PIPERAZINE))

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-16-13 78 FR 28735 5/16/2013 I CARBOXAMIDE (APINACA, AKB48) *

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-15-15 80 FR 27854 5/15/2015 I CARBOXAMIDE (APINACA; AKB48) **

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-11-16 81 FR 29142 5/11/2016 I CARBOXAMIDE (APINACA; AKB48)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-10-17 82 FR 17119 4/10/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-08-19 84 FR 13796 4/8/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 01-24-20 85 FR 4211 1/24/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB- FUBINACA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 02-05-16 81 FR 6171 2/5/2016 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-30-18 83 FR 4411 1/30/2018 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-29-19 84 FR 444 1/29/2019 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-10-14 79 FR 7577 2/10/2014 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-05-16 81 FR 6175 2/5/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 09-06-16 81 FR 61130 9/6/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-10-14 79 FR 7577 2/10/2014 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-05-16 81 FR 6175 2/5/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 09-06-16 81 FR 61130 9/6/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA)

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-10-18 83 FR 31877 7/10/2018 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-13-20 85 FR 42296 7/10/2020 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 06-10-21 86 FR 30775 6/10/2021 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 01-30-15 80 FR 5042 1/30/2015 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 10-16-17 82 FR 47971 10/16/2017 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 01-30-15 80 FR 5042 1/30/2015 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 10-16-17 82 FR 47971 10/16/2017 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE 04-20-18 83 FR 17486 4/20/2018 I (BUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-16 81 FR 85873 11/29/2016 I CARBOXAMIDE (FURANYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-18 83 FR 61320 11/29/2018 I CARBOXAMIDE (FURANYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 02-01-18 83 FR 4580 2/1/2018 I (VALERYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 01-30-20 85 FR 5321 2/1/2020 I (VALERYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 11-25-20 85 FR 75231 11/25/2020 I (VALERYL FENTANYL)

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 02-01-18 83 FR 4580 2/1/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) *

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) *

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) **

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 05-03-17 82 FR 20544 5/3/2017 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-29-18 83 FR 61320 11/29/2018 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) *

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) **

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-16-19 84 FR 15505 4/16/2019 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) *

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 03-31-21 86 FR 16669 4/16/2021 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) **

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-07-22 87 FR 20318 4/7/2022 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA)

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-10-17 82 FR 17119 4/10/2017 I 3-CARBOXAMIDE (5F–APINACA; 5F–AKB48) *

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-08-19 84 FR 13796 4/8/2019 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48) **

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 01-24-20 85 FR 4211 1/24/2020 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48)

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) *

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-11-24 89 FR 25517 4/12/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) **

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 10-25-24 89 FR 85047 10/25/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-12-22 87 FR 21556 4/12/2022 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-11-24 89 FR 25517 4/12/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) **

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 10-25-24 89 FR 85047 10/25/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 08-18-23 88 FR 56466 9/18/2023 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE)

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE) *

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-11-24 89 FR 25514 4/11/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE)

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N,N-DIISOPROPYLTRYPTAMINE (DiPT)01-14-2201-14-2287 FR 2376I
N,N-DIISOPROPYLTRYPTAMINE (DiPT)01-14-2207-27-2287 FR 45076I Withdrew

2022 proposed rule

N,N-DIMETHYLAMPHETAMINE *08-03-8853 FR 292328/3/1988I
N,N-DIMETHYLAMPHETAMINE **08-02-8954 FR 318158/2/1989I
N,N-DIMETHYLAMPHETAMINE08-02-8902-02-9055 FR 35862/2/1990I
NABILONE06-18-8604-07-8752 FR 110424/7/1987II
NALBUPHINE05-11-7610-01-7641 FR 4340110/1/1976II → NC
NALMEFENE05-31-8511-04-8550 FR 4581511/4/1985II → NC
NALOXEGEL10-29-1401-23-1580 FR 34681/23/2015II → NC
NALOXONE07-10-7412-24-7439 FR 4439212/24/1974 II → NC
NALOXONE HYDROCHLORIDE08-19-7109-29-7136 FR 191169/29/1971II → NC
NALTREXONE12-09-7403-06-7540 FR 104553/6/1975II → NC
NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-07-10-1883 FR 318777/10/2018I

CARBOXYLATE (NM2201; CBL2201) *

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXYLATE (NM2201; CBL2201) **

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXYLATE (NM2201; CBL2201)

NAPHTHALEN-1-YL(1-(PENT-4-EN-1-YL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–022)

NAPHYRONE *03-07-1479 FR 129383/7/2014I
NAPHYRONE **03-04-1681 FR 114293/4/2016I
NAPHYRONE03-04-1603-01-1782 FR 121713/1/2017I
NATURALLY DERIVED DELTA-9-04-28-2691 FR 227144/28/2026III

TETRAHYDROCANNABINOLS IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR IN MARIJUANA SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

N-BENZYLPIPERAZINE (BZP) *09-20-0267 FR 591619/20/2002I
N-BENZYLPIPERAZINE (BZP) **09-10-0368 FR 532899/20/2003I
N-BENZYLPIPERAZINE (BZP)09-08-0303-18-0469 FR 127943/18/2004I
N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H-07-29-2489 FR 608177/29/2024I

BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE) *

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 12-23-25 90 FR 59969 1/22/2026 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE)

N-ETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL PROTONITAZENE) *

N-ETHYLAMPHETAMINE09-10-8112-08-8146 FR 599691/7/1982I
N-ETHYLHEXEDRONE *07-18-1984 FR 342917/18/2019I
N-ETHYLHEXEDRONE **07-18-2186 FR 376727/18/2021I
N-ETHYLHEXEDRONE06-01-2287 FR 329966/1/2022I
N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE *10-15-8752 FR 3822510/15/1987I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE **10-13-8853 FR 4006110/13/1988I
N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE10-14-8804-13-8954 FR 147974/13/1989I
NIMETAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NITRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NORDIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NORFENTANYL (N-PHENYL-N-(PIPERIDIN-4-09-17-1904-17-2085 FR 213205/18/2020II

YL)PROPIONAMIDE)

O-DESMETHYLTRAMADOL (O-DSMT; DESMETRAMADOL; 3- 08-12-26 91 FR 52013 8/12/2026 I [(1R,2R)-2-[(DIMETHYLAMINO)METHYL]-1- HYDROXYCYCLOHEXYL]PHENOL) *

OLICERIDINE10-30-2085 FR 6874910/30/2020II
ORIPAVINE09-24-0772 FR 542089/24/2007II
ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1-12-30-2489 FR 106311 12/31/2024I

PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROACRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROBUTYRYL FENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-26-17 82 FR 49504 10/26/2017 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) *

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-25-19 84 FR 57323 10/25/2019 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))

ORTHO-FLUOROFURANYL FENTANYL (N-(2- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)FURAN- 2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROISOBUTYRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL ACETYLFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL METHOXYACETYL FENTANYL (Prior control 04-27-21 86 FR 22113 4/27/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 12-30-24 89 FR 106311 12/31/2024 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 09-18-25 90 FR 44979 9/18/2025 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

OVEPOREXTON11-12-2691 FR 7277511/12/2026IV
OXAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
OXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1-12-30-2489 FR 106311 12/31/2024I

PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO FURANYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 12-30-24 89 FR 106311 12/31/2024 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 09-18-25 90 FR 44979 9/18/2025 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUOROFENTANYL *02-07-8651 FR 47223/10/1986I
PARA-FLUOROFENTANYL **03-10-8752 FR 72703/10/1987I
PARA-FLUOROFENTANYL03-10-8705-29-8752 FR 200705/29/1987I
PARAHEXYL08-05-8211-22-8247 FR 5243212/22/1982I
PARA-METHOXYFURANYL FENTANYL (N-(4-12-07-2388 FR 8510412/7/2023I

METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)FURAN-2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4- 05-15-20 06-25-21 86 FR 33508 7/26/2021 I METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE

PARA-METHYLCYCLOPROPYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHYLPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)CYCLOPROPANECARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLFENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PCC (PCP PRECURSOR)03-20-7805-17-7843 FR 213246/16/1978II
PCE (PCP ANALOG)08-11-7809-25-7843 FR 4329510/25/1978I
PCH (PCP PRECURSOR)03-20-7805-17-7843 FR 213246/16/1978II
PEMOLINE11-07-7401-28-7540 FR 41501/28/1975IV
PENTAZOCINE09-13-7801-10-7944 FR 21692/9/1979IV
PENTEDRONE *03-07-1479 FR 129383/7/2014I
PENTEDRONE **03-04-1681 FR 114293/4/2016I
PENTEDRONE03-04-1603-01-1782 FR 121713/1/2017I
PENTOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
PENTYLONE *03-07-1479 FR 129383/7/2014I

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

PENTYLONE **03-04-1681 FR 114293/4/2016I
PENTYLONE03-04-1603-01-1782 FR 121713/1/2017I
PEPAP *07-10-8550 FR 280988/12/1985I
PEPAP **08-11-8651 FR 286958/12/1986I
PEPAP08-11-8601-23-8752 FR 25151/23/1987I
PERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2-10-22-1312-02-1378 FR 720131/2/2014III

DIHYDROPYRIDIN-3-YL)BENZONITRILE]

PHENCYCLIDINE (PCP)12-19-7701-25-7843 FR 33592/24/1978III → II
PHENDIMETRAZINE05-09-7306-15-7338 FR 157196/15/1973III
PHENMETRAZINE09-17-7110-28-7136 FR 2068610/28/1971III → II
PHENTERMINE05-09-7307-06-7338 FR 180137/6/1973IV
PHENYL FENTANYL (Prior control under Temporary Order for04-27-2186 FR 221134/27/2021I

Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PHENYLACETONE (P2P)12-12-7944 FR 718222/11/1980II
PHP (PCP ANALOG)08-11-7809-25-7843 FR 4329510/25/1978I
PINAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
PIPRADROL09-30-8045 FR 6457012/1/1980IV
PRAZEPAM07-29-7612-17-7641 FR 5517612/17/1976IV
PREGABALIN05-12-0507-28-0570 FR 436337/28/2005V
PROPIRAM01-29-7237 FR 14681/29/1972I
PROPYLHEXEDRINE10-30-8704-04-8853 FR 108695/4/1988V
PROPYLHEXEDRINE12-03-9156 FR 6137212/3/1991V → NC
PROSTANOZOL (17β-HYDROXY-5α-ANDROSTANO[3,2-11-23-1107-30-1277 FR 444568/29/2012III

C]PRYAZOLE)

PYROVALERONE10-30-8704-04-8853 FR 108695/4/1988V
QUAZEPAM02-07-8603-25-8651 FR 101903/25/1986IV
QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-02-10-1479 FR 75772/10/2014I

CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) *

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-05-16 81 FR 6175 2/5/2016 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) **

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 09-06-16 81 FR 61130 9/6/2016 I CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB–22; QUPIC) *

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-05-16 81 FR 6175 2/5/2016 I (PB–22; QUPIC) **

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB- 09-06-16 81 FR 61130 9/6/2016 I 22; QUPIC)

REMIFENTANIL09-16-9611-05-9661 FR 5689311/5/1996II
REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE-4-10-06-2085 FR 6301410/6/2020IV

PROPIONIC ACID)

SAMIDORPHAN04-19-2186 FR 202844/19/2021II → NC
SECOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
SERDEXMETHYLPHENIDATE05-07-2186 FR 244875/7/2021IV
SIBUTRAMINE12-08-9702-11-9863 FR 68622/11/1998IV

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CAR-BAMATE; 06-17-19 84 FR 27943 6/17/2019 IV BENZENEPROPANOL,BETA-AMINO-, CARBAMATE (ESTER))

SPA (LEFETAMINE)09-30-8045 FR 6457012/1/1980IV
SUFENTANIL09-30-8045 FR 6457112/1/1980I
SUFENTANIL03-20-8405-25-8449 FR 220745/25/1984I → II
SUVOREXANT02-13-1408-28-1479 FR 521439/29/2014IV
Synthetic Drug Abuse Prevention Act of 2012 (SDAPA)01-04-1378 FR 6641/4/2013I

Establishment of Drug Codes for 26 Substances (amended regulations consistent with SDAPA; updated 21 CFR 1308)

TAPENTADOL02-17-0905-21-0974 FR 237906/22/2009II
TCP (PCP ANALOG)05-29-7507-08-7540 FR 286118/11/1975I
TEMAZEPAM01-05-8104-07-8145 FR 206714/7/1981IV
TETRAHYDROFURANYL FENTANYL (N-(1-10-26-1782 FR 4950410/26/2017I

PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) *

TETRAHYDROFURANYL FENTANYL (N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
THENYLFENTANYL *10-29-8550 FR 4369811/29/1985 I Expired

11/29/86

THIAFENTANIL08-26-1681 FR 588348/26/2016II
THIOFENTANYL *10-29-8550 FR 4369811/29/1985I
THIOFENTANYL **11-26-8651 FR 4283411/29/1986I
THIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
THIOFURANYL FENTANYL (Prior control under Temporary04-27-2186 FR 221134/27/2021I

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TILETAMINE/ZOLAZEPAM (TELAZOL)08-11-8601-21-8752 FR 22212/20/1987III
TILIDINE09-30-8045 FR 645711/12/1980I
TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3-11-04-1307-02-1479 FR 376238/18/2014IV

METHOXYPHENYL)CYCLOHEXANOL)

TRIAZOLAM04-29-8112-28-8247 FR 5769412/28/1982IV
ZALEPLON05-05-9909-15-9964 FR 499829/15/1999IV
ZIPEPROL (1-METHOXY-3-[4-(2-METHOXY-2-05-14-2011-21-2287 FR 7071712/21/2022I

PHENYLETHYL)PIPERAZIN-1-YL]-1-PHENYLPROPAN-2-OL)

ZOLPIDEM11-24-9202-05-9358 FR 71862/5/1993IV
ZOPICLONE02-14-0504-04-0570 FR 169354/4/2005IV
ZURANOLONE10-31-2388 FR 7434710/31/2023IV

Scheduling Actions - Alphabetical Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

Scheduling Actions - Alphabetical Order

Chronological OrderScheduling Actions

- Chronological Order -

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

AMPHETAMINE05-26-7107-07-7136 FR 127347/7/1971III → II
METHAMPHETAMINE05-26-7107-07-7136 FR 127347/7/1971III → II
BIPHETAMINE & BIPHETAMINE-T05-26-7107-23-7136 FR 136867/23/1971III → II
FETAMIN05-26-7107-23-7136 FR 136867/23/1971III → II
ESKATROL05-26-7108-18-7136 FR 157448/18/1971III → II
NALOXONE HYDROCHLORIDE08-19-7109-29-7136 FR 191169/29/1971II → NC
METHYLPHENIDATE09-17-7110-28-7136 FR 2068610/28/1971III → II
PHENMETRAZINE09-17-7110-28-7136 FR 2068610/28/1971III → II
PROPIRAM01-29-7237 FR 14681/29/1972I
BENZPHETAMINE05-09-7306-15-7338 FR 157196/15/1973III
CHLORPHENTERMINE05-09-7306-15-7338 FR 157196/15/1973III
CLORTERMINE05-09-7306-15-7338 FR 157196/15/1973III
FENFLURAMINE05-09-7306-15-7338 FR 157196/15/1973IV
MAZINDOL05-09-7306-15-7338 FR 157196/15/1973III
PHENDIMETRAZINE05-09-7306-15-7338 FR 157196/15/1973III
DIETHYLPROPION05-10-7307-06-7338 FR 180137/6/1973IV
PHENTERMINE05-09-7307-06-7338 FR 180137/6/1973IV
DROTEBANOL07-03-7338 FR 177178/6/1973I
2,5-DIMETHOXYAMPHETAMINE (DMA)05-31-7309-21-7338 FR 264479/21/1973I
4-BROMO-2,5-DIMETHOXYAMPHETAMINE07-02-7309-21-7338 FR 264479/21/1973I
4-METHOXYAMPHETAMINE (PMA)07-02-7309-21-7338 FR 264479/21/1973I
METHAQUALONE04-11-7310-04-7338 FR 2751610/4/1973II
AMOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
PENTOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
SECOBARBITAL05-31-7311-13-7338 FR 3131011/13/1973III → II
ETORPHINE HYDROCHLORIDE11-23-7303-29-7439 FR 115354/19/1974I → II
NALOXONE07-10-7412-24-7439 FR 4439212/24/1974 II → NC
PEMOLINE11-07-7401-28-7540 FR 41501/28/1975IV
MEBUTAMATE12-13-7401-30-7540 FR 44181/30/1975IV
CONCENTRATE OF POPPY STRAW12-20-7402-14-7540 FR 67792/14/1975II
NALTREXONE12-09-7403-06-7540 FR 104553/6/1975II → NC
DIFENOXIN05-07-7540 FR 198136/1/1975I
CHLORDIAZEPOXIDE01-27-7506-04-7540 FR 239987/2/1975IV

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

CLONAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
CLORAZEPATE01-27-7506-04-7540 FR 239987/2/1975IV
DIAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
FLURAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
OXAZEPAM01-27-7506-04-7540 FR 239987/2/1975IV
MECLOQUALONE05-29-7507-08-7540 FR 286117/10/1975I
TCP (PCP ANALOG)05-29-7507-08-7540 FR 286118/11/1975I
LIBRAX06-05-7511-11-7540 FR 5260911/28/1975 Exempted

RX

MENRIUM 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

APOMORPHINE04-08-7606-28-7641 FR 265686/28/1976II → NC
DEXTRORPHAN04-19-7610-01-7641 FR 4340110/1/1976I → NC
NALBUPHINE05-11-7610-01-7641 FR 4340110/1/1976II → NC
PRAZEPAM07-29-7612-17-7641 FR 5517612/17/1976IV
DEXTROPROPOXYPHENE09-29-7602-11-7742 FR 86363/14/1977IV
LOPERAMIDE07-29-7605-18-7742 FR 254986/17/1977V
LORAZEPAM06-28-7710-07-7742 FR 5454610/3/1977IV
PHENCYCLIDINE (PCP)12-19-7701-25-7843 FR 33592/24/1978III → II
PCC (PCP PRECURSOR)03-20-7805-17-7843 FR 213246/16/1978II
PCH (PCP PRECURSOR)03-20-7805-17-7843 FR 213246/16/1978II
DIFENOXIN 1 MG WITH ATROPINE06-26-7808-28-7843 FR 383829/27/1978I→ IV
DIFENOXIN 1/2 MG WITH ATROPINE06-26-7808-28-7843 FR 383829/27/1978I→V
PCE (PCP ANALOG)08-11-7809-25-7843 FR 4329510/25/1978I
PHP (PCP ANALOG)08-11-7809-25-7843 FR 4329510/25/1978I
PENTAZOCINE09-13-7801-10-7944 FR 21692/9/1979IV
TILIDINE09-30-8045 FR 645711/12/1980I
PHENYLACETONE (P2P)12-12-7944 FR 718222/11/1980II
DEXTROPROPOXYPHENE01-21-8006-24-8045 FR 422647/24/1980IV
DEXTROPROPOXYPHENE (BULK)07-22-8045 FR 488819/22/1980IV → II
PIPRADROL09-30-8045 FR 6457012/1/1980IV
SPA (LEFETAMINE)09-30-8045 FR 6457012/1/1980IV
SUFENTANIL09-30-8045 FR 6457112/1/1980I
TEMAZEPAM01-05-8104-07-8145 FR 206714/7/1981IV
FENETHYLLINE05-01-8107-21-8146 FR 375038/20/1981I
ALPHA-METHYLFENTANYL08-05-8109-22-8146 FR 467999/22/1981I
HALAZEPAM04-29-8110-29-8146 FR 5340710/29/1981IV
ALPRAZOLAM04-29-8111-12-8146 FR 5568811/12/1981IV
MAZINDOL04-17-8110-27-8146 FR 5233311/27/1981III → IV

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-ETHYLAMPHETAMINE09-10-8112-08-8146 FR 599691/7/1982I
LOPERAMIDE07-28-8211-03-8247 FR 4984011/3/1982V → NC
PARAHEXYL08-05-8211-22-8247 FR 5243212/22/1982I
TRIAZOLAM04-29-8112-28-8247 FR 5769412/28/1982IV
SUFENTANIL03-20-8405-25-8449 FR 220745/25/1984I → II
ALFENTANIL06-25-8449 FR 258498/24/1984I
METHAQUALONE08-27-8449 FR 338708/27/1984II → I
BROMAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
CAMAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
CLOBAZAM08-01-8410-05-8449 FR 3930711/5/1984IV
CLOTIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
CLOXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
DELORAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
ESTAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
ETHYL LOFLAZEPATE08-01-8410-05-8449 FR 3930711/5/1984IV
FLUDIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
FLUNITRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
HALOXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
KETAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
LOPRAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
LORMETAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
MEDAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NIMETAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NITRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
NORDIAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
OXAZOLAM08-01-8410-05-8449 FR 3930711/5/1984IV
PINAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
TETRAZEPAM08-01-8410-05-8449 FR 3930711/5/1984IV
BUPRENORPHINE09-20-8202-28-8550 FR 81044/1/1985II → V
3-METHYLFENTANYL *03-25-8550 FR 116904/25/1985I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) *05-31-8550 FR 231187/1/1985I
MPPP *07-10-8550 FR 280988/12/1985I
PEPAP *07-10-8550 FR 280988/12/1985I
NALMEFENE05-31-8511-04-8550 FR 4581511/4/1985II → NC
3-METHYLTHIOFENTANYL *10-29-8550 FR 4369811/29/1985I
ACETYL-ALPHA-METHYLFENTANYL *10-29-8550 FR 4369811/29/1985I
ALPHA-METHYLTHIOFENTANYL *10-29-8550 FR 4369811/29/1985I

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

BENZYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

BETA-HYDROXY-3-METHYLFENTANYL *10-29-8550 FR 4369811/29/1985I
BETA-HYDROXYFENTANYL *10-29-8550 FR 4369811/29/1985I
THENYLFENTANYL *10-29-8550 FR 4369811/29/1985 I Expired

11/29/86

THIOFENTANYL *10-29-8550 FR 4369811/29/1985I
PARA-FLUOROFENTANYL *02-07-8651 FR 47223/10/1986I
MIDAZOLAM02-07-8603-25-8651 FR 101903/25/1986IV
QUAZEPAM02-07-8603-25-8651 FR 101903/25/1986IV
3-METHYLFENTANYL **04-24-8651 FR 154744/25/1986I
DRONABINOL PRODUCT (MARINOL)10-18-8505-13-8651 FR 174765/13/1986I → II
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) **06-17-8651 FR 219117/1/1986I
MPPP **08-11-8651 FR 286958/12/1986I
PEPAP **08-11-8651 FR 286958/12/1986I
3-METHYLFENTANYL04-24-8609-22-8651 FR 335929/22/1986I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)07-27-8410-14-8651 FR 3655211/13/1986I
3-METHYLTHIOFENTANYL **11-26-8651 FR 4283411/29/1986I
ACETYL-ALPHA-METHYLFENTANYL **11-26-8651 FR 4283411/29/1986I
ALPHA-METHYLTHIOFENTANYL **11-26-8651 FR 4283411/29/1986I
BETA-HYDROXY-3-METHYLFENTANYL **11-26-8651 FR 4283411/29/1986 I Expired

5/29/87

BETA-HYDROXYFENTANYL **11-26-8651 FR 4283411/29/1986I
THIOFENTANYL **11-26-8651 FR 4283411/29/1986I
ALFENTANIL04-17-8601-23-8752 FR 25161/23/1987I → II
MPPP08-11-8601-23-8752 FR 25151/23/1987I
PEPAP08-11-8601-23-8752 FR 25151/23/1987I
TILETAMINE/ZOLAZEPAM (TELAZOL)08-11-8601-21-8752 FR 22212/20/1987III
PARA-FLUOROFENTANYL **03-10-8752 FR 72703/10/1987I
NABILONE06-18-8604-07-8752 FR 110424/7/1987II
3-METHYLTHIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
ACETYL-ALPHA-METHYLFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
ALPHA-METHYLTHIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
BETA-HYDROXYFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
PARA-FLUOROFENTANYL03-10-8705-29-8752 FR 200705/29/1987I
THIOFENTANYL11-28-8605-29-8752 FR 200705/29/1987I
3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;10-15-8752 FR 3822510/15/1987I

MDEA) *

4-METHYLAMINOREX * 10-15-87 52 FR 38225 10/15/1987 I

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE *10-15-8752 FR 3822510/15/1987I
BETA-HYDROXY-3-METHYLFENTANYL11-28-8601-08-8853 FR 5001/8/1988I
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)01-27-8853 FR 22251/27/1988I→ NC
MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)02-22-8853 FR 51563/23/1988I
PROPYLHEXEDRINE10-30-8704-04-8853 FR 108695/4/1988V
PYROVALERONE10-30-8704-04-8853 FR 108695/4/1988V
CATHINE10-30-8705-17-8853 FR 174596/16/1988IV
FENCAMFAMIN10-30-8705-17-8853 FR 174596/16/1988IV
FENPROPOREX10-30-8705-17-8853 FR 174596/16/1988IV
MEFENOREX10-30-8705-17-8853 FR 174596/16/1988IV
N,N-DIMETHYLAMPHETAMINE *08-03-8853 FR 292328/3/1988I
3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;10-13-8853 FR 4006110/13/1988I

MDEA) **

4-METHYLAMINOREX **10-13-8853 FR 4006110/13/1988I
N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE **10-13-8853 FR 4006110/13/1988I
CARFENTANIL01-12-8810-28-8853 FR 4368410/28/1988II
3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;10-14-8804-13-8954 FR 147974/13/1989I

MDEA)

4-METHYLAMINOREX10-14-8804-13-8954 FR 147994/13/1989I
N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE10-14-8804-13-8954 FR 147974/13/1989I
1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE03-20-8907-06-8954 FR 284147/6/1989I
N,N-DIMETHYLAMPHETAMINE **08-02-8954 FR 318158/2/1989I
N,N-DIMETHYLAMPHETAMINE08-02-8902-02-9055 FR 35862/2/1990I
ANABOLIC STEROIDSPL 101-64702-13-9156 FR 57532/27/1991III
GLUTETHIMIDE07-26-9003-21-9156 FR 119303/21/1991III → II
PROPYLHEXEDRINE12-03-9156 FR 6137212/3/1991V → NC
METHCATHINONE *05-01-9257 FR 188245/1/1992I
BUTORPHANOL, THEBAINE DERIVED04-03-9207-14-9257 FR 311267/14/1992II → NC

Superseded 10/97

AMINOREX *09-21-9257 FR 433999/21/1992I
ZOLPIDEM11-24-9202-05-9358 FR 71862/5/1993IV
2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET)10-30-8701-14-9358 FR 43162/16/1993I
CATHINONE10-30-8701-14-9358 FR 43162/16/1993I
ALPHA-ETHYLTRYPTAMINE *03-12-9358 FR 135333/12/1993I
METHCATHINONE **04-29-9358 FR 259345/1/1993I
LEVO-ALPHACETYLMETHADOL (LAAM)04-28-9308-18-9358 FR 437958/18/1993I → II
AMINOREX **08-24-9358 FR 446119/21/1993I
METHCATHINONE04-28-9310-15-9358 FR 5340410/15/1993I

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE *01-06-9459 FR 006711/6/1994I
ALPHA-ETHYLTRYPTAMINE **03-07-9459 FR 107203/12/1994I
AMINOREX08-20-9303-18-9459 FR 128283/18/1994I
ALPHA-ETHYLTRYPTAMINE03-07-9409-12-9459 FR 467579/12/1994I
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE **12-21-9459 FR 657101/6/1995I
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE12-20-9406-02-9560 FR 287186/2/1995I
REMIFENTANIL09-16-9611-05-9661 FR 5689311/5/1996II
FENFLURAMINE05-06-9705-06-9762 FR 24620IV → NC
BUTORPHANOL07-10-9710-01-9762 FR 5137010/31/1997IV
SIBUTRAMINE12-08-9702-11-9863 FR 68622/11/1998IV
MODAFINIL04-14-9801-27-9964 FR 40501/27/1999IV
DRONABINOL PRODUCT (MARINOL)11-05-9807-02-9964 FR 359287/2/1999II → III
KETAMINE04-09-9907-13-9964 FR 376738/12/1999III
ZALEPLON05-05-9909-15-9964 FR 499829/15/1999IV
GAMMA HYDROXYBUTYRIC ACID (GHB)PL 106-17203-13-0065 FR 132353/13/2000I
GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug PL 106-17203-13-0065 FR 132353/13/2000III

products

DIHYDROETORPHINE (thebaine derivative) 11-17-00 65 FR 69442 11/17/2000 clarification of CII control

DICHLORALPHENAZONE (chloral hydrate compound) 12-11-00 08-16-01 66 FR 42943 8/16/2001 clarification of CIV control

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) *09-20-0267 FR 591619/20/2002I
2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-09-20-0267 FR 591639/20/2002I

T-7) *

N-BENZYLPIPERAZINE (BZP) *09-20-0267 FR 591619/20/2002I
BUPRENORPHINE03-21-0210-07-0267 FR 6235410/7/2002V → III
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) *04-04-0368 FR 164274/4/2003I
ALPHA-METHYLTRYPTAMINE (AMT) *04-04-0368 FR 164274/4/2003I
FENFLURAMINE05-06-9705-15-0368 FR 26247IV

Withdrew 97 proposed rule

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) **09-10-0368 FR 532899/20/2003I
2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-09-10-0368 FR 532899/20/2003I

T-7) **

N-BENZYLPIPERAZINE (BZP) **09-10-0368 FR 532899/20/2003I
2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-09-08-0303-18-0469 FR 127943/18/2004I

T-7)

N-BENZYLPIPERAZINE (BZP)09-08-0303-18-0469 FR 127943/18/2004I
1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP)09-08-0303-18-0469 FR 127943/19/2004I → NC

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 04-01-04 69 FR 17034 4/1/2004 I **

ALPHA-METHYLTRYPTAMINE (AMT) **04-01-0469 FR 170344/1/2004I
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT)09-29-0469 FR 580509/29/2004I
ALPHA-METHYLTRYPTAMINE (AMT)09-29-0469 FR 580509/29/2004I
ZOPICLONE02-14-0504-04-0570 FR 169354/4/2005IV
PREGABALIN05-12-0507-28-0570 FR 436337/28/2005V
ANABOLIC STEROIDSPL 108-35812-16-0570 FR 746531/17/2006III
EMBUTRAMIDE07-29-0508-29-0671 FR 511159/28/2006III
LISDEXAMFETAMINE02-22-0705-03-0772 FR 245326/4/2007II
ORIPAVINE09-24-0772 FR 542089/24/2007II
INDIPLON01-31-0801-31-081/31/2008IV
LACOSAMIDE03-10-0905-21-0974 FR 237896/22/2009V
TAPENTADOL02-17-0905-21-0974 FR 237906/22/2009II
FOSPROPOFOL07-23-0910-06-0974 FR 5123411/5/2009IV
19-NOR-4,9(10)-ANDROSTADIENEDIONE (ESTRA-4,9(10)-04-25-0812-04-0974 FR 636031/4/2010III

DIENE-3,17-DIONE)

BOLDIONE (ANDROSTA-1,4-DIENE-3,17-DIONE)04-25-0812-04-0974 FR 636031/4/2010III
DESOXYMETHYLTESTOSTERONE (17α-METHYL-5α-04-25-0812-04-0974 FR 636031/4/2010III

ANDROST-2-EN-17-OL; MADOL)

4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP)04-09-0806-29-1075 FR 372968/30/2010II
5-METHOXY-N,N-DIMETHYLTRYPTAMINE08-21-0912-20-1075 FR 792961/19/2011I
CP-47,497 C8 HOMOLOGUE *03-01-1176 FR 110753/1/2011I
CP-47,497 *03-01-1176 FR 110753/1/2011I
JWH–018 *03-01-1176 FR 110753/1/2011I
JWH–073 *03-01-1176 FR 110753/1/2011I
JWH–200 *03-01-1176 FR 110753/1/2011I
3,4-METHYLENEDIOXY-N-METHYLCATHINONE10-21-1176 FR 6537110/21/2011I

(METHYLONE) *

3,4-METHYLENEDIOXYPYROVALERONE (MDPV) *10-21-1176 FR 6537110/21/2011I
4-METHYL-N-METHYLCATHINONE (MEPHEDRONE) *10-21-1176 FR 6537110/21/2011I
EZOGABINE10-21-1112-15-1176 FR 7789512/15/2011V
CARISOPRODOL11-17-0912-12-1176 FR 773301/11/2012IV
CP-47,497 C8 HOMOLOGUE **02-29-1277 FR 122012/29/2012I
CP-47,497 **02-29-1277 FR 122012/29/2012I
JWH–018 **02-29-1277 FR 122012/29/2012I
JWH–073 **02-29-1277 FR 122012/29/2012I
JWH–200 **02-29-1277 FR 122012/29/2012I
METHASTERONE (2α,17α-DIMETHYL-5α-ANDROSTAN-17β-11-23-1107-30-1277 FR 444568/29/2012III

OL-3-ONE)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

PROSTANOZOL (17β-HYDROXY-5α-ANDROSTANO[3,2- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III C]PRYAZOLE)

JWH–01801-04-1378 FR 6641/4/2013I
Synthetic Drug Abuse Prevention Act of 2012 (SDAPA)01-04-1378 FR 6641/4/2013I

Establishment of Drug Codes for 26 Substances (amended regulations consistent with SDAPA; updated 21 CFR 1308)

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE)

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) *

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11) *

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-16-13 78 FR 28735 5/16/2013 I CARBOXAMIDE (APINACA, AKB48) *

LORCASERIN12-19-1205-08-1378 FR 267016/7/2013IV
2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2-11-15-1378 FR 6871611/15/2013I

METHOXYBENZYL)ETHANAMINE (25B-NBOMe) *

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25C-NBOMe) *

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe) *

PERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2- 10-22-13 12-02-13 78 FR 72013 1/2/2014 III DIHYDROPYRIDIN-3-YL)BENZONITRILE]

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-10-14 79 FR 7577 2/10/2014 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-10-14 79 FR 7577 2/10/2014 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) *

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-10-14 79 FR 7577 2/10/2014 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) *

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB–22; QUPIC) *

ALFAXALONE (5α-PREGNAN-3α-OL-11,20-DIONE)03-25-1302-27-1479 FR 109853/31/2014IV
3-FLUORO-N-METHYLCATHINONE (3-FMC) *03-07-1479 FR 129383/7/2014I
4-FLUORO-N-METHYLCATHINONE (4-FMC) *03-07-1479 FR 129383/7/2014I
4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-03-07-1479 FR 129383/7/2014I

MePPP) *

4-METHYL-N-ETHYLCATHINONE (4-MEC) *03-07-1479 FR 129383/7/2014I
ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) *03-07-1479 FR 129383/7/2014I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) *03-07-1479 FR 129383/7/2014I
BUTYLONE *03-07-1479 FR 129383/7/2014I
NAPHYRONE *03-07-1479 FR 129383/7/2014I
PENTEDRONE *03-07-1479 FR 129383/7/2014I
PENTYLONE *03-07-1479 FR 129383/7/2014I

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3- 11-04-13 07-02-14 79 FR 37623 8/18/2014 IV METHOXYPHENYL)CYCLOHEXANOL)

SUVOREXANT02-13-1408-28-1479 FR 521439/29/2014IV
HYDROCODONE COMBINATION PRODUCTS02-27-1408-22-1479 FR 4966110/6/2014III → II
NALOXEGEL10-29-1401-23-1580 FR 34681/23/2015II → NC
[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1-01-30-1580 FR 50421/30/2015I

YL)METHANONE (THJ-2201) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 01-30-15 80 FR 5042 1/30/2015 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 01-30-15 80 FR 5042 1/30/2015 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA) *

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-15-15 80 FR 27854 5/15/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) **

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-15-15 80 FR 27854 5/5/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11) **

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-15-15 80 FR 27854 5/15/2015 I CARBOXAMIDE (APINACA; AKB48) **

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-17-15 80 FR 42381 7/17/2015 I PHENYLACETAMIDE) *

[123I]IOFLUPANE06-03-1509-11-1580 FR 547159/11/2015II → NC
ELUXADOLINE08-11-1511-12-1580 FR 6986112/17/2015IV
N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-02-05-1681 FR 61712/5/2016I

(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-05-16 81 FR 6175 2/5/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-05-16 81 FR 6175 2/5/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) **

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-05-16 81 FR 6175 2/5/2016 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) **

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-05-16 81 FR 6175 2/5/2016 I (PB–22; QUPIC) **

3-FLUORO-N-METHYLCATHINONE (3-FMC) **03-04-1681 FR 114293/4/2016I
4-FLUORO-N-METHYLCATHINONE (4-FMC) **03-04-1681 FR 114293/4/2016I
4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-03-04-1681 FR 114293/4/2016I

MePPP) **

4-METHYL-N-ETHYLCATHINONE (4-MEC) **03-04-1681 FR 114293/4/2016I
ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) **03-04-1681 FR 114293/4/2016I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) **03-04-1681 FR 114293/4/2016I
BUTYLONE **03-04-1681 FR 114293/4/2016I
NAPHYRONE **03-04-1681 FR 114293/4/2016I
PENTEDRONE **03-04-1681 FR 114293/4/2016I
PENTYLONE **03-04-1681 FR 114293/4/2016I

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11)

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-11-16 81 FR 29142 5/11/2016 I CARBOXAMIDE (APINACA; AKB48)

BETA-HYDROXYTHIOFENTANYL *05-12-1681 FR 294925/12/2016I
BRIVARACETAM (BRV; UCB-34714; BRIVIACT)05-12-1681 FR 294875/12/2016V
BUTYRYL FENTANYL*05-12-1681 FR 294925/12/2016I
3,4-DICHLORO-N-[(1-04-14-1681 FR 220235/15/2016I

DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE (AH- 7921)

THIAFENTANIL08-26-1681 FR 588348/26/2016II
N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-09-06-1681 FR 611309/6/2016I

1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 09-06-16 81 FR 61130 9/6/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA)

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 09-06-16 81 FR 61130 9/6/2016 I CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB- 09-06-16 81 FR 61130 9/6/2016 I 22; QUPIC)

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 11-14-16 81 FR 79389 11/14/2016 I METHYLBENZAMIDE (U-47700) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-16 81 FR 85873 11/29/2016 I CARBOXAMIDE (FURANYL FENTANYL) *

3-FLUORO-N-METHYLCATHINONE (3-FMC)03-04-1603-01-1782 FR 121713/1/2017I
4-FLUORO-N-METHYLCATHINONE (4-FMC)03-04-1603-01-1782 FR 121713/1/2017I
4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-03-04-1603-01-1782 FR 121713/1/2017I

MePPP)

4-METHYL-N-ETHYLCATHINONE (4-MEC)03-04-1603-01-1782 FR 121713/1/2017I
ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP)03-04-1603-01-1782 FR 121713/1/2017I
ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP)03-04-1603-01-1782 FR 121713/1/2017I
BUTYLONE03-04-1603-01-1782 FR 121713/1/2017I
NAPHYRONE03-04-1603-01-1782 FR 121713/1/2017I
PENTEDRONE03-04-1603-01-1782 FR 121713/1/2017I
PENTYLONE03-04-1603-01-1782 FR 121713/1/2017I
DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT03-23-1782 FR 148153/23/2017II

APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMINISTRATION

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB–FUBINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) *

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-10-17 82 FR 17119 4/10/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) *

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-10-17 82 FR 17119 4/10/2017 I 3-CARBOXAMIDE (5F–APINACA; 5F–AKB48) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 05-03-17 82 FR 20544 5/3/2017 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) *

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 06-07-17 82 FR 26349 6/7/2017 I PHENYLACETAMIDE)

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-14-17 82 FR 32453 7/14/2017 I PHENYLACRYLAMIDE) *

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 10-16-17 82 FR 47971 10/16/2017 I YL)METHANONE (THJ-2201)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 10-16-17 82 FR 47971 10/16/2017 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 10-16-17 82 FR 47971 10/16/2017 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA)

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-26-17 82 FR 49504 10/26/2017 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) *

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-26-17 82 FR 49504 10/26/2017 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) *

TETRAHYDROFURANYL FENTANYL (N-(1- 10-26-17 82 FR 49504 10/26/2017 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) *

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 11-03-17 82 FR 51154 11/3/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) *

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 01-04-18 83 FR 469 1/4/2018 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) *

MT-45 (1-CYCLOHEXYL-4-(1,2- 12-13-17 82 FR 58557 1/12/2018 I DIPHENYLETHYL)PIPERAZINE))

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-30-18 83 FR 4411 1/30/2018 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 02-01-18 83 FR 4580 2/1/2018 I (VALERYL FENTANYL) *

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 02-01-18 83 FR 4580 2/1/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) *

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) *

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) *

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 02-06-18 83 FR 5188 2/6/2018 I CFR 1308.11(h)*

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 04-20-18 83 FR 17486 4/20/2018 I METHYLBENZAMIDE (U-47700)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE 04-20-18 83 FR 17486 4/20/2018 I (BUTYRYL FENTANYL)

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-10-18 83 FR 31877 7/10/2018 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) *

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXYLATE (NM2201; CBL2201) *

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-31-18 83 FR 44474 8/31/2018 I ONE (N-ETHYLPENTYLONE; EPHYLONE) *

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 09-28-18 83 FR 48953 9/28/2018 V AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-29-18 83 FR 61320 11/29/2018 I PHENYLACRYLAMIDE)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-18 83 FR 61320 11/29/2018 I CARBOXAMIDE (FURANYL FENTANYL)

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-29-18 83 FR 61320 11/29/2018 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)

TETRAHYDROFURANYL FENTANYL (N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-29-19 84 FR 444 1/29/2019 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA)

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) **

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-08-19 84 FR 13796 4/8/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) **

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-08-19 84 FR 13796 4/8/2019 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48) **

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-16-19 84 FR 15505 4/16/2019 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-16-19 84 FR 15505 4/16/2019 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) *

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) *

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-16-19 84 FR 15505 4/16/2019 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) *

BETA-HYDROXYTHIOFENTANYL05-08-1984 FR 200235/8/2019I
BREXANOLONE (3α-HYDROXY-5α-PREGNAN-20-ONE),06-17-1984 FR 279386/17/2019IV

ALLOPREGNANOLONE

SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CAR- 06-17-19 84 FR 27943 6/17/2019 IV BAMATE; BENZENEPROPANOL,BETA-AMINO-, CARBAMATE (ESTER))

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) *07-18-1984 FR 342917/18/2019I
4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4-07-18-1984 FR 342917/18/2019I

CHLORO-α-PVP) *

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-19 84 FR 34291 7/18/2019 I *

ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) *07-18-1984 FR 342917/18/2019I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) *07-18-1984 FR 342917/18/2019I
N-ETHYLHEXEDRONE *07-18-1984 FR 342917/18/2019I
CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-10-25-1984 FR 5732310/25/2019I

YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-25-19 84 FR 57323 10/25/2019 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-25-19 84 FR 57323 10/25/2019 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 10-30-19 84 FR 58045 11/3/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) **

6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5- 01-24-20 85 FR 4215 1/24/2020 II → NC EPOXYMORPHINAN-3,6,14-TRIOL)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 01-24-20 85 FR 4211 1/24/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB- FUBINACA)

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 01-24-20 85 FR 4211 1/24/2020 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48)

LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE- 01-31-20 85 FR 5557 1/31/2020 V 4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE]

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 01-30-20 85 FR 5321 2/1/2020 I (VALERYL FENTANYL) **

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) **

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) **

CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2- 03-10-20 85 FR 13741 3/10/2020 V YL)ETHYL]CARBAMATE

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 03-30-20 85 FR 17494 3/30/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE)

LEMBOREXANT04-07-2085 FR 193874/7/2020IV
NORFENTANYL (N-PHENYL-N-(PIPERIDIN-4-09-17-1904-17-2085 FR 213205/18/2020II

YL)PROPIONAMIDE)

ETHYLONE (Prior control as a positional isomer of BUTYLONE: 06-08-20 85 FR 34607 6/8/2020 I See 85 FR 34967 03/07/2014)

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-13-20 85 FR 42296 7/10/2020 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) **

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXYLATE (NM2201; CBL2201) **

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 08-20-20 85 FR 51342 8/20/2020 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE) *

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 08-21-20 85 FR 51639 8/21/2020 V → NC AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-27-20 85 FR 52915 8/31/2020 I ONE (N-ETHYLPENTYLONE; EPHYLONE) **

CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4- 10-02-20 85 FR 62215 10/2/2020 I YL)-N-PHENYLBUT-2-ENAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE- 10-06-20 85 FR 63014 10/6/2020 IV 4-PROPIONIC ACID)

OLICERIDINE10-30-2085 FR 6874910/30/2020II
N-(1-PHENETHYLPIPERIDIN-4-YL)-N-11-25-2085 FR 7523111/25/2020I

PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 11-25-20 85 FR 75231 11/25/2020 I (VALERYL FENTANYL)

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-01-21 86 FR 11862 3/1/2021 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE) *

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 03-31-21 86 FR 16669 4/16/2021 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 03-31-21 86 FR 16669 4/16/2021 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) **

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) **

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 03-31-21 86 FR 16669 4/16/2021 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) **

SAMIDORPHAN04-19-2186 FR 202844/19/2021II → NC
2'-FLUORO ORTHO-FLUOROFENTANYL (Prior control under04-27-2186 FR 221134/27/2021I

Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4'-METHYL ACETYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

BETA-METHYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA'-PHENYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROBUTYRYL FENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL ACETYLFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL METHOXYACETYL FENTANYL (Prior control 04-27-21 86 FR 22113 4/27/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLFENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PHENYL FENTANYL (Prior control under Temporary Order for 04-27-21 86 FR 22113 4/27/2021 I Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

THIOFURANYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

FENTANYL CARBAMATE (Prior control under Temporary Order 05-04-21 86 FR 23602 5/4/2021 I for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROACRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROISOBUTYRYL FENTANYL (Prior control 05-04-21 86 FR 23602 5/4/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO FURANYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

SERDEXMETHYLPHENIDATE05-07-2186 FR 244875/7/2021IV
1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H-06-10-2186 FR 307756/10/2021I

INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 06-10-21 86 FR 30775 6/10/2021 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA)

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXYLATE (NM2201; CBL2201)

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 06-14-21 86 FR 31427 6/14/2021 I ONE (N-ETHYLPENTYLONE; EPHYLONE)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBUTYL)-1H-INDAZOLE-3- 06-22-21 86 FR 32633 6/22/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (4F-MDMB- BINACA) (Prior control as a positional isomer of 5F-AMB: See 86 FR 32633 04/10/2017)

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) 07-18-21 86 FR 37672 7/18/2021 I **

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 07-18-21 86 FR 37672 7/18/2021 I CHLORO-α-PVP) **

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-21 86 FR 37672 7/18/2021 I **

ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) **07-18-2186 FR 376727/18/2021I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) **07-18-2186 FR 376727/18/2021I
N-ETHYLHEXEDRONE **07-18-2186 FR 376727/18/2021I
PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4-05-15-2006-25-2186 FR 335087/26/2021I

METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE

4,4′-DIMETHYLAMINOREX (4,4′-DMAR; 4,5-DIHYDRO-4- 04-07-20 08-12-21 86 FR 44270 9/13/2021 I METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE)

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 11-04-21 86 FR 60761 12/6/2021 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE)

4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)01-14-2201-14-2287 FR 2376I
5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT)01-14-2201-14-2287 FR 2376I
5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET)01-14-2201-14-2287 FR 2376I
5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-2201-14-2287 FR 2376I

MiPT)

N,N-DIISOPROPYLTRYPTAMINE (DiPT)01-14-2201-14-2287 FR 2376I
(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3-04-07-2287 FR 203184/7/2022I

TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-07-22 87 FR 20318 4/7/2022 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25)

DARIDOREXANT (QUVIVIQ)04-07-2287 FR 203134/7/2022IV
ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-04-07-2287 FR 203184/7/2022I

CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA)

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-07-22 87 FR 20318 4/7/2022 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA)

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC)04-11-2204-11-2287 FR 21069I
2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI)04-11-2204-11-2287 FR 21069I
2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)-04-12-2287 FR 215564/12/2022I

N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-12-22 87 FR 21556 4/12/2022 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE) *

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-12-22 87 FR 21556 4/12/2022 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE) *

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-12-22 87 FR 21556 4/12/2022 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE) *

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE) *

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP)06-01-2287 FR 329966/1/2022I
4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4-06-01-2287 FR 329966/1/2022I

CHLORO-α-PVP)

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP)06-01-2287 FR 329966/1/2022I
ALPHA-PYRROLIDINOHEPTAPHENONE (PV8)06-01-2287 FR 329966/1/2022I
ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP)06-01-2287 FR 329966/1/2022I
GANAXOLONE (3α-HYDROXY-3β-METHYL-5α-PREGNAN-20-06-01-2287 FR 329916/1/2022V

ONE)

N-ETHYLHEXEDRONE06-01-2287 FR 329966/1/2022I
METHOXETAMINE12-07-2106-07-2287 FR 341667/6/2022I
4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)01-14-2207-27-2287 FR 45076I Withdrew

2022 proposed rule

5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-2207-27-2287 FR 45076I Withdrew
MiPT)2022

proposed rule

N,N-DIISOPROPYLTRYPTAMINE (DiPT) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC) 04-11-22 08-29-22 87 FR 52712 I Withdrew 2022 proposed rule

2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI) 04-11-22 08-29-22 87 FR 52712 I Withdrew 2022 proposed rule

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

AMINEPTINE (7-[(10,11-DIHYDRO-5H- 07-22-22 11-17-22 87 FR 68895 12/19/2022 I DIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO]HEPTANOIC ACID)

[18F]FP-CIT11-04-2111-21-2287 FR 7071512/21/2022 II → NC
ZIPEPROL (1-METHOXY-3-[4-(2-METHOXY-2-05-14-2011-21-2287 FR 7071712/21/2022I

PHENYLETHYL)PIPERAZIN-1-YL]-1-PHENYLPROPAN-2-OL)

MESOCARB (N-PHENYL-N'-(3-(1-PHENYLPROPAN-2-YL)- 08-11-21 11-22-22 87 FR 71247 12/22/2022 I 1,2,3-OXADIAZOL-3-IUM-5-YL)CARBAMIMIDATE)

FENFLURAMINE07-19-2212-23-2287 FR 7885712/23/2022 IV → NC
METHIOPROPAMINE (N-METHYL-1-(THIOPHEN-2-09-02-2112-09-2287 FR 754701/9/2023I

YL)PROPANE-2-AMINE)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-06-23 88 FR 13692 4/5/2023 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)

EUTYLONE (1-(1,3-BENZODIOXOL-5-YL)-2- 04-10-23 88 FR 21101 4/10/2023 I (ETHYLAMINO)BUTAN-1-ONE) (Prior control as a positional isomer of PENTYLONE: See 88 FR 21101 03/07/2014)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-26-23 88 FR 48112 7/26/2023 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) *

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) *

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-26-23 88 FR 48112 7/26/2023 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) *

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) *

ANABOLIC STEROIDS (amended regulations consistent with 08-01-23 88 FR 50036 8/1/2023 III DASCA; updated and moved specific listing to 21 CFR 1308.13(f))

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 08-18-23 88 FR 56466 9/18/2023 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE)

ZURANOLONE10-31-2388 FR 7434710/31/2023IV
2',5'-DIMETHOXYFENTANYL (N-(1-(2,5-12-07-2388 FR 8510412/7/2023I

DIMETHOXYPHENETHYL)PIPERIDINE-4-YL)-N- PHENYLPROPIONAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

3-FURANYL FENTANYL (N-(1-PHENTHYLPIPERIDIN-4-YL)-N- 12-07-23 88 FR 85104 12/7/2023 I PHENYLFURAN-3-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ALPHA'-METHYL BUTYRYL FENTANYL (2-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ISOVALERY FENTANYL (3-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

META-FLUOROFENTANYL (N-(3-FLUORPHENYL)-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROISOBUTYRYL FENTANYL (N-(3- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROFURANYL FENTANYL (N-(2- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)FURAN- 2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHOXYFURANYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)FURAN-2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLCYCLOPROPYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHYLPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)CYCLOPROPANECARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-12-23 88 FR 86040 12/12/2023 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-12-23 88 FR 86040 12/12/2023 I 1-ONE (CUMYL-PEGACLONE, SGT-151) *

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-12-23 88 FR 86040 12/12/2023 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) *

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-12-23 88 FR 86040 12/12/2023 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) *

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) *

3-MMC (2-(METHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1- 12-13-23 88 FR 86266 12/13/2023 I ONE) (Prior control as a positional isomer of MEPHEDRONE: See 88 FR 86266 07/09/2012)

ADB-BUTINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2- 12-13-23 88 FR 86266 12/13/2023 I YL)-1-BUTYL-1H-INDAZOLE-3-CARBOXAMIDE) (Prior control as a positional isomer of AB-PINACA: See 88 FR 86266 01/30/2015)

ALPHA-PIHP (4-METHYL-1-PHENYL-2-(PYRROLIDIN-1- 12-13-23 88 FR 86266 12/13/2023 I YL)PENTAN-1-ONE) (Prior control as a positional isomer of A- PHP: See 88 FR 86266 07/18/2019)

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-11-24 89 FR 25514 4/11/2024 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-11-24 89 FR 25514 4/11/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE)

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-11-24 89 FR 25514 4/11/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE)

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-11-24 89 FR 25517 4/12/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) **

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-11-24 89 FR 25517 4/12/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) **

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-11-24 89 FR 25517 4/12/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) **

2-METHYL AP-237 (1-(2-METHYL-4-(3-PHENYLPROP-2-EN-1- 03-15-24 89 FR 18793 4/15/2024 I YL)PIPERAZIN-1-YL)BUTAN-1-ONE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1- 07-29-24 89 FR 60817 7/29/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE) *

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 07-29-24 89 FR 60817 7/29/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-25-24 89 FR 85047 10/25/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE)

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 10-25-24 89 FR 85047 10/25/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 10-25-24 89 FR 85047 10/25/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE)

ETHYLPHENIDATE (ETHYL 2-PHENYL-2-(PIPERIDIN-2- 09-22-23 10-22-24 89 FR 84281 11/21/2024 I YL)ACETATE)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 12-30-24 89 FR 106311 12/31/2024 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 12-30-24 89 FR 106311 12/31/2024 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2-CARBOXAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 12-30-24 89 FR 106311 12/31/2024 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 12-30-24 89 FR 106311 12/31/2024 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 90 FR 35236 7/26/2025 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) **

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) **

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 90 FR 35236 7/26/2025 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) **

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) **

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) **

1-(1,3-BENZODIOXOL-5-YL)-2-(DIMETHYLAMINO)PENTAN-1- 08-08-25 90 FR 38396 8/8/2025 I ONE (N,N-DIMETHYLPENTYLONE; DIPENTYLONE) (Prior control as a positional isomer of N-ETHYLPENTYLONE: See 90 FR 38396 08/31/2018)

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE) *

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE) *

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 09-18-25 90 FR 44979 9/18/2025 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 09-18-25 90 FR 44979 9/18/2025 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2- CARBOXAMIDE (Prior control under Temporary Order Fentanyl- Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 09-18-25 90 FR 44979 9/18/2025 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 09-18-25 90 FR 44979 9/18/2025 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2-(2-((2,3-DIHYDROBENZOFURAN-5-YL)METHYL)-5-NITRO- 10-15-25 90 FR 48259 10/15/2025 I 1H-BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (ETHYLENEOXYNITAZENE) *

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(2-(4-ETHOXYBENZYL)-5-METHYL-1H-BENZIMIDAZOL-1- 10-15-25 90 FR 48259 10/15/2025 I YL)-N,N-DIETHYLETHAN-1-AMINE (5-METHYL ETODESNITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N,N-DIMETHYLETHAN-1-AMINE (N,N-DIMETHYLAMINO ETONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N-ETHYLETHAN-1-AMINE (N-DESETHYL ETONITAZENE) *

2-(2-(BENZODIOXOL-5-YLMETHYL)-5-NITRO-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (METHYLENEDIOXYNITAZENE; 3′,4′- METHYLENEDIOXYNITAZENE) *

2-(4-ISOPROPOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 10-15-25 90 FR 48259 10/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ISOTONITAZENE) *

N-ETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL PROTONITAZENE) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 90 FR 57542 12/12/2025 I 1-ONE (CUMYL-PEGACLONE, SGT-151) **

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-11-25 90 FR 57356 12/12/2025 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) **

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-16-25 90 FR 58149 12/12/2025 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-16-25 90 FR 58149 12/12/2025 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) **

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) **

4-CHLOROMETHCATHINONE (4-CMC, 1-(4- 11-17-25 90 FR 51102 12/17/2025 I CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1- 12-23-25 90 FR 59969 1/22/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE)

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 12-23-25 90 FR 59969 1/22/2026 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE)

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE)

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE)

4-FLUOROAMPHETAMINE (4–FA, 1-(4- 06-03-25 01-15-26 91 FR 1692 2/17/2026 I FLUOROPHENYL)PROPAN-2-AMINE, PARA- FLUOROAMPHETAMINE)

(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (AM–1220)

(1-(5-FLUOROPENTYL)-1H-INDOL-3-YL)(4- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLNAPHTHALEN-1-YL)METHANONE (MAM–2201)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-HEXYL-5-PHENYL-1H-PYRROL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–147)

(2-IODOPHENYL)(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (AM–2233)

(2-METHYL-1-PENTYL-1H-INDOL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–007)

(4-ETHYLNAPHTHALEN-1-YL)(1-(5-FLUOROPENTYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (EAM–2201)

(4-ETHYLNAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–210)

(4-FLUORONAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–412)

(4-METHOXYNAPHTHALEN-1-YL)(2-METHYL-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (JWH–098)

(4-METHYLNAPHTHALEN-1-YL)(1-(2-MORPHOLINOETHYL)- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1H-INDOL-3-YL)METHANONE (JWH–193)

(5-(2-FLUOROPHENYL)-1-PENTYL-1H-PYRROL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (JWH–307)

(5-METHYL-3-(MORPHOLINOMETHYL)-2,3-DIHYDRO- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I [1,4]OXAZINO[2,3,4-HI]INDOL-6-YL)(NAPHTHALEN-1- YL)METHANONE (WIN 55,212– 2)

1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE (AM2201) 04-13-23 01-20-26 91 FR 2297 2/19/2026 I (Prior control under SDAPA: See 78 FR 664 01/04/2013)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLDECAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C9 HOMOLOG)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLHEPTAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C6 HOMOLOG)

2-(3-METHOXYPHENYL)-1-(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)ETHAN-1-ONE (JWH–302)

2-(5-HYDROXY-2-(3-HYDROXYPROPYL)CYCLOHEXYL)-5-(2-04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLOCTAN-2-YL)PHENOL (CP–55,940)

3-((4-METHYLNAPHTHALEN-1-YL)METHYL)-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOLE (JWH–184)

CANNABIMIMETIC AGENTS (as defined in 21 CFR § 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1308.11(g))

CP-47,497 C8 HOMOLOGUE (Consolidated under 04-13-23 01-20-26 91 FR 2297 2/19/2026 I "CANNABIMIMETIC AGENTS" as defined in 21 CFR § 1308.11(g))

CP-47,497 (Consolidated under "CANNABIMIMETIC AGENTS" 04-13-23 01-20-26 91 FR 2297 2/19/2026 I as defined in 21 CFR § 1308.11(g))

JWH–018 (Reclassified under 21 CFR § 1308.11(d))04-13-2301-20-2691 FR 22972/19/2026I
JWH–073 (Consolidated under "CANNABIMIMETIC AGENTS"04-13-2301-20-2691 FR 22972/19/2026I

as defined in 21 CFR § 1308.11(g))

JWH–200 (Consolidated under "CANNABIMIMETIC AGENTS" 04-13-23 01-20-26 91 FR 2297 2/19/2026 I as defined in 21 CFR § 1308.11(g))

NAPHTHALEN-1-YL(1-(PENT-4-EN-1-YL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–022)

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

8-BROMO-1-METHYL-6-PHENYL-4H- 03-16-26 91 FR 12504 3/16/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (BROMAZOLAM) *

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2-07-25-25 03-02-26 91 FR 9985 4/1/2026 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM)

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM)

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO-07-25-25 03-02-26 91 FR 9985 4/1/2026 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM)

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM)

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM)

3-METHOXYPHENCYCLIDINE (1-(1-(3- 03-23-26 91 FR 13733 4/22/2026 I METHOXYPHENYL)CYCLOHEXYL)PIPERIDINE; 3-MEO–PCP)

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 10-02-25 04-24-26 91 FR 21958 4/27/2026 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE)

MARIJUANA EXTRACT, AS DEFINED IN 21 CFR 04-28-26 91 FR 22714 4/28/2026 III 1308.11(D)(58), IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

MARIJUANA, AS DEFINED IN 21 U.S.C. 802(16), IN A U.S. 04-28-26 91 FR 22714 4/28/2026 III FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

NATURALLY DERIVED DELTA-9- 04-28-26 91 FR 22714 4/28/2026 III TETRAHYDROCANNABINOLS IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR IN MARIJUANA SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE)

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE)

6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,9,10,10A-HEXAHYDRO- 05-04-26 91 FR 23913 5/4/2026 I 6H-BENZO[C]CHROMEN-1-OL (HEXAHYDROCANNABINOL, HHC)

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL-12-11-25 05-13-26 91 FR 26913 5/13/2026 I 1-ONE (CUMYL-PEGACLONE, SGT-151)

2-FLUORODESCHLOROKETAMINE (2-(2-FLUOROPHENYL)-2- 05-22-26 91 FR 30204 5/22/2026 I (METHYLAMINO)CYCLOHEXAN-1-ONE; 2-FDCK) *

O-DESMETHYLTRAMADOL (O-DSMT; DESMETRAMADOL; 3- 08-12-26 91 FR 52013 8/12/2026 I [(1R,2R)-2-[(DIMETHYLAMINO)METHYL]-1- HYDROXYCYCLOHEXYL]PHENOL) *

Scheduling Actions - Chronological Order

Scheduled under 21 USC 811(h) FINAL ORDER *Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL (E)-2-((1′S,6′S,7′S)-6′-ETHYL-4-METHOXY-3-OXO- 08-26-26 91 FR 54948 8/26/2026 I 3′,5′,6′,7′,8′,8A′-HEXAHYDRO-2′H-SPIRO[INDOLINE-2,1′- INDOLIZINE]-7′-YL)-3-METHOXYACRYLATE (MITRAGYNINE PSEUDOINDOXYL) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-7A- 08-26-26 91 FR 54948 8/26/2026 I HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–15, DIHYDRO-7- HYDROXYMITRAGYNINE) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-9-FLUORO- 08-26-26 91 FR 54948 8/26/2026 I 7A-HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–16) *

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-5,6- 08-27-26 91 FR 55252 8/27/2026 I DICHLORO-1,3-DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6- DICHLORO BRORPHINE, SR–14968) *

3-(3-(1-(1-(4-CHLOROPHENYL)ETHYL)PIPERIDIN-4-YL)-2- 08-27-26 91 FR 55252 8/27/2026 I OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-1- YL)PROPANENITRILE (N-PROPIONITRILE CHLORPHINE, CYCHLORPHINE) *

5,6-DICHLORO-1-(1-(4-CHLOROBENZYL)PIPERIDIN-4-YL)-1,3- 08-27-26 91 FR 55252 8/27/2026 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6-DICHLORO DESMETHYLCHLORPHINE,SR–17018) *

8-(1-(4-CHLOROPHENYL)ETHYL)-1-PHENYL-1,3,8- 08-27-26 91 FR 55252 8/27/2026 I TRIAZASPIRO[4.5]DECAN-4-ONE (SPIROCHLORPHINE, R–6890) *

CIPEPOFOL08-27-2691 FR 552598/27/2026IV
DIPHENIDINE (1-(1,2-DIPHENYLETHYL)PIPERIDINE)05-26-2609-21-2691 FR 5969510/21/2026I
CENTANAFADINE10-30-2691 FR 6847010/30/2026III
3-CHLOROMETHCATHINONE (3-CMC; 1-(3-11-06-2691 FR 7000911/6/2026I

CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

OVEPOREXTON 11-12-26 91 FR 72775 11/12/2026 IV

Scheduling Actions - Chronological Order

Alphabetical OrderControlled Substances

Controlled Substances

CSA

SUBSTANCE CSCN SCH NARC OTHER NAMES

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

[3,2-c]-Furazan-5α-androstan-17β-ol4000IIIN
[3,2-c]Pyrazole-androst-4-en-17β-ol4000IIIN
1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6-9097IY5,6-Dichloro brorphine; SR–14968

dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one 7552INDipentylone; N,N-dimethylpentylone
1-(1-Phenylcyclohexyl)pyrrolidine7458INPCPy; PHP; rolicyclidine
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine9663IYPEPAP; synthetic heroin
1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-7083IN5F-CUMYL-PINACA; SGT-25

3-carboxamide

1-[1-(2-Thienyl)cyclohexyl]piperidine7470INTCP; tenocyclidine
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473INTCPy
13β-Ethyl-17β-hydroxygon-4-en-3-one4000IIIN
17α-Methyl-3α,17β-dihydroxy-5α-androstane4000IIIN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

17α-Methyl-3β,17β-dihydroxy-5α-androstane4000IIIN
17α-Methyl-3β,17β-dihydroxyandrost-4-ene4000IIIN
17α-Methyl-4-hydroxynandrolone (17α-methyl-4-4000IIIN

hydroxy-17β-hydroxyestr-4-en-3-one)

17α-Methyl-5α-androstan-17β-ol4000IIIN
17α-Methyl-androst-2-ene-3,17β-diol4000IIIN
17α-Methyl-androsta-1,4-diene-3,17β-diol4000IIIN
17α-Methyl-androstan-3-hydroxyimine-17β-ol4000IIIN
17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-4000IIIN17α-Methyl-1-testosterone

methyl-5α-androst-1-en-3-one)

17β-Hydroxy-androstano[2,3-d]isoxazole4000IIIN
17β-Hydroxy-androstano[3,2-c]isoxazole4000IIIN
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one4000IIIN
19-Nor-4,9(10)-androstadienedione (estra-4,9(10)-4000IIIN

diene-3,17-dione)

19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenedione (estr-4-en-3,17-dione)4000IIIN
19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenedione (estr-5-en-3,17-dione)4000IIIN
1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenedione (5α-androst-1-en-3,17-dione)4000IIIN
1-Methyl-4-phenyl-4-propionoxypiperidine9661IYMPPP; synthetic heroin
1-Phenylcyclohexylamine7460IINPCP precursor
1-Piperidinocyclohexanecarbonitrile8603IINPCC; PCP precursor
2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-9770IYEthyleneoxynitazene

benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-9766IYMethylenedioxynitazene; 3′,4′-
1-yl)-N,N-diethylethan-1-amineMethylenedioxynitazene
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-7524IN2C-P

P)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) 7509 I N 2C-E

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508IN2C-D
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521IN2C-N
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517IN2C-H
2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol7000IN

(CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519IN2C-C
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)7537IN25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82

ethanamine (25C-NBOMe)

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T- 7385 I N 2C-T-2 2)

2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518IN2C-I
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)7538IN25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5

ethanamine (25I-NBOMe)

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE; methoxetamine (methoxetamine)

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 7348 I N 2C-T-7

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

2,5-Dimethoxyamphetamine7396INDMA; 2,5-DMA
2',5'-Dimethoxyfentanyl (N-(1-(2,5-9861IY

dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

2-Fluorodeschloroketamine 7284 I N 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1- one; 2-FDCK

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1- 9664 I Y yl)piperazin-1-yl)butan-1-one)

2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one4000IIIN
2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol4000IIIN
3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole7000IN

(JWH–184)

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA-5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3-MDA))

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-Ethyl MDA; MDE; MDEA

(Positional Isomer: MBDB)

3-Chloromethcathinone 1241 I N 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1- one

3-Fluoro-N-methylcathinone (3-FMC) 1233 I N 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one

(Positional Isomer: 2-FMC)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

3-Methoxyphencyclidine 7457 I N 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3- MeO–PCP

3-Methylfentanyl9813IYChina White; fentanyl
3-Methylmethcathinone (2-(methylamino)-1-(3-1259IN3-MMC; 3-methylmethcathinone

methylphenyl)propan-1-one)

3-Methylthiofentanyl9833IYChina White; fentanyl
3α,17β-Dihydroxy-5α-androstane4000IIIN
3β,17β-Dihydroxy-5α-androstane4000IIIN
3β-Hydroxy-estra-4,9,11-trien-17-one4000IIIN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- 1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) 7446 I N MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

4-Androstenediol (3β,17β-dihydroxy-androst-4-ene)4000IIIN4-AD
4-Androstenedione (androst-4-en-3,17-dione)4000IIIN
4-Anilino-N-phenethyl-4-piperidine (ANPP)8333IINANPP; despropionyl fentanyl
4-Bromo-2,5-dimethoxyamphetamine7391INDOB; 4-bromo-DMA
4-Bromo-2,5-dimethoxyphenethylamine7392IN2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA
4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one4000IIIN
4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-4000IIIN

dione

4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol4000IIIN
4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol4000IIIN
4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-7443IN4-Chloro-α-PVP; 4'-chloro-α-
PVP)pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-

(pyrrolidin-1-yl)pentan-1-one

4-Chloromethcathinone 1239 I N 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1- one

4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-7089IN4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL
phenylpropan-2-yl)-1 H-indazole-3-carboxamide)BINACA; CUMYL-4CN-BINACA; SGT-78
4-Dihydrotestosterone (17β-hydroxy-androstan-3-one)4000IIINAnabolex; Andractim; Pesomax; Stanolone
4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan-1476IN4–FA; 1-(4-fluorophenyl)propan-2-amine; para-
2-amine, para-fluoroamphetamine)fluoroamphetamine
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-9824IYpara-Fluoroisobutyryl fentanyl

phenethylpiperidin-4-yl)isobutyramide)

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N Flephedrone; 1-(4-fluorophenyl)-2- (methylamino)propan-1-one

(Positional Isomer: 2-FMC)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4- 4000 III N en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

4-Methoxyamphetamine 7411 I N PMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

4'-Methyl acetyl fentanyl (N-(1-(4- 9819 I Y methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM; STP

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

4-Methyl-alpha-ethylaminopentiophenone (4-MEAP) 7245 I N 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1- one

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) 7498 I N MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4- methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

4-Methylaminorex (cis isomer)1590INU4Euh; McN-422
4-Methyl-N-ethylcathinone (4-MEC)1249IN2-(Ethylamino)-1-(4-methylphenyl)propan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4- dimethylmethcathinone(3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

5-Androstenediol (3β,17β-dihydroxy-androst-5-ene)4000IIIN
5-Androstenedione (androst-5-en-3,17-dione)4000IIIN
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-7025IN

1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

dimethylbutanoate)(Positional isomers: 5F-AEB; 5F-EMB-PINACA)
5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-7033IN5F-AMB

carboxamido)-3-methylbutanoate)

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 7225 I N 5-Fluoro-PB-22; 5F-PB-22 carboxylate)

5-Methoxy-3,4-methylenedioxyamphetamine7401INMMDA
5-Methoxy-N,N-diisopropyltryptamine7439IN5-MeO-DIPT

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5-MeO-DPT))

5-Methoxy-N,N-dimethyltryptamine 7431 I N 5-MeO-DMT

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4-MeO-DMT, 4-methoxy-DMT))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

5α-Androstan-3,17-dione4000IIINAndrostanedione
5α-Androstan-3,6,17-trione4000IIIN
6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-7220INHexahydrocannabinol; HHC

benzo[c]chromen-1-ol

6-Bromo-androsta-1,4-diene-3,17-dione4000IIIN
6-Bromo-androstan-3,17-dione4000IIIN
6α-Methyl-androst-4-ene-3,17-dione4000IIIN
8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8-9093IYSpirochlorphine; R–6890

triazaspiro[4.5]decan-4-one

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

Acetorphine9319IY
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9821IY

phenylacetamide)

Acetyl-alpha-methylfentanyl9815IY
Acetyldihydrocodeine9051IYAcetylcodone
Acetylmethadol9601IYMethadyl acetate
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9811IYAcryloylfentanyl

phenylacrylamide)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I N ADB-PINACA yl)-1-pentyl-1H-indazole-3-carboxamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

Alfaxalone2731IVNAlfaxan; 5α-pregnan-3α-ol-11,20-dione
Alfentanil9737IIYAlfenta
Allylprodine9602IY
Alphacetylmethadol except levo-alphacetylmethadol9603IY
Alpha-ethyltryptamine7249INET; Trip
Alphameprodine9604IY
Alphamethadol9605IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

alpha'-Methyl butyryl fentanyl (2-methyl-N-(1- 9864 I Y phenethylpiperidin-4-yl)-N-phenylbutanamide)

alpha-Methylfentanyl9814IYChina White; fentanyl
alpha-Methylthiofentanyl9832IYChina White; fentanyl
alpha-Methyltryptamine7432INAMT

(Positional Isomer: N-Methyltryptamine)

Alphaprodine9010IIYNisentil
alpha-pyrrolidinobutiophenone (α-PBP)7546IN1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one
alpha-Pyrrolidinoheptaphenone (PV8)7548INPV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α-PiHPP; iso-PV8))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2- (piperidin-1-yl)butan-1-one)

Alprazolam2882IVNXanax
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201IN
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7000INPrior drug code 7694 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

Amineptine (7-[(10,11-dihydro-5H- 1219 I N dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

Aminorex1585INHas been sold as methamphetamine
Amobarbital2125IINAmytal; Tuinal
Amobarbital & noncontrolled active ingred.2126IIIN
Amobarbital suppository dosage form2126IIIN
Amphetamine1100IINDexedrine; Adderall; Obetrol
Anabolic steroids4000IIINAny substance meeting the definition of anabolic

steroid as set forth in 21 CFR 1300.01

Anileridine9020IIYLeritine
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-7048INAPINACA; AKB48

indazole-3-carboxamide

Aprobarbital2100IIINAlurate
Barbital2145IVNVeronal; Plexonal; barbitone
Barbituric acid derivative2100IIINBarbiturates not specifically listed
Benzethidine9606IY
Benzphetamine1228IIINDidrex; Inapetyl
Benzylmorphine9052IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Betacetylmethadol9607IY
beta-Hydroxy-3-methylfentanyl9831IYChina White; fentanyl
beta-Hydroxyfentanyl9830IYChina White; fentanyl
beta-Hydroxythiofentanyl9836IYN-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-

N-phenylpropionamide; N-[1-[2-hydroxy-2-(2- thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide

Betameprodine9608IY
Betamethadol9609IY
beta-Methyl fentanyl (N-phenyl-N-(1-(2-9856IY

phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

Betaprodine9611IY
Bezitramide9800IIYBurgodin
Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-4000IIIN

en-3-one)

Boldenone (17β-hydroxyandrost-1,4-diene-3-one)4000IIINEquipoise; Parenabol; Vebonol; dehydrotestosterone
Boldione (androsta-1,4-diene-3,17-dione)4000IIIN
Brexanolone (3α-hydroxy-5α-pregnan-20-one)2400IVNAllopregnanolone
Brivaracetam2710VNBRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4-

propylpyrrolidin-1-yl] butanamide)

Bromazepam2748IVNLexotan; Lexatin; Lexotanil
Bromazolam (8-bromo-1-methyl-6-phenyl-4H-2778IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-9098IY1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3-
1,3-dihydro-2H-benzo[d]imidazol-2-one)dihydro-2H-benzimidazol-2-one
Bufotenine7433INMappine; N,N-dimethylserotonin
Buprenorphine9064IIIYBuprenex; Temgesic; Subutex; Suboxone
Butabarbital (secbutabarbital)2100IIINButisol; Butibel
Butalbital2100IIINFiorinal; Butalbital with aspirin
Butobarbital (butethal)2100IIINSoneryl (UK)
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-9751IY

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Butorphanol9720IVNStadol; Stadol NS; Torbugesic; Torbutrol
Butylone7541INbk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-

(methylamino)butan-1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4- methylenedioxycathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N- (1-phenethylpiperidin-4-yl)-N-phenylbutanamide

Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4- 4000 III N Methosarb en-3-one)

Camazepam2749IVNAlbego; Limpidon; Paxor
Cannabimimetic agents7000INAny substance meeting the definition of

cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

Carfentanil9743IIYWildnil
Carisoprodol8192IVNSoma
Cathine1230IVNConstituent of "Khat" plant; (+)-norpseudoephedrine
Cathinone1235INConstituent of "Khat" plant
Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-2720VN2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-,
yl)ethyl]carbamate)carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1-

(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

Centanafadine1641IIIN
Chloral betaine2460IVNBeta Chlor
Chloral hydrate2465IVNNoctec
Chlordiazepoxide2744IVNLibrium; Libritabs; Limbitrol; SK-Lygen
Chlorhexadol2510IIINMechloral; Mecoral; Medodorm; Chloralodol
Chlorphentermine1645IIINPre-Sate; Lucofen; Apsedon; Desopimon
Cipepofol2139IVN
Clobazam2751IVNUrbadan; Urbanyl
Clonazepam2737IVNKlonopin; Clonopin
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-2786IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Clonitazene9612IY
Clorazepate2768IVNTranxene
Clortermine1647IIINVoranil
Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)4000IIINAlfa-Trofodermin; Clostene; 4-chlorotestosterone
Clotiazepam2752IVNTrecalmo; Rize; Clozan; Veratran
Cloxazolam2753IVNAkton; Lubalix; Olcadil; Sepazon
Coca Leaves9040IIY
Cocaine9041IIYMethyl benzoylecgonine; Crack
Codeine9050IIYMorphine methyl ester; methyl morphine
Codeine & isoquinoline alkaloid 90 mg/du9803IIIYCodeine with papaverine or noscapine
Codeine combination product 90 mg/du9804IIIYEmpirin; Fiorinal; Tylenol; ASA or APAP w/codeine
Codeine methylbromide9070IY
Codeine preparations - 200 mg/(100 ml or 100 gm)VYCosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof
Codeine-N-oxide9053IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-7000INPrior drug code 7297 under Synthetic Drug Abuse
hydroxycyclohexy]-phenol)Prevention Act; consolidated to 7000 under 91 FR

2297

CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2-7000INPrior drug code 7298 under Synthetic Drug Abuse
[(1R,3S)3-hydroxycyclohexyl]-phenol)Prevention Act; consolidated to 7000 under 91 FR

2297

Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- 9844 I Y phenylbut-2-enamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

Cyprenorphine9054IY
Daridorexant ([(S)-2-(5-chloro-4-methyl-2410IVNQUVIVIQ

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

Dehydrochloromethyltestosterone (4-chloro-17β- 4000 III N Oral-Turinabol hydroxy-17α-methyl-androst-1,4-dien-3-one)

Delorazepam2754IVN
Desomorphine9055IY
Desoxymethyltestosterone (17α-methyl-5α-androst-2-4000IIINMadol

en-17β-ol)

Dextromoramide9613IYPalfium; Jetrium; Narcolo
Dextropropoxyphene dosage forms9278IVYDarvon; propoxyphene; Darvocet; Propacet
Dextropropoxyphene, bulk (non-dosage forms)9273IIYPropoxyphene
Diampromide9615IY
Diazepam2765IVNValium; Diastat
Dichloralphenazone2467IVNMidrin; dichloralantipyrine
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-2789IN

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

Diethylpropion1610IVNTenuate; Tepanil
Diethylthiambutene9616IY
Diethyltryptamine7434INDET, N,N-diethyltryptamine

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

Difenoxin9168IYLyspafen
Difenoxin 1 mg/25 ug AtSO4/du9167IVYMotofen
Difenoxin preparations - 0.5 mg/25 ug AtSO4/duVYMotofen
Dihydrocodeine9120IIYDidrate; Parzone
Dihydrocodeine combination product 90 mg/du9807IIIYSynalgos-DC; Compal
Dihydrocodeine preparations 100mg/(100 ml or 100 gm)VYCophene-S, various others

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Dihydroetorphine9334IIYDHE
Dihydromorphine9145IY
Dimenoxadol9617IY
Dimepheptanol9618IY
Dimethylthiambutene9619IY
Dimethyltryptamine7435INDMT
Dioxaphetyl butyrate9621IY
Diphenidine7292IY1-(1,2-Diphenylethyl)piperidine
Diphenoxylate9170IIY
Diphenoxylate preparations 2.5 mg/25 ug AtSO4VYLomotil; Logen
Dipipanone9622IYDipipan; phenylpiperone HCl; Diconal; Wellconal
Dronabinol (synthetic) in sesame oil in soft gelatin7369IIINMarinol; synthetic THC in sesame oil/soft gelatin as
capsule as approved by FDAapproved by FDA
Dronabinol in an oral solution in a drug product7365IINSyndros

approved for marketing by the U.S. Food and Drug Administration

Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- 4000 III N Drolban; Masterid; Permastril one)

Drotebanol9335IYMetebanyl; oxymethebanol
Ecgonine9180IIYCocaine precursor, in Coca leaves
Eluxadoline9725IVNVIBERZI
Embutramide2020IIINTributane
Estazolam2756IVNProSom; Domnamid; Eurodin; Nuctalon
Estra-4,9,11-triene-3,17-dione4000IIIN
Ethchlorvynol2540IVNPlacidyl
Ethinamate2545IVNValmid; Valamin
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-7036IN5F-EDMB-PINACA

3,3-dimethylbutanoate

Ethyl loflazepate2758IVN
Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)4000IIINMaxibolin; Orabolin; Durabolin-O; Duraboral
Ethylmethylthiambutene9623IY
Ethylmorphine9190IIYDionin
Ethylmorphine combination product 15 mg/du9808IIIY
Ethylmorphine preparations 100 mg/(100 ml or 100 gm)VY
Ethylone7547IN1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one;

3,4-methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)1727IN
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-2780IN

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Etonitazene9624IY
Etorphine (except HCl)9056IY
Etorphine HCl9059IIYM 99
Etoxeridine9625IY
Eutylone7549IN1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one;

bk-EBDB

Ezogabine2779VNPotiga
Fencamfamin1760IVNReactivan
Fenethylline1503INCaptagon; amfetyline; ethyltheophylline amphetamine
Fenproporex1575IVNGacilin; Solvolip
Fentanyl9801IIYDuragesic; Oralet; Actiq; Sublimaze; Innovar
Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-9851IY

yl)(phenyl)carbamate)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H- 2785 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-2788IN8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-
4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Fludiazepam2759IVN
Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-9756IY

1H-benzimidazol-1-yl)ethan-1-amine)

Flunitrazepam2763IVNRohypnol; Narcozep; Darkene; Roipnol
Fluoxymesterone (9-fluoro-17α-methyl-11β,17β-4000IIINAnadroid-F; Halotestin; Ora-Testryl

dihydroxyandrost-4-en-3-one)

Flurazepam2767IVNDalmane
Formebolone (2-formyl-17α-methyl-11α,17β-4000IIINEsiclene; Hubernol

dihydroxyandrost-1,4-dien-3-one)

Fospropofol2138IVNLusedra
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9834IY

phenylfuran-2-carboxamide)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

Furethidine9626IY
Gamma Hydroxybutyric Acid2010INGHB; gamma hydroxybutyrate; sodium oxybate
Gamma Hydroxybutyric Acid preparations2012IIINXyrem
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) 2401VN
Glutethimide2550IINDoriden; Dorimide
Halazepam2762IVNPaxipam
Haloxazolam2771IVN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Heroin9200IYDiacetylmorphine; diamorphine
Hydrocodone9193IIYDihydrocodeinone
Hydromorphinol9301IY
Hydromorphone9150IIYDilaudid; dihydromorphinone
Hydroxypethidine9627IY
Ibogaine7260INConstituent of "Tabernanthe iboga" plant
Isobutyryl fentanyl9827IYN-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
Isomethadone9226IIYIsoamidone
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-9614IYN,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-
nitro-1H-benzimidazol-1-yl)ethan-1-amine)nitro-1H-benzimidazole-1-ethanamine
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-9862IY

yl)-N-phenylbutanamide)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-7000INPrior drug code 7200 under Synthetic Drug Abuse
naphthoyl)indole)Prevention Act; consolidated to 7000 under 91 FR

2297

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) 7000 I N Prior drug code 7203 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Ketamine7285IIINKetaset; Ketalar; Special K; K
Ketazolam2772IVNAnxon; Loftran; Solatran; Contamex
Ketobemidone9628IYCliradon
Lacosamide2746VNVimpat
Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-2790VNReyvow

carbonyl)pyridine-2-yl-benzamide]

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Lemborexant 2245 IV N (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2- (3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane- 1-carboxamide

Levo-alphacetylmethadol9648IIYLAAM; long acting methadone; levomethadyl acetate
Levomethorphan9210IIY
Levomoramide9629IY
Levophenacylmorphan9631IY
Levorphanol9220IIYLevo-Dromoran
Lisdexamfetamine1205IINVyvanse
Loprazolam2773IVN
Lorazepam2885IVNAtivan
Lorcaserin1625IVNBelviq
Lormetazepam2774IVNNoctamid
Lysergic acid7300IIINLSD precursor
Lysergic acid amide7310IIINLSD precursor
Lysergic acid diethylamide7315INLSD; lysergide
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-7032INMAB-CHMINACA; ADB-CHMINACA

2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

Marihuana7360INCannabis; marijuana
Marihuana Extract7350IN
Marijuana extract, as defined in 21 CFR7353IIIN

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. 7362 III N Food and Drug Administration approved product or subject to a state medical marijuana license

Mazindol1605IVNSanorex; Mazanor
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4-7090INMDMB-4en-PINACA

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ; 1-(1,3-benzodioxol- 4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

Mebutamate 2800 IV N Capla

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Mecloqualone2572INNubarene
Medazepam2836IVNNobrium
Mefenorex1580IVNAnorexic; Amexate; Doracil; Pondinil
Meperidine9230IIYDemerol; Mepergan; pethidine
Meperidine intermediate-A9232IIYMeperidine precursor
Meperidine intermediate-B9233IIYMeperidine precursor; normeperidine
Meperidine intermediate-C9234IIYMeperidine precursor
Mephedrone (4-Methyl-N-methylcathinone)1248IN4-MMC

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

Meprobamate2820IVNMiltown; Equanil; Micrainin; Equagesic; Meprospan
Mescaline7381INConstituent of "Peyote" cacti
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-1227IN

oxadiazol-3-ium-5-yl)carbamimidate)

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

Metazocine9240IIY
Methadone9250IIYDolophine; Methadose; Amidone
Methadone intermediate (4-cyano-2-dimethylamino-4,4-9254IIYMethadone precursor

diphenylbutane)

Methamphetamine1105IINDesoxyn; D-desoxyephedrine; ICE; Crank; Speed
Methandienone (17α-methyl-17β-hydroxyandrost-1,4-4000IIINDianabol; Metabolina; Nerobol; Perbolin

dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

Methaqualone2565INQuaalude; Parest; Somnafac; Opitimil; Mandrax
Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-4000IIINMethasterone; 2α,17α-dimethyl-17β-hydroxy-5α-
one)androstan-3-one
Methcathinone1237INN-Methylcathinone, "cat"
Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-4000IIINPrimobolan; Primobolan Depot; Primobolan S

one)

Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine)

Methohexital 2264 IV N Brevital

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo- 9672 I Y Mitragynine pseudoindoxyl 3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-9674IYMGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10-
7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-fluoro-dihydro-7-hydroxymitragynine

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB- PICA)

Methyldesorphine9302IY
Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-4000IIIN

dien-3-one)

Methyldihydromorphine9304IY
Methylone (3,4-Methylenedioxy-N-methylcathinone)7540IN

(Positional Isomer: ￿2,3- methylenedioxymethcathinone (2,3-MDMC, 1- (benzo[d][1,3]dioxol-4-yl)-2-(methylamino)propan-1- one))

Methylphenidate1724IINConcerta; Ritalin; Methylin
Methylphenobarbital (mephobarbital)2250IVNMebaral; mephobarbital
Methyltestosterone (17α-methyl-17β-hydroxyandrost-4-4000IIINAndroid; Oreton; Testred; Virilon

en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

Methyprylon2575IIINNoludar
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-9764IY

1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

Metopon9260IIY
Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-4000IIINCheque; Matenon

one)

Midazolam2884IVNVersed
MMB-CHMICA; AMB-CHMICA (methyl 2-(1-7044IN

(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

Modafinil1680IVNProvigil
Moramide-intermediate9802IIY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Morpheridine9632IY
Morphine9300IIYMS Contin; Roxanol; Oramorph; RMS; MSIR
Morphine combination product/50 mg/(100 ml or 1009810IIIY

gm)

Morphine methylbromide9305IY
Morphine methylsulfonate9306IY
Morphine-N-oxide9307IY
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)9560IY
Myrophine9308IY
N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-9843IYTetrahydrofuranyl fentanyl

2-carboxamide

N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I Y ortho-Fluorofentanyl or 2-fluorofentanyl yl)propionamide

N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-7047INFUB-AKB48; FUB-APINACA; AKB48 N-(4-
carboxamideFLUOROBENZYL)
N,N-Dimethylamphetamine1480IN
Nabilone7379IINCesamet
Nalorphine9400IIIYNalline
Nandrolone (17β-hydroxyestr-4-en-3-one)4000IIINDeca-Durabolin; Durabolin; Durabolin-50
Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3-7000IN

yl)methanone (JWH–022)

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one

(Positional Isomer: α-naphyrone)

Naturally derived delta-9-tetrahydrocannabinols in a7386IIIN(i) Naturally derived delta-9-tetrahydrocannabinols
U.S. Food and Drug Administration approved productmeans those delta-9-tetrahydrocannabinols, except
or in marijuana subject to a state medical marijuanaas in paragraphs 21 CFR 1308.13(g)(2) and (3), that
licenseare naturally contained in a plant of the genus

Cannabis (cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

N-Benzylpiperazine7493INBZP; 1-benzylpiperazine
N-Desethyl isotonitazene (N-ethyl-2-(2-(4-9760IY

isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

N-Ethyl-1-phenylcyclohexylamine7455INPCE
N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-9769IYN-Desethyl protonitazene

benzimidazol-1-yl)ethan-1-amine

N-Ethyl-3-piperidyl benzilate7482INJB 323
N-Ethylamphetamine1475INNEA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

N-Ethylhexedrone 7246 I N α-Ethylaminohexanophenone; 2-(ethylamino)-1- phenylhexan-1-one

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

N-Hydroxy-3,4-methylenedioxyamphetamine7402INN-Hydroxy MDA
Nicocodeine9309IY
Nicomorphine9312IYVilan
Nimetazepam2837IVNErimin
Nitrazepam2834IVNMogadon
NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-7221IN

1H-indole-3-carboxylate)

N-Methyl-3-piperidyl benzilate7484INJB 336
Noracymethadol9633IY
Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3-4000IIINGenabol

one)

Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)4000IIINAnabol-4-19; Lentabol
Nordiazepam2838IVNNordazepam; Demadar; Madar
Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-4000IIINNilevar; Pronabol; Solevar

one)

Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide)8366IIY
Norlevorphanol9634IY
Normethadone9635IYPhenyldimazone
Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-4000IIINLutenin; Matronal; Orgasteron

one)

Normorphine9313IY
Noroxymorphone9668IIY
Norpipanone9636IY
N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-9761IYEtonitazepipne

(2-(piperidin-1-yl)ethyl-1H-benzimidazole)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2- 9245 II Y [(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

Opium combination product 25 mg/du9809IIIYParegoric, other combination products
Opium extracts9610IIY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Opium fluid extract9620IIY
Opium poppy9650IIYPapaver somniferum
Opium preparations - 100 mg/(100 ml or 100 gm)VYParepectolin; Kapectolin PG; Kaolin Pectin P.G.
Opium tincture9630IIYLaudanum
Opium, granulated9640IIYGranulated opium
Opium, powdered9639IIYPowdered opium
Opium, raw9600IIYRaw opium; gum opium
Oripavine9330IIY
ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1-9828IY

phenethylpiperidin-4-yl)propionamide)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

Oveporexton 1775 IV N N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2- fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- 4000 III N Anavar; Lonavar; Oxandrin; Provitar; Vasorome androstan-3-one)

Oxazepam2835IVNSerax; Serenid-D
Oxazolam2839IVNSerenal; Convertal
Oxycodone9143IIYOxyContin; Percocet; Endocet; Roxicodone; Roxicet
Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-4000IIINAnamidol; Balnimax; Oranabol; Oranabol 10

en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

Oxymorphone9652IIYNumorphan
para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1-9818IY

phenethylpiperidin-4-yl)propionamide)

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

para-Fluorofentanyl9812IYChina White; fentanyl
Parahexyl7374INSynhexyl
Paraldehyde2585IVNParal
para-Methoxybutyryl fentanyl9837IYN-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4-

yl)butyramide

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Methoxymethamphetamine (PMMA); 1-(4- 1245 I N (Positional isomer: methoxyphenamine (OMMA)) methoxyphenyl)-N-methylpropan-2-amine

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222INQUPIC; PB-22
Pemoline1530IVNCylert
Pentazocine9709IVNTalwin; Talwin NX; Talacen; Talwin Compound
Pentedrone (α-methylaminovalerophenone)1246IN2-(Methylamino)-1-phenylpentan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Pentobarbital2270IINNembutal
Pentobarbital & noncontrolled active ingred.2271IIINFP-3
Pentobarbital suppository dosage form2271IIINWANS
Pentylone7542INbk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-

(methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2- (propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

Perampanel 2261 III N Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- dihydropyridin-3-yl) benzonitrile]

Petrichloral2591IVNPentaerythritol chloral; Periclor
Peyote7415INCactus which contains mescaline
Phenadoxone9637IY
Phenampromide9638IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Phenazocine9715IIYNarphen; Prinadol
Phencyclidine7471IINPCP; Sernylan
Phendimetrazine1615IIINPlegine; Prelu-2; Bontril; Melfiat; Statobex
Phenmetrazine1631IINPreludin
Phenobarbital2285IVNLuminal; Bellergal-S
Phenomorphan9647IY
Phenoperidine9641IYOperidine; Lealgin
Phentermine1640IVNIonamin; Fastin; Adipex-P; Obe-Nix; Zantryl
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9841IY

phenylbenzamide; also known as benzoyl fentanyl)

Phenylacetone8501IINP2P; phenyl-2-propanone; benzyl methyl ketone
Pholcodine9314IYCopholco; Adaphol; Codisol; Lantuss; Pholcolin
Piminodine9730IIY
Pinazepam2883IVNDomar
Pipradrol1750IVNDetari; Stimolag Fortis
Piritramide9642IYPiridolan
Poppy Straw9650IIYOpium poppy capsules; poppy heads
Poppy Straw Concentrate9670IIYConcentrate of Poppy Straw, CPS
Prazepam2764IVNCentrax
Pregabalin2782VNLyrica
Proheptazine9643IY
Properidine9644IY
Propiram9649IYAlgeril
Prostanozol (17β-hydroxy-5α-androstano[3,2-4000IIINProstanozol; [3,2-c]pyrazole-5α-androstan-17β-ol

c]pyrazole)

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I Y propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

Psilocybin7437INConstituent of "Magic mushrooms"
Psilocyn7438INPsilocin, constituent of "Magic mushrooms"

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

Pyrovalerone1485VNCentroton; Thymergix
Quazepam2881IVNDoral
Racemethorphan9732IIY
Racemoramide9645IY
Racemorphan9733IIYDromoran
Remifentanil9739IIYUltiva

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-2846IVN8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester,
4-propionic acid)benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1-

methyl-6-pyridin-2-yl-4H-imidazo[1,2- a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

Secobarbital2315IINSeconal; Tuinal
Secobarbital & noncontrolled active ingred2316IIIN
Secobarbital suppository dosage form2316IIIN
Serdexmethylphenidate1729IVN
Sibutramine1675IVNMeridia
Solriamfetol (2-amino-3-phenylpropyl car-bamate;1650IVN

benzenepropanol, beta-amino-, carbamate (ester))

SPA1635IVN1-Dimethylamino-1,2-diphenylethane; Lefetamine
SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl)7000INRCS-8
indole)Prior drug code 7008 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- 4000 III N Winstrol; Winstrol-V eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

Stimulant compounds previously excepted1405IIINMediatric
Sufentanil9740IIYSufenta
Sulfondiethylmethane2600IIIN
Sulfonethylmethane2605IIIN
Sulfonmethane2610IIIN
Suvorexant2223IVNMK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-

methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3- triazol-2-yl)phenyl]methanone

Talbutal2100IIINLotusate
Tapentadol9780IIY
Temazepam2925IVNRestoril
Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-4000IIINTeolit; Teslac

1,4-dien-17-oic acid lactone)

Testosterone (17β-hydroxyandrost-4-en-3-one)4000IIINAndroid-T; Androlan; Depotest; Delatestryl
Tetrahydrocannabinols7370INTHC; Delta-8 THC; Delta-9 THC; dronabinol and

others

Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon- 4000 III N THG 4,9,11-trien-3-one)

Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin- 9869 I Y Tetrahydrothiophene fentanyl 4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Tetrazepam2886IVNMyolastan; Musaril
Thebacon9315IYAcetylhydrocodone; Acedicon; Thebacetyl
Thebaine9333IIYPrecursor of many narcotics
Thiafentanil9729IIYThianil
Thiamylal2100IIINSurital
Thiofentanyl9835IYChine white; fentanyl
Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9839IY

phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

Thiopental2100IIINPentothal
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-7024IN

yl](naphthalen-1-yl)methanone)

Tiletamine & Zolazepam Combination Product7295IIINTelazol
Tilidine9750IYTilidate; Valoron; Kitadol; Lak; Tilsa
Tramadol (2-[(dimethylamino)methyl]-1-(3-9752IVYTramadol

methoxyphenyl)cyclohexanol)

Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)4000IIINFinaplix-S; Finajet; Parabolan
Triazolam2887IVNHalcion
Trimeperidine9646IYPromedolum
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-9547IY

N-methylbenzamide)

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

Valeryl fentanyl9840IYN-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide
Vinbarbital2100IIINDelvinal; vinbarbitone
Zaleplon2781IVNSonata
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-9873IY

phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

Zolpidem2783IVNAmbien; Ivadal; Stilnoct; Stilnox
Zopiclone2784IVNLunesta
Zuranolone2420IVNZURZUVAE
α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-7551INα-PiHP; alpha-PiHP

one)

Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en- 4000 III N 1-Testosterone 3-one)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

DEA Drug Code NumberControlled Substances

- by Controlled Substance Code Number -

SUBSTANCE CSCN SCH NARC OTHER NAMES

Codeine preparations - 200 mg/(100 ml or 100 gm)VY Cosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof
Difenoxin preparations - 0.5 mg/25 ug AtSO4/duVY Motofen
Dihydrocodeine preparations 100mg/(100 ml or 100 gm)VY Cophene-S, various others
Diphenoxylate preparations 2.5 mg/25 ug AtSO4VY Lomotil; Logen
Ethylmorphine preparations 100 mg/(100 ml or 100 gm)VY
Opium preparations - 100 mg/(100 ml or 100 gm)VY Parepectolin; Kapectolin PG; Kaolin Pectin P.G.
Amphetamine1100IIN Dexedrine; Adderall; Obetrol
Methamphetamine1105IIN Desoxyn; D-desoxyephedrine; ICE; Crank; Speed
Lisdexamfetamine1205IIN Vyvanse
Amineptine (7-[(10,11-dihydro-5H-1219IN

dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3- 1227 I N oxadiazol-3-ium-5-yl)carbamimidate)

Benzphetamine1228IIIN Didrex; Inapetyl
Cathine1230IVN Constituent of "Khat" plant; (+)-norpseudoephedrine
3-Fluoro-N-methylcathinone (3-FMC)1233IN 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one

(Positional Isomer: 2-FMC)

Cathinone1235IN Constituent of "Khat" plant
Methcathinone1237IN N-Methylcathinone, "cat"
4-Fluoro-N-methylcathinone (4-FMC)1238IN Flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1-

one

(Positional Isomer: 2-FMC)

4-Chloromethcathinone1239IN 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1-one
3-Chloromethcathinone1241IN 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1-one
para-Methoxymethamphetamine (PMMA); 1-(4-1245IN (Positional isomer: methoxyphenamine (OMMA))

methoxyphenyl)-N-methylpropan-2-amine

Pentedrone (α-methylaminovalerophenone) 1246 I N 2-(Methylamino)-1-phenylpentan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Mephedrone (4-Methyl-N-methylcathinone) 1248 I N 4-MMC

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

4-Methyl-N-ethylcathinone (4-MEC) 1249 I N 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone(3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomer: α-naphyrone)

3-Methylmethcathinone (2-(methylamino)-1-(3- 1259 I N 3-MMC; 3-methylmethcathinone methylphenyl)propan-1-one)

Stimulant compounds previously excepted1405IIIN Mediatric
N-Ethylamphetamine1475IN NEA
4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan-1476IN 4–FA; 1-(4-fluorophenyl)propan-2-amine; para-
2-amine, para-fluoroamphetamine)fluoroamphetamine
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-1478IN

amine)

N,N-Dimethylamphetamine1480IN
Pyrovalerone1485VN Centroton; Thymergix
Fenethylline1503IN Captagon; amfetyline; ethyltheophylline amphetamine
Pemoline1530IVN Cylert
Fenproporex1575IVN Gacilin; Solvolip
Mefenorex1580IVN Anorexic; Amexate; Doracil; Pondinil
Aminorex1585IN Has been sold as methamphetamine
4-Methylaminorex (cis isomer)1590IN U4Euh; McN-422
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595IN

methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

Mazindol1605IVN Sanorex; Mazanor
Diethylpropion1610IVN Tenuate; Tepanil
Phendimetrazine1615IIIN Plegine; Prelu-2; Bontril; Melfiat; Statobex
Lorcaserin1625IVN Belviq
Phenmetrazine1631IIN Preludin
SPA1635IVN 1-Dimethylamino-1,2-diphenylethane; Lefetamine
Phentermine1640IVN Ionamin; Fastin; Adipex-P; Obe-Nix; Zantryl
Centanafadine1641IIIN
Chlorphentermine1645IIIN Pre-Sate; Lucofen; Apsedon; Desopimon
Clortermine1647IIIN Voranil
Solriamfetol (2-amino-3-phenylpropyl car-bamate;1650IVN

benzenepropanol, beta-amino-, carbamate (ester))

Sibutramine1675IVN Meridia
Modafinil1680IVN Provigil

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Methylphenidate1724IIN Concerta; Ritalin; Methylin
Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)1727IN
Serdexmethylphenidate1729IVN
Pipradrol1750IVN Detari; Stimolag Fortis
Fencamfamin1760IVN Reactivan
Oveporexton1775IVN N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2-

fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

Gamma Hydroxybutyric Acid2010IN GHB; gamma hydroxybutyrate; sodium oxybate
Gamma Hydroxybutyric Acid preparations2012IIIN Xyrem
Embutramide2020IIIN Tributane
Aprobarbital2100IIIN Alurate
Barbituric acid derivative2100IIIN Barbiturates not specifically listed
Butabarbital (secbutabarbital)2100IIIN Butisol; Butibel
Butalbital2100IIIN Fiorinal; Butalbital with aspirin
Butobarbital (butethal)2100IIIN Soneryl (UK)
Talbutal2100IIIN Lotusate
Thiamylal2100IIIN Surital
Thiopental2100IIIN Pentothal
Vinbarbital2100IIIN Delvinal; vinbarbitone
Amobarbital2125IIN Amytal; Tuinal
Amobarbital & noncontrolled active ingred.2126IIIN
Amobarbital suppository dosage form2126IIIN
Fospropofol2138IVN Lusedra
Cipepofol2139IVN
Barbital2145IVN Veronal; Plexonal; barbitone
Suvorexant2223IVN MK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-

1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone

Lemborexant 2245 IV N (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2-(3- fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1- carboxamide

Methylphenobarbital (mephobarbital)2250IVN Mebaral; mephobarbital
Perampanel2261IIIN Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2-

dihydropyridin-3-yl) benzonitrile]

Methohexital2264IVN Brevital
Pentobarbital2270IIN Nembutal
Pentobarbital & noncontrolled active ingred.2271IIIN FP-3
Pentobarbital suppository dosage form2271IIIN WANS
Phenobarbital2285IVN Luminal; Bellergal-S

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Secobarbital2315IIN Seconal; Tuinal
Secobarbital & noncontrolled active ingred2316IIIN
Secobarbital suppository dosage form2316IIIN
Brexanolone (3α-hydroxy-5α-pregnan-20-one)2400IVN Allopregnanolone
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one)2401VN
Daridorexant ([(S)-2-(5-chloro-4-methyl-2410IVN QUVIVIQ

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

Zuranolone2420IVN ZURZUVAE
Chloral betaine2460IVN Beta Chlor
Chloral hydrate2465IVN Noctec
Dichloralphenazone2467IVN Midrin; dichloralantipyrine
Chlorhexadol2510IIIN Mechloral; Mecoral; Medodorm; Chloralodol
Ethchlorvynol2540IVN Placidyl
Ethinamate2545IVN Valmid; Valamin
Glutethimide2550IIN Doriden; Dorimide
Methaqualone2565IN Quaalude; Parest; Somnafac; Opitimil; Mandrax
Mecloqualone2572IN Nubarene
Methyprylon2575IIIN Noludar
Paraldehyde2585IVN Paral
Petrichloral2591IVN Pentaerythritol chloral; Periclor
Sulfondiethylmethane2600IIIN
Sulfonethylmethane2605IIIN
Sulfonmethane2610IIIN
Brivaracetam2710VN BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4-

propylpyrrolidin-1-yl] butanamide)

Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-2720VN 2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-,
yl)ethyl]carbamate)carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1-(2-

chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

Alfaxalone2731IVN Alfaxan; 5α-pregnan-3α-ol-11,20-dione
Clonazepam2737IVN Klonopin; Clonopin
Chlordiazepoxide2744IVN Librium; Libritabs; Limbitrol; SK-Lygen
Lacosamide2746VN Vimpat
Bromazepam2748IVN Lexotan; Lexatin; Lexotanil
Camazepam2749IVN Albego; Limpidon; Paxor
Clobazam2751IVN Urbadan; Urbanyl
Clotiazepam2752IVN Trecalmo; Rize; Clozan; Veratran
Cloxazolam2753IVN Akton; Lubalix; Olcadil; Sepazon
Delorazepam2754IVN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Estazolam2756IVN ProSom; Domnamid; Eurodin; Nuctalon
Ethyl loflazepate2758IVN
Fludiazepam2759IVN
Halazepam2762IVN Paxipam
Flunitrazepam2763IVN Rohypnol; Narcozep; Darkene; Roipnol
Prazepam2764IVN Centrax
Diazepam2765IVN Valium; Diastat
Flurazepam2767IVN Dalmane
Clorazepate2768IVN Tranxene
Haloxazolam2771IVN
Ketazolam2772IVN Anxon; Loftran; Solatran; Contamex
Loprazolam2773IVN
Lormetazepam2774IVN Noctamid
Bromazolam (8-bromo-1-methyl-6-phenyl-4H-2778IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Ezogabine2779VN Potiga
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-2780IN

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Zaleplon2781IVN Sonata
Pregabalin2782VN Lyrica
Zolpidem2783IVN Ambien; Ivadal; Stilnoct; Stilnox
Zopiclone2784IVN Lunesta
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-2785IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H- 2786 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-2788IN 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-
4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)a][1,4]benzodiazepine
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-2789IN

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4- 2790 V N Reyvow carbonyl)pyridine-2-yl-benzamide]

Mebutamate2800IVN Capla
Meprobamate2820IVN Miltown; Equanil; Micrainin; Equagesic; Meprospan
Nitrazepam2834IVN Mogadon
Oxazepam2835IVN Serax; Serenid-D
Medazepam2836IVN Nobrium
Nimetazepam2837IVN Erimin
Nordiazepam2838IVN Nordazepam; Demadar; Madar
Oxazolam2839IVN Serenal; Convertal

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-2846IVN 8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester,
4-propionic acid)benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1-methyl-

6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

Quazepam2881IVN Doral
Alprazolam2882IVN Xanax
Pinazepam2883IVN Domar
Midazolam2884IVN Versed
Lorazepam2885IVN Ativan
Tetrazepam2886IVN Myolastan; Musaril
Triazolam2887IVN Halcion
Temazepam2925IVN Restoril
[3,2-c]-Furazan-5α-androstan-17β-ol4000IIIN
[3,2-c]Pyrazole-androst-4-en-17β-ol4000IIIN
13β-Ethyl-17β-hydroxygon-4-en-3-one4000IIIN
17α-Methyl-3α,17β-dihydroxy-5α-androstane4000IIIN
17α-Methyl-3β,17β-dihydroxy-5α-androstane4000IIIN
17α-Methyl-3β,17β-dihydroxyandrost-4-ene4000IIIN
17α-Methyl-4-hydroxynandrolone (17α-methyl-4-4000IIIN

hydroxy-17β-hydroxyestr-4-en-3-one)

17α-Methyl-5α-androstan-17β-ol4000IIIN
17α-Methyl-androst-2-ene-3,17β-diol4000IIIN
17α-Methyl-androsta-1,4-diene-3,17β-diol4000IIIN
17α-Methyl-androstan-3-hydroxyimine-17β-ol4000IIIN
17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-4000IIIN 17α-Methyl-1-testosterone

methyl-5α-androst-1-en-3-one)

17β-Hydroxy-androstano[2,3-d]isoxazole4000IIIN
17β-Hydroxy-androstano[3,2-c]isoxazole4000IIIN
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one4000IIIN
19-Nor-4,9(10)-androstadienedione (estra-4,9(10)-4000IIIN

diene-3,17-dione)

19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenedione (estr-4-en-3,17-dione)4000IIIN
19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenedione (estr-5-en-3,17-dione)4000IIIN
1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenedione (5α-androst-1-en-3,17-dione)4000IIIN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one4000IIIN
2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol4000IIIN
3α,17β-Dihydroxy-5α-androstane4000IIIN
3β,17β-Dihydroxy-5α-androstane4000IIIN
3β-Hydroxy-estra-4,9,11-trien-17-one4000IIIN
4-Androstenediol (3β,17β-dihydroxy-androst-4-ene)4000IIIN 4-AD
4-Androstenedione (androst-4-en-3,17-dione)4000IIIN
4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one4000IIIN
4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-4000IIIN

dione

4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol4000IIIN
4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol4000IIIN
4-Dihydrotestosterone (17β-hydroxy-androstan-3-one)4000IIIN Anabolex; Andractim; Pesomax; Stanolone
4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4-4000IIIN

en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

5-Androstenediol (3β,17β-dihydroxy-androst-5-ene)4000IIIN
5-Androstenedione (androst-5-en-3,17-dione)4000IIIN
5α-Androstan-3,17-dione4000IIIN Androstanedione
5α-Androstan-3,6,17-trione4000IIIN
6-Bromo-androsta-1,4-diene-3,17-dione4000IIIN
6-Bromo-androstan-3,17-dione4000IIIN
6α-Methyl-androst-4-ene-3,17-dione4000IIIN
Anabolic steroids4000IIIN Any substance meeting the definition of anabolic steroid

as set forth in 21 CFR 1300.01

Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4- 4000 III N en-3-one)

Boldenone (17β-hydroxyandrost-1,4-diene-3-one)4000IIIN Equipoise; Parenabol; Vebonol; dehydrotestosterone
Boldione (androsta-1,4-diene-3,17-dione)4000IIIN
Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-4000IIIN Methosarb

en-3-one)

Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)4000IIIN Alfa-Trofodermin; Clostene; 4-chlorotestosterone
Dehydrochloromethyltestosterone (4-chloro-17β-4000IIIN Oral-Turinabol

hydroxy-17α-methyl-androst-1,4-dien-3-one)

Desoxymethyltestosterone (17α-methyl-5α-androst-2- 4000 III N Madol en-17β-ol)

Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- 4000 III N Drolban; Masterid; Permastril one)

Estra-4,9,11-triene-3,17-dione 4000 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)4000IIIN Maxibolin; Orabolin; Durabolin-O; Duraboral
Fluoxymesterone (9-fluoro-17α-methyl-11β,17β-4000IIIN Anadroid-F; Halotestin; Ora-Testryl

dihydroxyandrost-4-en-3-one)

Formebolone (2-formyl-17α-methyl-11α,17β- 4000 III N Esiclene; Hubernol dihydroxyandrost-1,4-dien-3-one)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

Methandienone (17α-methyl-17β-hydroxyandrost-1,4- 4000 III N Dianabol; Metabolina; Nerobol; Perbolin dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-4000IIIN Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α-androstan-
one)3-one
Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-4000IIIN Primobolan; Primobolan Depot; Primobolan S

one)

Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- 4000 III N dien-3-one)

Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- 4000 III N Android; Oreton; Testred; Virilon en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3- 4000 III N Cheque; Matenon one)

Nandrolone (17β-hydroxyestr-4-en-3-one)4000IIIN Deca-Durabolin; Durabolin; Durabolin-50
Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3-4000IIIN Genabol

one)

Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)4000IIIN Anabol-4-19; Lentabol
Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-4000IIIN Nilevar; Pronabol; Solevar

one)

Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- 4000 III N Lutenin; Matronal; Orgasteron one)

Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- 4000 III N Anavar; Lonavar; Oxandrin; Provitar; Vasorome androstan-3-one)

Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- 4000 III N Anamidol; Balnimax; Oranabol; Oranabol 10 en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

Prostanozol (17β-hydroxy-5α-androstano[3,2- 4000 III N Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol c]pyrazole)

Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- 4000 III N Winstrol; Winstrol-V eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- 4000 III N Teolit; Teslac 1,4-dien-17-oic acid lactone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Testosterone (17β-hydroxyandrost-4-en-3-one)4000IIIN Android-T; Androlan; Depotest; Delatestryl
Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon-4000IIIN THG

4,9,11-trien-3-one)

Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)4000IIIN Finaplix-S; Finajet; Parabolan
Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en-4000IIIN 1-Testosterone

3-one)

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol 7000 I N (CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole 7000 I N (JWH–184)

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) 7000 I N Prior drug code 7694 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Cannabimimetic agents 7000 I N Any substance meeting the definition of cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-7000IN Prior drug code 7297 under Synthetic Drug Abuse
hydroxycyclohexy]-phenol)Prevention Act; consolidated to 7000 under 91 FR 2297
CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2-7000IN Prior drug code 7298 under Synthetic Drug Abuse
[(1R,3S)3-hydroxycyclohexyl]-phenol)Prevention Act; consolidated to 7000 under 91 FR 2297

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-7000IN Prior drug code 7200 under Synthetic Drug Abuse
naphthoyl)indole)Prevention Act; consolidated to 7000 under 91 FR 2297
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)7000IN Prior drug code 7203 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3- 7000 I N yl)methanone (JWH–022)

SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl)7000IN RCS-8
indole)Prior drug code 7008 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I N yl](naphthalen-1-yl)methanone)

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7025 I N 1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan- 7032 I N MAB-CHMINACA; ADB-CHMINACA 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- 7033 I N 5F-AMB carboxamido)-3-methylbutanoate)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

dimethylbutanoate)(Positional isomers: 5F-AEB; 5F-EMB-PINACA)
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-7035IN ADB-PINACA

yl)-1-pentyl-1H-indazole-3-carboxamide)

Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- 7036 I N 5F-EDMB-PINACA 3,3-dimethylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB-PICA)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

MMB-CHMICA; AMB-CHMICA (methyl 2-(1- 7044 I N (cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-7047IN FUB-AKB48; FUB-APINACA; AKB48 N-(4-
carboxamideFLUOROBENZYL)
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-7048IN APINACA; AKB48

indazole-3-carboxamide

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- 7083 I N 5F-CUMYL-PINACA; SGT-25 3-carboxamide

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-7089IN 4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA;
phenylpropan-2-yl)-1 H-indazole-3-carboxamide)CUMYL-4CN-BINACA; SGT-78
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4-7090IN MDMB-4en-PINACA

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201IN
6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-7220IN Hexahydrocannabinol; HHC

benzo[c]chromen-1-ol

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)- 7221 I N 1H-indole-3-carboxylate)

PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222IN QUPIC; PB-22
5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-7225IN 5-Fluoro-PB-22; 5F-PB-22

carboxylate)

4-Methyl-alpha-ethylaminopentiophenone (4-MEAP)7245IN 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one
N-Ethylhexedrone7246IN α-Ethylaminohexanophenone; 2-(ethylamino)-1-

phenylhexan-1-one

Alpha-ethyltryptamine7249IN ET; Trip
Ibogaine7260IN Constituent of "Tabernanthe iboga" plant
2-Fluorodeschloroketamine7284IN 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one; 2-

FDCK

Ketamine7285IIIN Ketaset; Ketalar; Special K; K
2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one7286IN MXE; methoxetamine

(methoxetamine)

Diphenidine7292IY 1-(1,2-Diphenylethyl)piperidine
Tiletamine & Zolazepam Combination Product7295IIIN Telazol
Lysergic acid7300IIIN LSD precursor
Lysergic acid amide7310IIIN LSD precursor
Lysergic acid diethylamide7315IN LSD; lysergide
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348IN 2C-T-7

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

Marihuana Extract7350IN
Marijuana extract, as defined in 21 CFR7353IIIN

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

Marihuana7360IN Cannabis; marijuana
Marijuana, as defined in 21 U.S.C. 802(16), in a U.S.7362IIIN

Food and Drug Administration approved product or subject to a state medical marijuana license

Dronabinol in an oral solution in a drug product 7365 II N Syndros approved for marketing by the U.S. Food and Drug Administration

Dronabinol (synthetic) in sesame oil in soft gelatin7369IIIN Marinol; synthetic THC in sesame oil/soft gelatin as
capsule as approved by FDAapproved by FDA
Tetrahydrocannabinols7370IN THC; Delta-8 THC; Delta-9 THC; dronabinol and others
Parahexyl7374IN Synhexyl
Nabilone7379IIN Cesamet
Mescaline7381IN Constituent of "Peyote" cacti
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-7385IN 2C-T-2

2)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Naturally derived delta-9-tetrahydrocannabinols in a7386IIIN (i) Naturally derived delta-9-tetrahydrocannabinols means
U.S. Food and Drug Administration approved productthose delta-9-tetrahydrocannabinols, except as in
or in marijuana subject to a state medical marijuanaparagraphs 21 CFR 1308.13(g)(2) and (3), that are
licensenaturally contained in a plant of the genus Cannabis

(cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA- 5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

4-Bromo-2,5-dimethoxyamphetamine7391IN DOB; 4-bromo-DMA
4-Bromo-2,5-dimethoxyphenethylamine7392IN 2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA
4-Methyl-2,5-dimethoxyamphetamine7395IN DOM; STP

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

2,5-Dimethoxyamphetamine7396IN DMA; 2,5-DMA
2,5-Dimethoxy-4-ethylamphetamine7399IN DOET

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3- MDA))

5-Methoxy-3,4-methylenedioxyamphetamine7401IN MMDA
N-Hydroxy-3,4-methylenedioxyamphetamine7402IN N-Hydroxy MDA
3,4-Methylenedioxy-N-ethylamphetamine7404IN N-Ethyl MDA; MDE; MDEA

(Positional Isomer: MBDB)

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

4-Methoxyamphetamine7411IN PMA
Peyote7415IN Cactus which contains mescaline
5-Methoxy-N,N-dimethyltryptamine7431IN 5-MeO-DMT

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4- MeO-DMT, 4-methoxy-DMT))

alpha-Methyltryptamine 7432 I N AMT

(Positional Isomer: N-Methyltryptamine)

Bufotenine 7433 I N Mappine; N,N-dimethylserotonin

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Diethyltryptamine 7434 I N DET, N,N-diethyltryptamine

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

Dimethyltryptamine7435IN DMT
Psilocybin7437IN Constituent of "Magic mushrooms"
Psilocyn7438IN Psilocin, constituent of "Magic mushrooms"

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

5-Methoxy-N,N-diisopropyltryptamine 7439 I N 5-MeO-DIPT

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5- MeO-DPT))

4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-7443IN 4-Chloro-α-PVP; 4'-chloro-α-pyrrolidinopentiophenone; 1-
PVP)(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP)7446IN MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4-

methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

N-Ethyl-1-phenylcyclohexylamine7455IN PCE
3-Methoxyphencyclidine7457IN 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3-MeO–PCP
1-(1-Phenylcyclohexyl)pyrrolidine7458IN PCPy; PHP; rolicyclidine
1-Phenylcyclohexylamine7460IIN PCP precursor
1-[1-(2-Thienyl)cyclohexyl]piperidine7470IN TCP; tenocyclidine
Phencyclidine7471IIN PCP; Sernylan
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473IN TCPy
N-Ethyl-3-piperidyl benzilate7482IN JB 323
N-Methyl-3-piperidyl benzilate7484IN JB 336
N-Benzylpiperazine7493IN BZP; 1-benzylpiperazine
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498IN MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4-

methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508IN 2C-D
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)7509IN 2C-E

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517IN 2C-H
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518IN 2C-I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519IN 2C-C
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521IN 2C-N
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-7524IN 2C-P

P)

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ;1- (1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7537 I N 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 ethanamine (25C-NBOMe)

2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7538 I N 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 ethanamine (25I-NBOMe)

Methylone (3,4-Methylenedioxy-N-methylcathinone) 7540 I N (Positional Isomer: ￿2,3-methylenedioxymethcathinone (2,3-MDMC, 1-(benzo[d][1,3]dioxol-4-yl)-2- (methylamino)propan-1-one))

Butylone 7541 I N bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan- 1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4-methylenedioxycathinone)

Pentylone 7542 I N bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2-(propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2-(piperidin-1-yl)butan-1-one)

alpha-pyrrolidinobutiophenone (α-PBP)7546IN 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one
Ethylone7547IN 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4-

methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

alpha-Pyrrolidinoheptaphenone (PV8) 7548 I N PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α- PiHPP; iso-PV8))

Eutylone 7549 I N 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; bk- EBDB

α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- 7551 I N α-PiHP; alpha-PiHP one)

1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one7552IN Dipentylone; N,N-dimethylpentylone
Carisoprodol8192IVN Soma
4-Anilino-N-phenethyl-4-piperidine (ANPP)8333IIN ANPP; despropionyl fentanyl

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide)8366IIY
Phenylacetone8501IIN P2P; phenyl-2-propanone; benzyl methyl ketone
1-Piperidinocyclohexanecarbonitrile8603IIN PCC; PCP precursor
Alphaprodine9010IIY Nisentil
Anileridine9020IIY Leritine
Coca Leaves9040IIY
Cocaine9041IIY Methyl benzoylecgonine; Crack
Codeine9050IIY Morphine methyl ester; methyl morphine
Acetyldihydrocodeine9051IY Acetylcodone
Benzylmorphine9052IY
Codeine-N-oxide9053IY
Cyprenorphine9054IY
Desomorphine9055IY
Etorphine (except HCl)9056IY
Etorphine HCl9059IIY M 99
Buprenorphine9064IIIY Buprenex; Temgesic; Subutex; Suboxone
Codeine methylbromide9070IY
8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8-9093IY Spirochlorphine; R–6890

triazaspiro[4.5]decan-4-one

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6- 9097 I Y 5,6-Dichloro brorphine; SR–14968 dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-9098IY 1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro-
1,3-dihydro-2H-benzo[d]imidazol-2-one)2H-benzimidazol-2-one
Dihydrocodeine9120IIY Didrate; Parzone
Oxycodone9143IIY OxyContin; Percocet; Endocet; Roxicodone; Roxicet
Dihydromorphine9145IY
Hydromorphone9150IIY Dilaudid; dihydromorphinone
Difenoxin 1 mg/25 ug AtSO4/du9167IVY Motofen
Difenoxin9168IY Lyspafen
Diphenoxylate9170IIY
Ecgonine9180IIY Cocaine precursor, in Coca leaves
Ethylmorphine9190IIY Dionin
Hydrocodone9193IIY Dihydrocodeinone
Heroin9200IY Diacetylmorphine; diamorphine
Levomethorphan9210IIY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Levorphanol9220IIY Levo-Dromoran
Isomethadone9226IIY Isoamidone
Meperidine9230IIY Demerol; Mepergan; pethidine
Meperidine intermediate-A9232IIY Meperidine precursor
Meperidine intermediate-B9233IIY Meperidine precursor; normeperidine
Meperidine intermediate-C9234IIY Meperidine precursor
Metazocine9240IIY
Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-9245IIY

[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

Methadone9250IIY Dolophine; Methadose; Amidone
Methadone intermediate (4-cyano-2-dimethylamino-4,4-9254IIY Methadone precursor

diphenylbutane)

Metopon9260IIY
Dextropropoxyphene, bulk (non-dosage forms)9273IIY Propoxyphene
Dextropropoxyphene dosage forms9278IVY Darvon; propoxyphene; Darvocet; Propacet
Morphine9300IIY MS Contin; Roxanol; Oramorph; RMS; MSIR
Hydromorphinol9301IY
Methyldesorphine9302IY
Methyldihydromorphine9304IY
Morphine methylbromide9305IY
Morphine methylsulfonate9306IY
Morphine-N-oxide9307IY
Myrophine9308IY
Nicocodeine9309IY
Nicomorphine9312IY Vilan
Normorphine9313IY
Pholcodine9314IY Copholco; Adaphol; Codisol; Lantuss; Pholcolin
Thebacon9315IY Acetylhydrocodone; Acedicon; Thebacetyl
Acetorphine9319IY
Oripavine9330IIY
Thebaine9333IIY Precursor of many narcotics
Dihydroetorphine9334IIY DHE
Drotebanol9335IY Metebanyl; oxymethebanol
Nalorphine9400IIIY Nalline
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-9547IY

N-methylbenzamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)9560IY
Opium, raw9600IIY Raw opium; gum opium
Acetylmethadol9601IY Methadyl acetate
Allylprodine9602IY
Alphacetylmethadol except levo-alphacetylmethadol9603IY
Alphameprodine9604IY
Alphamethadol9605IY
Benzethidine9606IY
Betacetylmethadol9607IY
Betameprodine9608IY
Betamethadol9609IY
Opium extracts9610IIY
Betaprodine9611IY
Clonitazene9612IY
Dextromoramide9613IY Palfium; Jetrium; Narcolo
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-9614IY N,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-
nitro-1H-benzimidazol-1-yl)ethan-1-amine)1H-benzimidazole-1-ethanamine
Diampromide9615IY
Diethylthiambutene9616IY
Dimenoxadol9617IY
Dimepheptanol9618IY
Dimethylthiambutene9619IY
Opium fluid extract9620IIY
Dioxaphetyl butyrate9621IY
Dipipanone9622IY Dipipan; phenylpiperone HCl; Diconal; Wellconal
Ethylmethylthiambutene9623IY
Etonitazene9624IY
Etoxeridine9625IY
Furethidine9626IY
Hydroxypethidine9627IY
Ketobemidone9628IY Cliradon
Levomoramide9629IY
Opium tincture9630IIY Laudanum
Levophenacylmorphan9631IY
Morpheridine9632IY
Noracymethadol9633IY
Norlevorphanol9634IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Normethadone9635IY Phenyldimazone
Norpipanone9636IY
Phenadoxone9637IY
Phenampromide9638IY
Opium, powdered9639IIY Powdered opium
Opium, granulated9640IIY Granulated opium
Phenoperidine9641IY Operidine; Lealgin
Piritramide9642IY Piridolan
Proheptazine9643IY
Properidine9644IY
Racemoramide9645IY
Trimeperidine9646IY Promedolum
Phenomorphan9647IY
Levo-alphacetylmethadol9648IIY LAAM; long acting methadone; levomethadyl acetate
Propiram9649IY Algeril
Opium poppy9650IIY Papaver somniferum
Poppy Straw9650IIY Opium poppy capsules; poppy heads
Oxymorphone9652IIY Numorphan
1-Methyl-4-phenyl-4-propionoxypiperidine9661IY MPPP; synthetic heroin
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine9663IY PEPAP; synthetic heroin
2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-9664IY

yl)piperazin-1-yl)butan-1-one)

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

Noroxymorphone9668IIY
Poppy Straw Concentrate9670IIY Concentrate of Poppy Straw, CPS
Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo-9672IY Mitragynine pseudoindoxyl

3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-9674IY MGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10-
7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-fluoro-dihydro-7-hydroxymitragynine

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Pentazocine9709IVN Talwin; Talwin NX; Talacen; Talwin Compound
Phenazocine9715IIY Narphen; Prinadol
Butorphanol9720IVN Stadol; Stadol NS; Torbugesic; Torbutrol
Eluxadoline9725IVN VIBERZI
Thiafentanil9729IIY Thianil

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Piminodine9730IIY
Racemethorphan9732IIY
Racemorphan9733IIY Dromoran
Alfentanil9737IIY Alfenta
Remifentanil9739IIY Ultiva
Sufentanil9740IIY Sufenta
Carfentanil9743IIY Wildnil
Tilidine9750IY Tilidate; Valoron; Kitadol; Lak; Tilsa
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-9751IY

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Tramadol (2-[(dimethylamino)methyl]-1-(3- 9752 IV Y Tramadol methoxyphenyl)cyclohexanol)

Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 9756 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I Y propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

N-Desethyl isotonitazene (N-ethyl-2-(2-(4- 9760 I Y isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9761 I Y Etonitazepipne (2-(piperidin-1-yl)ethyl-1H-benzimidazole)

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 9764 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol- 9766 I Y Methylenedioxynitazene; 3′,4′-Methylenedioxynitazene 1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H- 9769 I Y N-Desethyl protonitazene benzimidazol-1-yl)ethan-1-amine

2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H- 9770 I Y Ethyleneoxynitazene benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

Tapentadol 9780 II Y

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Bezitramide9800IIY Burgodin
Fentanyl9801IIY Duragesic; Oralet; Actiq; Sublimaze; Innovar
Moramide-intermediate9802IIY
Codeine & isoquinoline alkaloid 90 mg/du9803IIIY Codeine with papaverine or noscapine
Codeine combination product 90 mg/du9804IIIY Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine
Dihydrocodeine combination product 90 mg/du9807IIIY Synalgos-DC; Compal
Ethylmorphine combination product 15 mg/du9808IIIY
Opium combination product 25 mg/du9809IIIY Paregoric, other combination products
Morphine combination product/50 mg/(100 ml or 1009810IIIY

gm)

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9811 I Y Acryloylfentanyl phenylacrylamide)

para-Fluorofentanyl9812IY China White; fentanyl
3-Methylfentanyl9813IY China White; fentanyl
alpha-Methylfentanyl9814IY China White; fentanyl
Acetyl-alpha-methylfentanyl9815IY
N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4-9816IY ortho-Fluorofentanyl or 2-fluorofentanyl

yl)propionamide

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1- 9818 I Y phenethylpiperidin-4-yl)propionamide)

4'-Methyl acetyl fentanyl (N-(1-(4- 9819 I Y methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9821 I Y phenylacetamide)

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- 9824 I Y para-Fluoroisobutyryl fentanyl phenethylpiperidin-4-yl)isobutyramide)

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

Isobutyryl fentanyl9827IY N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1-9828IY

phenethylpiperidin-4-yl)propionamide)

beta-Hydroxyfentanyl9830IY China White; fentanyl
beta-Hydroxy-3-methylfentanyl9831IY China White; fentanyl
alpha-Methylthiofentanyl9832IY China White; fentanyl

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

3-Methylthiofentanyl9833IY China White; fentanyl
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9834IY

phenylfuran-2-carboxamide)

Thiofentanyl9835IY Chine white; fentanyl
beta-Hydroxythiofentanyl9836IY N-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-

phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4- piperidinyl]-N-phenylpropanamide

para-Methoxybutyryl fentanyl 9837 I Y N-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4- yl)acetamide

Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9839 I Y phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

Valeryl fentanyl9840IY N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9841IY

phenylbenzamide; also known as benzoyl fentanyl)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran- 9843 I Y Tetrahydrofuranyl fentanyl 2-carboxamide

Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- 9844 I Y phenylbut-2-enamide)

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- 9851 I Y yl)(phenyl)carbamate)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

beta-Methyl fentanyl (N-phenyl-N-(1-(2- 9856 I Y phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

2',5'-Dimethoxyfentanyl (N-(1-(2,5- 9861 I Y dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- 9862 I Y yl)-N-phenylbutanamide)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

alpha'-Methyl butyryl fentanyl (2-methyl-N-(1- 9864 I Y phenethylpiperidin-4-yl)-N-phenylbutanamide)

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin- 9869 I Y Tetrahydrothiophene fentanyl 4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

Zipeprol (1-methoxy-3[-4-(2-methoxy-2- 9873 I Y phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

CSA ScheduleControlled Substances

- by CSA Schedule -

SUBSTANCE CSCN SCH NARC OTHER NAMES

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6- 9097 I Y 5,6-Dichloro brorphine; SR–14968 dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one7552IN Dipentylone; N,N-dimethylpentylone
1-(1-Phenylcyclohexyl)pyrrolidine7458IN PCPy; PHP; rolicyclidine
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine9663IY PEPAP; synthetic heroin
1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-7083IN 5F-CUMYL-PINACA; SGT-25

3-carboxamide

1-[1-(2-Thienyl)cyclohexyl]piperidine7470IN TCP; tenocyclidine
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473IN TCPy
1-Methyl-4-phenyl-4-propionoxypiperidine9661IY MPPP; synthetic heroin
2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-9770IY Ethyleneoxynitazene

benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol- 9766 I Y Methylenedioxynitazene; 3′,4′-Methylenedioxynitazene 1-yl)-N,N-diethylethan-1-amine

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- 7524 I N 2C-P P)

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) 7509 I N 2C-E

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508IN 2C-D
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521IN 2C-N
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517IN 2C-H
2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol7000IN

(CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519IN 2C-C
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)7537IN 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82

ethanamine (25C-NBOMe)

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T- 7385 I N 2C-T-2 2)

2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518IN 2C-I
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)7538IN 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5

ethanamine (25I-NBOMe)

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE; methoxetamine (methoxetamine)

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 7348 I N 2C-T-7

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

2,5-Dimethoxyamphetamine 7396 I N DMA; 2,5-DMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

2',5'-Dimethoxyfentanyl (N-(1-(2,5- 9861 I Y dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

2-Fluorodeschloroketamine 7284 I N 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one; 2- FDCK

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1- 9664 I Y yl)piperazin-1-yl)butan-1-one)

3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole 7000 I N (JWH–184)

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA- 5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3- MDA))

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-Ethyl MDA; MDE; MDEA

(Positional Isomer: MBDB)

3-Chloromethcathinone1241IN 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1-one
3-Fluoro-N-methylcathinone (3-FMC)1233IN 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one

(Positional Isomer: 2-FMC)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

3-Methoxyphencyclidine7457IN 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3-MeO–PCP
3-Methylfentanyl9813IY China White; fentanyl
3-Methylmethcathinone (2-(methylamino)-1-(3-1259IN 3-MMC; 3-methylmethcathinone

methylphenyl)propan-1-one)

3-Methylthiofentanyl9833IY China White; fentanyl
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595IN

methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) 7446 I N MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4- methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

4-Bromo-2,5-dimethoxyamphetamine 7391 I N DOB; 4-bromo-DMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

4-Bromo-2,5-dimethoxyphenethylamine7392IN 2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA
4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-7443IN 4-Chloro-α-PVP; 4'-chloro-α-pyrrolidinopentiophenone; 1-
PVP)(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
4-Chloromethcathinone1239IN 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1-one
4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-7089IN 4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA;
phenylpropan-2-yl)-1 H-indazole-3-carboxamide)CUMYL-4CN-BINACA; SGT-78
4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan-1476IN 4–FA; 1-(4-fluorophenyl)propan-2-amine; para-
2-amine, para-fluoroamphetamine)fluoroamphetamine
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-9824IY para-Fluoroisobutyryl fentanyl

phenethylpiperidin-4-yl)isobutyramide)

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N Flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1- one

(Positional Isomer: 2-FMC)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

4-Methoxyamphetamine7411IN PMA
4'-Methyl acetyl fentanyl (N-(1-(4-9819IY

methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM; STP

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

4-Methyl-alpha-ethylaminopentiophenone (4-MEAP)7245IN 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498IN MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4-

methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

4-Methylaminorex (cis isomer)1590IN U4Euh; McN-422
4-Methyl-N-ethylcathinone (4-MEC)1249IN 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone(3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7025 I N 1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

dimethylbutanoate)(Positional isomers: 5F-AEB; 5F-EMB-PINACA)
5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-7033IN 5F-AMB

carboxamido)-3-methylbutanoate)

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 7225 I N 5-Fluoro-PB-22; 5F-PB-22 carboxylate)

5-Methoxy-3,4-methylenedioxyamphetamine7401IN MMDA
5-Methoxy-N,N-diisopropyltryptamine7439IN 5-MeO-DIPT

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5- MeO-DPT))

5-Methoxy-N,N-dimethyltryptamine 7431 I N 5-MeO-DMT

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4- MeO-DMT, 4-methoxy-DMT))

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- 7220 I N Hexahydrocannabinol; HHC benzo[c]chromen-1-ol

8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8- 9093 I Y Spirochlorphine; R–6890 triazaspiro[4.5]decan-4-one

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

Acetorphine9319IY
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9821IY

phenylacetamide)

Acetyl-alpha-methylfentanyl9815IY
Acetyldihydrocodeine9051IY Acetylcodone
Acetylmethadol9601IY Methadyl acetate
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9811IY Acryloylfentanyl

phenylacrylamide)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I N ADB-PINACA yl)-1-pentyl-1H-indazole-3-carboxamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

Allylprodine9602IY
Alphacetylmethadol except levo-alphacetylmethadol9603IY
Alpha-ethyltryptamine7249IN ET; Trip

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Alphameprodine9604IY
Alphamethadol9605IY
alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-9864IY

phenethylpiperidin-4-yl)-N-phenylbutanamide)

alpha-Methylfentanyl9814IY China White; fentanyl
alpha-Methylthiofentanyl9832IY China White; fentanyl
alpha-Methyltryptamine7432IN AMT

(Positional Isomer: N-Methyltryptamine)

alpha-pyrrolidinobutiophenone (α-PBP)7546IN 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one
alpha-Pyrrolidinoheptaphenone (PV8)7548IN PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α- PiHPP; iso-PV8))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2-(piperidin-1-yl)butan-1-one)

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201IN
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7000IN Prior drug code 7694 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

Amineptine (7-[(10,11-dihydro-5H- 1219 I N dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

Aminorex1585IN Has been sold as methamphetamine
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-7048IN APINACA; AKB48

indazole-3-carboxamide

Benzethidine9606IY
Benzylmorphine9052IY
Betacetylmethadol9607IY
beta-Hydroxy-3-methylfentanyl9831IY China White; fentanyl
beta-Hydroxyfentanyl9830IY China White; fentanyl
beta-Hydroxythiofentanyl9836IY N-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-

phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4- piperidinyl]-N-phenylpropanamide

Betameprodine9608IY
Betamethadol9609IY
beta-Methyl fentanyl (N-phenyl-N-(1-(2-9856IY

phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Betaprodine9611IY
Bromazolam (8-bromo-1-methyl-6-phenyl-4H-2778IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-9098IY 1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro-
1,3-dihydro-2H-benzo[d]imidazol-2-one)2H-benzimidazol-2-one
Bufotenine7433IN Mappine; N,N-dimethylserotonin
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-9751IY

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Butylone 7541 I N bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan- 1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4-methylenedioxycathinone)

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide

Cannabimimetic agents 7000 I N Any substance meeting the definition of cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

Cathinone1235IN Constituent of "Khat" plant
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-2786IN

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Clonitazene9612IY
Codeine methylbromide9070IY
Codeine-N-oxide9053IY
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-7000IN Prior drug code 7297 under Synthetic Drug Abuse
hydroxycyclohexy]-phenol)Prevention Act; consolidated to 7000 under 91 FR 2297
CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2-7000IN Prior drug code 7298 under Synthetic Drug Abuse
[(1R,3S)3-hydroxycyclohexyl]-phenol)Prevention Act; consolidated to 7000 under 91 FR 2297
Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-9844IY

phenylbut-2-enamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

Cyprenorphine9054IY
Desomorphine9055IY
Dextromoramide9613IY Palfium; Jetrium; Narcolo
Diampromide9615IY
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-2789IN

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

Diethylthiambutene9616IY
Diethyltryptamine7434IN DET, N,N-diethyltryptamine

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

Difenoxin9168IY Lyspafen
Dihydromorphine9145IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Dimenoxadol9617IY
Dimepheptanol9618IY
Dimethylthiambutene9619IY
Dimethyltryptamine7435IN DMT
Dioxaphetyl butyrate9621IY
Diphenidine7292IY 1-(1,2-Diphenylethyl)piperidine
Dipipanone9622IY Dipipan; phenylpiperone HCl; Diconal; Wellconal
Drotebanol9335IY Metebanyl; oxymethebanol
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-7036IN 5F-EDMB-PINACA

3,3-dimethylbutanoate

Ethylmethylthiambutene9623IY
Ethylone7547IN 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4-

methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)1727IN
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-2780IN

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Etonitazene9624IY
Etorphine (except HCl)9056IY
Etoxeridine9625IY
Eutylone7549IN 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; bk-

EBDB

Fenethylline1503IN Captagon; amfetyline; ethyltheophylline amphetamine
Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-9851IY

yl)(phenyl)carbamate)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H- 2785 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-2788IN 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-
4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)a][1,4]benzodiazepine
Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-9756IY

1H-benzimidazol-1-yl)ethan-1-amine)

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9834 I Y phenylfuran-2-carboxamide)

Furethidine9626IY
Gamma Hydroxybutyric Acid2010IN GHB; gamma hydroxybutyrate; sodium oxybate
Heroin9200IY Diacetylmorphine; diamorphine
Hydromorphinol9301IY
Hydroxypethidine9627IY
Ibogaine7260IN Constituent of "Tabernanthe iboga" plant
Isobutyryl fentanyl9827IY N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-9614IY N,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-
nitro-1H-benzimidazol-1-yl)ethan-1-amine)1H-benzimidazole-1-ethanamine
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-9862IY

yl)-N-phenylbutanamide)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-7000IN Prior drug code 7200 under Synthetic Drug Abuse
naphthoyl)indole)Prevention Act; consolidated to 7000 under 91 FR 2297
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)7000IN Prior drug code 7203 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Ketobemidone9628IY Cliradon
Levomoramide9629IY
Levophenacylmorphan9631IY
Lysergic acid diethylamide7315IN LSD; lysergide
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-7032IN MAB-CHMINACA; ADB-CHMINACA

2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

Marihuana7360IN Cannabis; marijuana
Marihuana Extract7350IN
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4-7090IN MDMB-4en-PINACA

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ;1- (1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

Mecloqualone2572IN Nubarene
Mephedrone (4-Methyl-N-methylcathinone)1248IN 4-MMC

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Mescaline7381IN Constituent of "Peyote" cacti
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-1227IN

oxadiazol-3-ium-5-yl)carbamimidate)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

Methaqualone2565IN Quaalude; Parest; Somnafac; Opitimil; Mandrax
Methcathinone1237IN N-Methylcathinone, "cat"
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-1478IN

amine)

Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo- 9672 I Y Mitragynine pseudoindoxyl 3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-9674IY MGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10-
7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-fluoro-dihydro-7-hydroxymitragynine

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB-PICA)

Methyldesorphine9302IY
Methyldihydromorphine9304IY
Methylone (3,4-Methylenedioxy-N-methylcathinone)7540IN

(Positional Isomer: ￿2,3-methylenedioxymethcathinone (2,3-MDMC, 1-(benzo[d][1,3]dioxol-4-yl)-2- (methylamino)propan-1-one))

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 9764 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

MMB-CHMICA; AMB-CHMICA (methyl 2-(1- 7044 I N (cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

Morpheridine9632IY
Morphine methylbromide9305IY
Morphine methylsulfonate9306IY
Morphine-N-oxide9307IY
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)9560IY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Myrophine9308IY
N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-9843IY Tetrahydrofuranyl fentanyl

2-carboxamide

N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I Y ortho-Fluorofentanyl or 2-fluorofentanyl yl)propionamide

N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-7047IN FUB-AKB48; FUB-APINACA; AKB48 N-(4-
carboxamideFLUOROBENZYL)
N,N-Dimethylamphetamine1480IN
Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3-7000IN

yl)methanone (JWH–022)

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomer: α-naphyrone)

N-Benzylpiperazine7493IN BZP; 1-benzylpiperazine
N-Desethyl isotonitazene (N-ethyl-2-(2-(4-9760IY

isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

N-Ethyl-1-phenylcyclohexylamine7455IN PCE
N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-9769IY N-Desethyl protonitazene

benzimidazol-1-yl)ethan-1-amine

N-Ethyl-3-piperidyl benzilate7482IN JB 323
N-Ethylamphetamine1475IN NEA
N-Ethylhexedrone7246IN α-Ethylaminohexanophenone; 2-(ethylamino)-1-

phenylhexan-1-one

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

N-Hydroxy-3,4-methylenedioxyamphetamine7402IN N-Hydroxy MDA
Nicocodeine9309IY
Nicomorphine9312IY Vilan
NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-7221IN

1H-indole-3-carboxylate)

N-Methyl-3-piperidyl benzilate7484IN JB 336
Noracymethadol9633IY
Norlevorphanol9634IY
Normethadone9635IY Phenyldimazone
Normorphine9313IY
Norpipanone9636IY
N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-9761IY Etonitazepipne

(2-(piperidin-1-yl)ethyl-1H-benzimidazole)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4- yl)acetamide

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1- 9828 I Y phenethylpiperidin-4-yl)propionamide)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1- 9818 I Y phenethylpiperidin-4-yl)propionamide)

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

para-Fluorofentanyl9812IY China White; fentanyl
Parahexyl7374IN Synhexyl
para-Methoxybutyryl fentanyl9837IY N-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4-

yl)butyramide

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Methoxymethamphetamine (PMMA); 1-(4- 1245 I N (Positional isomer: methoxyphenamine (OMMA)) methoxyphenyl)-N-methylpropan-2-amine

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222IN QUPIC; PB-22
Pentedrone (α-methylaminovalerophenone)1246IN 2-(Methylamino)-1-phenylpentan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Pentylone 7542 I N bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2-(propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

Peyote7415IN Cactus which contains mescaline
Phenadoxone9637IY
Phenampromide9638IY
Phenomorphan9647IY
Phenoperidine9641IY Operidine; Lealgin
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9841IY

phenylbenzamide; also known as benzoyl fentanyl)

Pholcodine9314IY Copholco; Adaphol; Codisol; Lantuss; Pholcolin
Piritramide9642IY Piridolan
Proheptazine9643IY
Properidine9644IY
Propiram9649IY Algeril
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-9759IY

propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

Psilocybin7437IN Constituent of "Magic mushrooms"
Psilocyn7438IN Psilocin, constituent of "Magic mushrooms"

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

Racemoramide9645IY
SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl)7000IN RCS-8
indole)Prior drug code 7008 under Synthetic Drug Abuse

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Tetrahydrocannabinols7370IN THC; Delta-8 THC; Delta-9 THC; dronabinol and others
Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin-9869IY Tetrahydrothiophene fentanyl

4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

Thebacon9315IY Acetylhydrocodone; Acedicon; Thebacetyl
Thiofentanyl9835IY Chine white; fentanyl
Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9839IY

phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I N yl](naphthalen-1-yl)methanone)

Tilidine9750IY Tilidate; Valoron; Kitadol; Lak; Tilsa
Trimeperidine9646IY Promedolum
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-9547IY

N-methylbenzamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

Valeryl fentanyl9840IY N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-9873IY

phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- 7551 I N α-PiHP; alpha-PiHP one)

1-Phenylcyclohexylamine7460IIN PCP precursor
1-Piperidinocyclohexanecarbonitrile8603IIN PCC; PCP precursor
4-Anilino-N-phenethyl-4-piperidine (ANPP)8333IIN ANPP; despropionyl fentanyl
Alfentanil9737IIY Alfenta
Alphaprodine9010IIY Nisentil
Amobarbital2125IIN Amytal; Tuinal
Amphetamine1100IIN Dexedrine; Adderall; Obetrol
Anileridine9020IIY Leritine
Bezitramide9800IIY Burgodin
Carfentanil9743IIY Wildnil
Coca Leaves9040IIY
Cocaine9041IIY Methyl benzoylecgonine; Crack
Codeine9050IIY Morphine methyl ester; methyl morphine
Dextropropoxyphene, bulk (non-dosage forms)9273IIY Propoxyphene
Dihydrocodeine9120IIY Didrate; Parzone
Dihydroetorphine9334IIY DHE
Diphenoxylate9170IIY
Dronabinol in an oral solution in a drug product7365IIN Syndros

approved for marketing by the U.S. Food and Drug Administration

Ecgonine9180IIY Cocaine precursor, in Coca leaves
Ethylmorphine9190IIY Dionin
Etorphine HCl9059IIY M 99
Fentanyl9801IIY Duragesic; Oralet; Actiq; Sublimaze; Innovar
Glutethimide2550IIN Doriden; Dorimide
Hydrocodone9193IIY Dihydrocodeinone
Hydromorphone9150IIY Dilaudid; dihydromorphinone
Isomethadone9226IIY Isoamidone
Levo-alphacetylmethadol9648IIY LAAM; long acting methadone; levomethadyl acetate
Levomethorphan9210IIY
Levorphanol9220IIY Levo-Dromoran
Lisdexamfetamine1205IIN Vyvanse

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Meperidine9230IIY Demerol; Mepergan; pethidine
Meperidine intermediate-A9232IIY Meperidine precursor
Meperidine intermediate-B9233IIY Meperidine precursor; normeperidine
Meperidine intermediate-C9234IIY Meperidine precursor
Metazocine9240IIY
Methadone9250IIY Dolophine; Methadose; Amidone
Methadone intermediate (4-cyano-2-dimethylamino-4,4-9254IIY Methadone precursor

diphenylbutane)

Methamphetamine1105IIN Desoxyn; D-desoxyephedrine; ICE; Crank; Speed
Methylphenidate1724IIN Concerta; Ritalin; Methylin
Metopon9260IIY
Moramide-intermediate9802IIY
Morphine9300IIY MS Contin; Roxanol; Oramorph; RMS; MSIR
Nabilone7379IIN Cesamet
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide)8366IIY
Noroxymorphone9668IIY
Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-9245IIY

[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

Opium extracts9610IIY
Opium fluid extract9620IIY
Opium poppy9650IIY Papaver somniferum
Opium tincture9630IIY Laudanum
Opium, granulated9640IIY Granulated opium
Opium, powdered9639IIY Powdered opium
Opium, raw9600IIY Raw opium; gum opium
Oripavine9330IIY
Oxycodone9143IIY OxyContin; Percocet; Endocet; Roxicodone; Roxicet
Oxymorphone9652IIY Numorphan
Pentobarbital2270IIN Nembutal
Phenazocine9715IIY Narphen; Prinadol
Phencyclidine7471IIN PCP; Sernylan
Phenmetrazine1631IIN Preludin
Phenylacetone8501IIN P2P; phenyl-2-propanone; benzyl methyl ketone
Piminodine9730IIY
Poppy Straw9650IIY Opium poppy capsules; poppy heads
Poppy Straw Concentrate9670IIY Concentrate of Poppy Straw, CPS
Racemethorphan9732IIY

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Racemorphan9733IIY Dromoran
Remifentanil9739IIY Ultiva
Secobarbital2315IIN Seconal; Tuinal
Sufentanil9740IIY Sufenta
Tapentadol9780IIY
Thebaine9333IIY Precursor of many narcotics
Thiafentanil9729IIY Thianil
[3,2-c]-Furazan-5α-androstan-17β-ol4000IIIN
[3,2-c]Pyrazole-androst-4-en-17β-ol4000IIIN
13β-Ethyl-17β-hydroxygon-4-en-3-one4000IIIN
17α-Methyl-3α,17β-dihydroxy-5α-androstane4000IIIN
17α-Methyl-3β,17β-dihydroxy-5α-androstane4000IIIN
17α-Methyl-3β,17β-dihydroxyandrost-4-ene4000IIIN
17α-Methyl-4-hydroxynandrolone (17α-methyl-4-4000IIIN

hydroxy-17β-hydroxyestr-4-en-3-one)

17α-Methyl-5α-androstan-17β-ol4000IIIN
17α-Methyl-androst-2-ene-3,17β-diol4000IIIN
17α-Methyl-androsta-1,4-diene-3,17β-diol4000IIIN
17α-Methyl-androstan-3-hydroxyimine-17β-ol4000IIIN
17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-4000IIIN 17α-Methyl-1-testosterone

methyl-5α-androst-1-en-3-one)

17β-Hydroxy-androstano[2,3-d]isoxazole4000IIIN
17β-Hydroxy-androstano[3,2-c]isoxazole4000IIIN
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one4000IIIN
19-Nor-4,9(10)-androstadienedione (estra-4,9(10)-4000IIIN

diene-3,17-dione)

19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene)4000IIIN
19-Nor-4-androstenedione (estr-4-en-3,17-dione)4000IIIN
19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene)4000IIIN
19-Nor-5-androstenedione (estr-5-en-3,17-dione)4000IIIN
1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)4000IIIN
1-Androstenedione (5α-androst-1-en-3,17-dione)4000IIIN
2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one4000IIIN
2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol4000IIIN
3α,17β-Dihydroxy-5α-androstane4000IIIN

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

3β,17β-Dihydroxy-5α-androstane4000IIIN
3β-Hydroxy-estra-4,9,11-trien-17-one4000IIIN
4-Androstenediol (3β,17β-dihydroxy-androst-4-ene)4000IIIN 4-AD
4-Androstenedione (androst-4-en-3,17-dione)4000IIIN
4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one4000IIIN
4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-4000IIIN

dione

4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol4000IIIN
4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol4000IIIN
4-Dihydrotestosterone (17β-hydroxy-androstan-3-one)4000IIIN Anabolex; Andractim; Pesomax; Stanolone
4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4-4000IIIN

en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

5-Androstenediol (3β,17β-dihydroxy-androst-5-ene)4000IIIN
5-Androstenedione (androst-5-en-3,17-dione)4000IIIN
5α-Androstan-3,17-dione4000IIIN Androstanedione
5α-Androstan-3,6,17-trione4000IIIN
6-Bromo-androsta-1,4-diene-3,17-dione4000IIIN
6-Bromo-androstan-3,17-dione4000IIIN
6α-Methyl-androst-4-ene-3,17-dione4000IIIN
Amobarbital & noncontrolled active ingred.2126IIIN
Amobarbital suppository dosage form2126IIIN
Anabolic steroids4000IIIN Any substance meeting the definition of anabolic steroid

as set forth in 21 CFR 1300.01

Aprobarbital2100IIIN Alurate
Barbituric acid derivative2100IIIN Barbiturates not specifically listed
Benzphetamine1228IIIN Didrex; Inapetyl
Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-4000IIIN

en-3-one)

Boldenone (17β-hydroxyandrost-1,4-diene-3-one)4000IIIN Equipoise; Parenabol; Vebonol; dehydrotestosterone
Boldione (androsta-1,4-diene-3,17-dione)4000IIIN
Buprenorphine9064IIIY Buprenex; Temgesic; Subutex; Suboxone
Butabarbital (secbutabarbital)2100IIIN Butisol; Butibel
Butalbital2100IIIN Fiorinal; Butalbital with aspirin
Butobarbital (butethal)2100IIIN Soneryl (UK)
Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-4000IIIN Methosarb

en-3-one)

Centanafadine 1641 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Chlorhexadol2510IIIN Mechloral; Mecoral; Medodorm; Chloralodol
Chlorphentermine1645IIIN Pre-Sate; Lucofen; Apsedon; Desopimon
Clortermine1647IIIN Voranil
Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)4000IIIN Alfa-Trofodermin; Clostene; 4-chlorotestosterone
Codeine & isoquinoline alkaloid 90 mg/du9803IIIY Codeine with papaverine or noscapine
Codeine combination product 90 mg/du9804IIIY Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine
Dehydrochloromethyltestosterone (4-chloro-17β-4000IIIN Oral-Turinabol

hydroxy-17α-methyl-androst-1,4-dien-3-one)

Desoxymethyltestosterone (17α-methyl-5α-androst-2- 4000 III N Madol en-17β-ol)

Dihydrocodeine combination product 90 mg/du9807IIIY Synalgos-DC; Compal
Dronabinol (synthetic) in sesame oil in soft gelatin7369IIIN Marinol; synthetic THC in sesame oil/soft gelatin as
capsule as approved by FDAapproved by FDA
Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-4000IIIN Drolban; Masterid; Permastril

one)

Embutramide2020IIIN Tributane
Estra-4,9,11-triene-3,17-dione4000IIIN
Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)4000IIIN Maxibolin; Orabolin; Durabolin-O; Duraboral
Ethylmorphine combination product 15 mg/du9808IIIY
Fluoxymesterone (9-fluoro-17α-methyl-11β,17β-4000IIIN Anadroid-F; Halotestin; Ora-Testryl

dihydroxyandrost-4-en-3-one)

Formebolone (2-formyl-17α-methyl-11α,17β- 4000 III N Esiclene; Hubernol dihydroxyandrost-1,4-dien-3-one)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

Gamma Hydroxybutyric Acid preparations2012IIIN Xyrem
Ketamine7285IIIN Ketaset; Ketalar; Special K; K
Lysergic acid7300IIIN LSD precursor
Lysergic acid amide7310IIIN LSD precursor
Marijuana extract, as defined in 21 CFR7353IIIN

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. 7362 III N Food and Drug Administration approved product or subject to a state medical marijuana license

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

Methandienone (17α-methyl-17β-hydroxyandrost-1,4- 4000 III N Dianabol; Metabolina; Nerobol; Perbolin dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-4000IIIN Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α-androstan-
one)3-one

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3- 4000 III N Primobolan; Primobolan Depot; Primobolan S one)

Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- 4000 III N dien-3-one)

Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- 4000 III N Android; Oreton; Testred; Virilon en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

Methyprylon2575IIIN Noludar
Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-4000IIIN Cheque; Matenon

one)

Morphine combination product/50 mg/(100 ml or 100 9810 III Y gm)

Nalorphine9400IIIY Nalline
Nandrolone (17β-hydroxyestr-4-en-3-one)4000IIIN Deca-Durabolin; Durabolin; Durabolin-50
Naturally derived delta-9-tetrahydrocannabinols in a7386IIIN (i) Naturally derived delta-9-tetrahydrocannabinols means
U.S. Food and Drug Administration approved productthose delta-9-tetrahydrocannabinols, except as in
or in marijuana subject to a state medical marijuanaparagraphs 21 CFR 1308.13(g)(2) and (3), that are
licensenaturally contained in a plant of the genus Cannabis

(cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3- 4000 III N Genabol one)

Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)4000IIIN Anabol-4-19; Lentabol
Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-4000IIIN Nilevar; Pronabol; Solevar

one)

Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- 4000 III N Lutenin; Matronal; Orgasteron one)

Opium combination product 25 mg/du9809IIIY Paregoric, other combination products
Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α-4000IIIN Anavar; Lonavar; Oxandrin; Provitar; Vasorome

androstan-3-one)

Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- 4000 III N Anamidol; Balnimax; Oranabol; Oranabol 10 en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

Pentobarbital & noncontrolled active ingred.2271IIIN FP-3
Pentobarbital suppository dosage form2271IIIN WANS
Perampanel2261IIIN Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2-

dihydropyridin-3-yl) benzonitrile]

Phendimetrazine1615IIIN Plegine; Prelu-2; Bontril; Melfiat; Statobex
Prostanozol (17β-hydroxy-5α-androstano[3,2-4000IIIN Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol

c]pyrazole)

Secobarbital & noncontrolled active ingred 2316 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Secobarbital suppository dosage form2316IIIN
Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-4000IIIN Winstrol; Winstrol-V

eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

Stimulant compounds previously excepted1405IIIN Mediatric
Sulfondiethylmethane2600IIIN
Sulfonethylmethane2605IIIN
Sulfonmethane2610IIIN
Talbutal2100IIIN Lotusate
Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-4000IIIN Teolit; Teslac

1,4-dien-17-oic acid lactone)

Testosterone (17β-hydroxyandrost-4-en-3-one)4000IIIN Android-T; Androlan; Depotest; Delatestryl
Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon-4000IIIN THG

4,9,11-trien-3-one)

Thiamylal2100IIIN Surital
Thiopental2100IIIN Pentothal
Tiletamine & Zolazepam Combination Product7295IIIN Telazol
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)4000IIIN Finaplix-S; Finajet; Parabolan
Vinbarbital2100IIIN Delvinal; vinbarbitone
Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en-4000IIIN 1-Testosterone

3-one)

Alfaxalone2731IVN Alfaxan; 5α-pregnan-3α-ol-11,20-dione
Alprazolam2882IVN Xanax
Barbital2145IVN Veronal; Plexonal; barbitone
Brexanolone (3α-hydroxy-5α-pregnan-20-one)2400IVN Allopregnanolone
Bromazepam2748IVN Lexotan; Lexatin; Lexotanil
Butorphanol9720IVN Stadol; Stadol NS; Torbugesic; Torbutrol
Camazepam2749IVN Albego; Limpidon; Paxor
Carisoprodol8192IVN Soma
Cathine1230IVN Constituent of "Khat" plant; (+)-norpseudoephedrine
Chloral betaine2460IVN Beta Chlor
Chloral hydrate2465IVN Noctec
Chlordiazepoxide2744IVN Librium; Libritabs; Limbitrol; SK-Lygen
Cipepofol2139IVN
Clobazam2751IVN Urbadan; Urbanyl
Clonazepam2737IVN Klonopin; Clonopin
Clorazepate2768IVN Tranxene
Clotiazepam2752IVN Trecalmo; Rize; Clozan; Veratran

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Cloxazolam2753IVN Akton; Lubalix; Olcadil; Sepazon
Daridorexant ([(S)-2-(5-chloro-4-methyl-2410IVN QUVIVIQ

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

Delorazepam2754IVN
Dextropropoxyphene dosage forms9278IVY Darvon; propoxyphene; Darvocet; Propacet
Diazepam2765IVN Valium; Diastat
Dichloralphenazone2467IVN Midrin; dichloralantipyrine
Diethylpropion1610IVN Tenuate; Tepanil
Difenoxin 1 mg/25 ug AtSO4/du9167IVY Motofen
Eluxadoline9725IVN VIBERZI
Estazolam2756IVN ProSom; Domnamid; Eurodin; Nuctalon
Ethchlorvynol2540IVN Placidyl
Ethinamate2545IVN Valmid; Valamin
Ethyl loflazepate2758IVN
Fencamfamin1760IVN Reactivan
Fenproporex1575IVN Gacilin; Solvolip
Fludiazepam2759IVN
Flunitrazepam2763IVN Rohypnol; Narcozep; Darkene; Roipnol
Flurazepam2767IVN Dalmane
Fospropofol2138IVN Lusedra
Halazepam2762IVN Paxipam
Haloxazolam2771IVN
Ketazolam2772IVN Anxon; Loftran; Solatran; Contamex
Lemborexant2245IVN (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2-(3-

fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1- carboxamide

Loprazolam2773IVN
Lorazepam2885IVN Ativan
Lorcaserin1625IVN Belviq
Lormetazepam2774IVN Noctamid
Mazindol1605IVN Sanorex; Mazanor
Mebutamate2800IVN Capla
Medazepam2836IVN Nobrium
Mefenorex1580IVN Anorexic; Amexate; Doracil; Pondinil
Meprobamate2820IVN Miltown; Equanil; Micrainin; Equagesic; Meprospan
Methohexital2264IVN Brevital
Methylphenobarbital (mephobarbital)2250IVN Mebaral; mephobarbital
Midazolam2884IVN Versed

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Modafinil1680IVN Provigil
Nimetazepam2837IVN Erimin
Nitrazepam2834IVN Mogadon
Nordiazepam2838IVN Nordazepam; Demadar; Madar
Oveporexton1775IVN N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2-

fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

Oxazepam2835IVN Serax; Serenid-D
Oxazolam2839IVN Serenal; Convertal
Paraldehyde2585IVN Paral
Pemoline1530IVN Cylert
Pentazocine9709IVN Talwin; Talwin NX; Talacen; Talwin Compound
Petrichloral2591IVN Pentaerythritol chloral; Periclor
Phenobarbital2285IVN Luminal; Bellergal-S
Phentermine1640IVN Ionamin; Fastin; Adipex-P; Obe-Nix; Zantryl
Pinazepam2883IVN Domar
Pipradrol1750IVN Detari; Stimolag Fortis
Prazepam2764IVN Centrax
Quazepam2881IVN Doral
Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-2846IVN 8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester,
4-propionic acid)benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1-methyl-

6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

Serdexmethylphenidate1729IVN
Sibutramine1675IVN Meridia
Solriamfetol (2-amino-3-phenylpropyl car-bamate;1650IVN

benzenepropanol, beta-amino-, carbamate (ester))

SPA1635IVN 1-Dimethylamino-1,2-diphenylethane; Lefetamine
Suvorexant2223IVN MK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-

1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone

Temazepam2925IVN Restoril
Tetrazepam2886IVN Myolastan; Musaril
Tramadol (2-[(dimethylamino)methyl]-1-(3-9752IVY Tramadol

methoxyphenyl)cyclohexanol)

Triazolam2887IVN Halcion
Zaleplon2781IVN Sonata
Zolpidem2783IVN Ambien; Ivadal; Stilnoct; Stilnox
Zopiclone2784IVN Lunesta
Zuranolone2420IVN ZURZUVAE

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Brivaracetam 2710 V N BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4- propylpyrrolidin-1-yl] butanamide)

Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-2720VN 2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-,
yl)ethyl]carbamate)carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1-(2-

chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

Codeine preparations - 200 mg/(100 ml or 100 gm)VY Cosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof
Difenoxin preparations - 0.5 mg/25 ug AtSO4/duVY Motofen
Dihydrocodeine preparations 100mg/(100 ml or 100 gm)VY Cophene-S, various others
Diphenoxylate preparations 2.5 mg/25 ug AtSO4VY Lomotil; Logen
Ethylmorphine preparations 100 mg/(100 ml or 100 gm)VY
Ezogabine2779VN Potiga
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one)2401VN
Lacosamide2746VN Vimpat
Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-2790VN Reyvow

carbonyl)pyridine-2-yl-benzamide]

Opium preparations - 100 mg/(100 ml or 100 gm)VY Parepectolin; Kapectolin PG; Kaolin Pectin P.G.
Pregabalin2782VN Lyrica
Pyrovalerone1485VN Centroton; Thymergix

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

List

I and List

II

  1. Alphabetical Order Regulated Chemicals 2. DEA Number 3. List Number 4. Illicit Uses and Threshold Quantities

List I and II Regulated Chemicals

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its salts I 8336 87 FR 67550 11/9/2022 (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its salts I 8331 90 FR 47563 10/2/2025 (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, its I 8330 88 FR 21902 5/12/2023 carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

ACETIC ANHYDRIDEII8519Pub. L. 100-6903/18/1989
ACETONEII6532Pub. L. 100-6903/18/1989
N-ACETYLANTHRANILIC ACID, salts & estersI8522Pub. L. 100-6903/18/1989
ANTHRANILIC ACID, salts & estersI8530Pub. L. 100-6903/18/1989
APAA (Alpha-phenylacetoacetamide) and its optical isomers (EffectiveI851586 FR 247036/9/2021

06/09/2021)

APAAN (Alpha-phenylacetoacetoniltrile), salts, optical isomers, salts of I 8512 82 FR 32457 8/14/2017 optical isomers

BENZALDEHYDEI8256Pub. L. 103-2004/17/1994
BENZYL CHLORIDEII8570Pub. L. 100-6903/18/1989
BENZYL CYANIDEI8735Pub. L. 100-6903/18/1989
BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide),I833485 FR 208225/15/2020

including its salts.

gamma-BUTYROLACTONEI2011Pub. L. 106-1722/18/2000
EPHEDRINE, salts, optical isomers, & salts of optical isomersI8113Pub. L. 100-6903/18/1989
EPHEDRINE - remove exemption for OTC single entity drug productI8113Pub. L. 103-2004/17/1994
EPHEDRINE-remove exemption for OTC combination products and establishI8113Pub. L. 104-23710/3/1996

a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313

ERGONOVINE or ERGOMETRINE & saltsI8675Pub. L. 100-6903/18/1989
ERGOCRISTINEI861276 FR 177785/2/2011
ERGOTAMINE & saltsI8676Pub. L. 100-6903/18/1989
ETHYLAMINE & saltsI8678Pub. L. 101-6472/27/1991
N-ETHYLEPHEDRINE - superseded by 1994 actionIPub. L. 101-6472/27/1991
N-ETHYLEPHEDRINEREMOVEDPub. L. 103-2004/17/1994

* Remain in Schedule III

List I and II Regulated Chemicals - Alphabetical Order

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

ETHYL ETHERII6584Pub. L. 100-6903/18/1989
N-ETHYLPSEUDOEPHEDRINE - superseded by 1994 actionIPub. L. 101-6472/27/1991
N-ETHYLPSEUDOEPHEDRINEREMOVEDPub. L. 103-2004/17/1994
HYDROCHLORIC ACID (including anhydrous hydrogen chloride)II654557 FR 4361410/22/1992
HYDROCHLORIC GAS (anhydrous hydrogen chloride)II6545Pub. L. 104-23710/3/1996
HYDRIODIC ACID - superseded by 1990 actionII6695Pub. L. 100-6903/18/1989
HYDRIODIC ACIDI6695Pub. L. 101-6472/27/1991
HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite,I679766 FR 5267011/16/2001

calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

IODINE - superseded by 2007 actionII6699Pub. L. 104-23710/3/1996
IODINEI669972 FR 359208/1/2007
ISOSAFROLEI8704Pub. L. 101-6472/27/1991
D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers-I7300Pub. L. 101-6472/27/1991

superseded

D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers*REMOVED7300Pub. L. 103-2004/17/1994
METHYLAMINE and saltsI8520Pub. L. 101-6472/27/1991
METHYL ALPHA-PHENYLACETOACETATE (MAPA)I879586 FR 6436212/20/2021
3,4-METHYLENEDIOXYPHENYL-2-PROPANONEI8502Pub. L. 100-6903/18/1989
N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomersI8115Pub. L. 101-6472/27/1991
METHYL ETHYL KETONE (MEK) or 2-BUTANONEII6714Pub. L. 100-6903/18/1989
METHYL ISOBUTYL KETONE (MIBK)II671560 FR 195095/19/1995
N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of opticalI8119Pub. L. 101-6472/27/1991

isomers

NITROETHANEI6724Pub. L. 103-2004/17/1994
NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8317Pub. L. 100-6903/18/1989
P2P METHYL GLYCIDIC ACID (2-methyl-3-phenyloxirane-2-carboxylic acid;I852691 FR 168315/4/2026

BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

N-PHENETHYL-4-PIPERIDONE (NPP)I833273 FR 433554/23/2007
PHENYLACETIC ACID, esters, and saltsI8791Pub. L. 100-6903/18/1989
PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomersI1225Pub. L. 100-6903/18/1989
PHENYLPROPANOLAMINE-remove exemption for certain OTC transactions.I1225Pub. L. 104-23710/3/1997

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

PIPERIDINE and saltsI2704Pub. L. 100-6903/18/1989
PIPERONALI8750Pub. L. 101-6472/27/1991
PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical andI853586 FR 247036/9/2021

geometric isomers (Effective 06/09/2021)

PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its I 8525 86 FR 24703 6/9/2021 salts, optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

List I and II Regulated Chemicals - Alphabetical Order

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

POTASSIUM PERMANGANATEII6579Pub. L. 100-6903/18/1989
PROPIONIC ANHYDRIDEI8328Pub. L. 101-6472/27/1991
PROPIONYL CHLORIDEI833791 FR 114504/9/2026
PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8112Pub. L. 100-6903/18/1989
PSEUDOEPHEDRINE -remove exemption for certain OTC transactions.I8112Pub. L. 104-23710/3/1997

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

RED PHOSPHORUSI679566 FR 5267011/16/2001
SAFROLE (includes sassafras oil)I8323Pub. L. 101-6472/27/1991
SODIUM PERMANGANATEII658871 FR 6082312/18/2006
SULFURIC ACIDII655257 FR 4361410/22/1992
TOLUENEII6594Pub. L. 100-6903/18/1989
WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS)I679666 FR 5267011/16/2001

List I and II Regulated Chemicals - Alphabetical Order

- by DEA Chemical Code Number -

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

N-ETHYLEPHEDRINE - superseded by 1994 actionIPub. L. 101-6472/27/1991
N-ETHYLEPHEDRINEREMOVEDPub. L. 103-2004/17/1994
N-ETHYLPSEUDOEPHEDRINE - superseded by 1994 actionIPub. L. 101-6472/27/1991
N-ETHYLPSEUDOEPHEDRINEREMOVEDPub. L. 103-2004/17/1994
PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomersI1225Pub. L. 100-6903/18/1989
PHENYLPROPANOLAMINE-remove exemption for certain OTC transactions.I1225Pub. L. 104-23710/3/1997

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

gamma-BUTYROLACTONEI2011Pub. L. 106-1722/18/2000
PIPERIDINE and saltsI2704Pub. L. 100-6903/18/1989
ACETONEII6532Pub. L. 100-6903/18/1989
HYDROCHLORIC ACID (including anhydrous hydrogen chloride)II654557 FR 4361410/22/1992
HYDROCHLORIC GAS (anhydrous hydrogen chloride)II6545Pub. L. 104-23710/3/1996
SULFURIC ACIDII655257 FR 4361410/22/1992
POTASSIUM PERMANGANATEII6579Pub. L. 100-6903/18/1989
ETHYL ETHERII6584Pub. L. 100-6903/18/1989
SODIUM PERMANGANATEII658871 FR 6082312/18/2006
TOLUENEII6594Pub. L. 100-6903/18/1989
HYDRIODIC ACID - superseded by 1990 actionII6695Pub. L. 100-6903/18/1989
HYDRIODIC ACIDI6695Pub. L. 101-6472/27/1991
IODINE - superseded by 2007 actionII6699Pub. L. 104-23710/3/1996
IODINEI669972 FR 359208/1/2007
METHYL ETHYL KETONE (MEK) or 2-BUTANONEII6714Pub. L. 100-6903/18/1989
METHYL ISOBUTYL KETONE (MIBK)II671560 FR 195095/19/1995
NITROETHANEI6724Pub. L. 103-2004/17/1994
RED PHOSPHORUSI679566 FR 5267011/16/2001
WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS)I679666 FR 5267011/16/2001
HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite,I679766 FR 5267011/16/2001

calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers- I 7300 Pub. L. 101-647 2/27/1991 superseded

D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers*REMOVED7300Pub. L. 103-2004/17/1994
PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8112Pub. L. 100-6903/18/1989

* Remain in Schedule III

List I and II Regulated Chemicals - by DEA Chemical Code Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

PSEUDOEPHEDRINE -remove exemption for certain OTC transactions. Retail I 8112 Pub. L. 104-237 10/3/1997 threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

EPHEDRINE, salts, optical isomers, & salts of optical isomersI8113Pub. L. 100-6903/18/1989
EPHEDRINE - remove exemption for OTC single entity drug productI8113Pub. L. 103-2004/17/1994
EPHEDRINE-remove exemption for OTC combination products and establishI8113Pub. L. 104-23710/3/1996

a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313

N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomersI8115Pub. L. 101-6472/27/1991
N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of opticalI8119Pub. L. 101-6472/27/1991

isomers

BENZALDEHYDEI8256Pub. L. 103-2004/17/1994
NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8317Pub. L. 100-6903/18/1989
SAFROLE (includes sassafras oil)I8323Pub. L. 101-6472/27/1991
PROPIONIC ANHYDRIDEI8328Pub. L. 101-6472/27/1991
4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, itsI833088 FR 219025/12/2023

carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its salts I 8331 90 FR 47563 10/2/2025 (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

N-PHENETHYL-4-PIPERIDONE (NPP)I833273 FR 433554/23/2007
BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide),I833485 FR 208225/15/2020

including its salts.

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its salts I 8336 87 FR 67550 11/9/2022 (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

PROPIONYL CHLORIDEI833791 FR 114504/9/2026
3,4-METHYLENEDIOXYPHENYL-2-PROPANONEI8502Pub. L. 100-6903/18/1989
APAAN (Alpha-phenylacetoacetoniltrile), salts, optical isomers, salts of opticalI851282 FR 324578/14/2017

isomers

APAA (Alpha-phenylacetoacetamide) and its optical isomers (Effective I 8515 86 FR 24703 6/9/2021 06/09/2021)

ACETIC ANHYDRIDEII8519Pub. L. 100-6903/18/1989
METHYLAMINE and saltsI8520Pub. L. 101-6472/27/1991
N-ACETYLANTHRANILIC ACID, salts & estersI8522Pub. L. 100-6903/18/1989
PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its salts,I852586 FR 247036/9/2021

optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

P2P METHYL GLYCIDIC ACID (2-methyl-3-phenyloxirane-2-carboxylic acid; I 8526 91 FR 16831 5/4/2026 BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

List I and II Regulated Chemicals - by DEA Chemical Code Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

ANTHRANILIC ACID, salts & estersI8530Pub. L. 100-6903/18/1989
PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical andI853586 FR 247036/9/2021

geometric isomers (Effective 06/09/2021)

BENZYL CHLORIDEII8570Pub. L. 100-6903/18/1989
ERGOCRISTINEI861276 FR 177785/2/2011
ERGONOVINE or ERGOMETRINE & saltsI8675Pub. L. 100-6903/18/1989
ERGOTAMINE & saltsI8676Pub. L. 100-6903/18/1989
ETHYLAMINE & saltsI8678Pub. L. 101-6472/27/1991
ISOSAFROLEI8704Pub. L. 101-6472/27/1991
BENZYL CYANIDEI8735Pub. L. 100-6903/18/1989
PIPERONALI8750Pub. L. 101-6472/27/1991
PHENYLACETIC ACID, esters, and saltsI8791Pub. L. 100-6903/18/1989
METHYL ALPHA-PHENYLACETOACETATE (MAPA)I879586 FR 6436212/20/2021

List I and II Regulated Chemicals - by DEA Chemical Code Number

- by List Number -

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its I 8336 87 FR 67550 5/15/2020 salts (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its I 8331 90 FR 47563 10/2/2025 salts (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023) piperidone was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, its I 8330 88 FR 21902 5/12/2023 carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

N-ACETYLANTHRANILIC ACID, salts & estersI8522Pub. L. 100-6903/18/1989
ANTHRANILIC ACID, salts & estersI8530Pub. L. 100-6903/18/1989
APAA (Alpha-phenylacetoacetamide) and its optical isomers (EffectiveI851586 FR 247036/9/2021

06/09/2021)

APAAN (Alpha-phenylacetoacetonitrile), salts, optical isomers, & salts of I 8512 82 FR 32457 8/14/2017 optical isomer

BENZALDEHYDEI8256Pub. L. 103-2004/17/1994
BENZYL CYANIDEI8735Pub. L. 100-6903/18/1989
BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide),I833485 FR 208225/15/2020

including its salts.

gamma-BUTYROLACTONEI2011Pub. L. 106-1722/18/2000
EPHEDRINE, salts, optical isomers, & salts of optical isomersI8113Pub. L. 100-6903/18/1989
EPHEDRINE - remove exemption for OTC single entity drug productI8113Pub. L. 103-2004/17/1994
EPHEDRINE remove exemption for OTC ephedrine combination productsI8113Pub. L. 104-23710/3/1996

and establish a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313.

ERGONOVINE or ERGOMETRINE & saltsI8675Pub. L. 100-6903/18/1989
ERGOCRISTINE and its saltsI861276 FR 177785/2/2011
ERGOTAMINE & saltsI8676Pub. L. 100-6903/18/1989
ETHYLAMINE & saltsI8678Pub. L. 101-6472/27/1991
HYDRIODIC ACIDI6695Pub. L. 101-6472/27/1991

List I and II Regulated Chemicals - by List Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite, I 6797 66 FR 52670 11/16/2001 calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

IODINEI669972 FR 359208/1/2007
ISOSAFROLEI8704Pub. L. 101-6472/27/1991
METHYLAMINE and saltsI8520Pub. L. 101-6472/27/1991
METHYL ALPHA-PHENYLACETOACETATE (MAPA) and its optical isomersI879586 FR 6436212/20/2021
3,4-METHYLENEDIOXYPHENYL-2-PROPANONEI8502Pub. L. 100-6903/18/1989
N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomersI8115Pub. L. 101-6472/27/1991
N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of opticalI8119Pub. L. 101-6472/27/1991

isomers

NITROETHANEI6724Pub. L. 103-2004/17/1994
NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8317Pub. L. 100-6903/18/1989
P2P methyl glycidic acid (2-methyl-3-phenyloxirane-2-carboxylic acid; BMKI852691 FR 168315/4/2026

glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

N-PHENETHYL-4-PIPERIDONE (NPP)I833273 FR 433554/23/2007
PHENYLACETIC ACID, esters, and saltsI8791Pub. L. 100-6903/18/1989
PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomersI1225Pub. L. 100-6903/18/1989
PHENYLPROPANOLAMINE -remove exemption for certain OTCI1225Pub. L. 104-23710/3/1997

transactions. Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

PIPERIDINE and saltsI2704Pub. L. 100-6903/18/1989
PIPERONALI8750Pub. L. 101-6472/27/1991
PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical andI853586 FR 247036/9/2021

geometric isomers (Effective 06/09/2021)

PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its I 8525 86 FR 24703 6/9/2021 salts, optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

PROPIONIC ANHYDRIDEI8328Pub. L. 101-6472/27/1991
PROPIONYL CHLORIDEI833791 FR 114504/9/2026
PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomersI8112Pub. L. 100-6903/18/1989
PSEUDOEPHEDRINE -remove exemption for certain OTC transactions.I8112Pub. L. 104-23710/3/1997

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

RED PHOSPHORUSI679566 FR 5267011/16/2001
SAFROLE (includes sassafras oil)I8323Pub. L. 101-6472/27/1991
WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS)I679666 FR 5267011/16/2001

List I and II Regulated Chemicals - by List Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

ACETIC ANHYDRIDEII8519Pub. L. 100-6903/18/1989
ACETONEII6532Pub. L. 100-6903/18/1989
BENZYL CHLORIDEII8570Pub. L. 100-6903/18/1989
ETHYL ETHERII6584Pub. L. 100-6903/18/1989
HYDROCHLORIC ACID (including anhydrous hydrogen chloride)II654557 FR 4361410/22/1992
HYDROCHLORIC GAS (anhydrous hydrogen chloride)II6545Pub. L. 104-23710/3/1996
HYDRIODIC ACID - superseded by 1990 actionII6695Pub. L. 100-6903/18/1989
IODINE - superseded by 2007 actionII6699Pub. L. 104-23710/3/1996
METHYL ETHYL KETONE (MEK) or 2-BUTANONEII6714Pub. L. 100-6903/18/1989
METHYL ISOBUTYL KETONE (MIBK)II671560 FR 195095/19/1995
POTASSIUM PERMANGANATEII6579Pub. L. 100-6903/18/1989
SODIUM PERMANGANATEII658871 FR 6082312/18/2006
SULFURIC ACIDII655257 FR 4361410/22/1992
TOLUENEII6594Pub. L. 100-6903/18/1989

List I and II Regulated Chemicals - by List Number

Listed Chemicals Regulated Under CONTROLLED SUBSTANCE PRODUCED

the Controlled Substances Act

See 21 C.F.R. §§ 1309, 1310, 1313 and 1314 for details

DEA

Reagent = 

Chemical

Last Update: Nov 12, 2026 Precursor = 

Code

Solvent = 

Number AmphetamineCocaineN,N-DimethylamphetamineEthylamphetamineFentanyl & analoguesGHBHeroinLSD MDA MDE MDMAMethamphetamineMethaqualoneMethcathinone4-MethylaminorexPhencyclidine (PCP)Phenyl-2-propanoneTHRESHOLDS

1. 1-Boc-4-AP¹833600
2. 1-Boc-4-piperidone¹833100
3. 4-Anilinopiperidine⁸833500
4. 4-Piperidone¹²833000
5. N-Acetylanthranilic acid²85224040
6. Alpha-Phenylacetoacetamide⁹(APAA)851500
7. Alpha-Phenylacetoacetonitrile³(APAAN)851200
8. Anthranilic acid²85303030
9. Benzaldehyde825644
10. Benzyl cyanide873511
11. Benzylfentanyl¹833400

3&7

12. Ephedrine811300
13. Ergocristine¹861200
14. Ergonovine¹86750.010 0.010
15. Ergotamine¹86760.020 0.020
16. Ethylamine¹867811
17. gamma-Butyrolactone (GBL)201100
18. Hydriodic acid66951.7 1.7
19. Hypophosphorous acid¹679700
20. Iodine669900
21. Isosafrole8704  44
LIST I22. Methyl alpha-phenylacetoacetate (MAPA)⁹879500
23. Methylamine¹8520 11
24. 3,4-Methylenedioxyphenyl-2-propanone8502  44
25. N-Methylephedrine³811511
26. N-Methylpseudoephedrine³811911
27. N-phenethyl-4-piperidone (NPP)833200
28. Nitroethane67242.5 2.5
29. Norpseudoephedrine³83172.5 2.5
30. P2P methyl glycidic acid¹³852600
31. Phenylacetic acid²879111

3&7

32. Phenylpropanolamine122500
33. Phosphorus (red)679500
34. Phosphorus (white or yellow)679600
35. Piperidine¹27040.500 0.500
36. Piperonal (heliotropin)8750  44
37. PMK glycidate¹⁰8535  00
38. PMK glycidic acid¹¹8525  00
39. Propionic anhydride83280.001 0.001
40. Propionyl chloride833700

3&7

41. Pseudoephedrine811200
42. Safrole8323  44
43. Acetic anhydride8519 1,023 1,023
44. Acetone6532     150 1,500
45. Benzyl chloride857014
46. Ethyl ether6584          135.8 1,364

5&6

Hydrochloric acid 6545               N/C 222.3 47.

5&6

Hydrogen chloride gas6545           027
LIST II48.Methyl ethyl ketone (2-Butanone)6714 ¹⁴⁵ 1,455
49. Methyl isobutyl ketone⁴6715 N/C 1,523
50. Potassium permanganate657955 500
51. Sodium permanganate658855 500

5&6

52. Sulfuric acid6552     N/C 347
53. Toluene6594  159 1,591

1 and its salts 2 and its salts and esters 3 and its salts, optical isomers, and salts of optical isomers 4 Exports only, to all Western Hemisphere except Canada 5 Exports to all South American countries & Panama - Domestic for HCI gas 6 Threshold for HCI acid and sulfuric acid is 50 gallons, the equivalent weight in kilograms is shown 7 For pseudoephedrine, phenylpropanolamine and ephedrine drug products, see 21 USC § 802(45)(A) and 21 C.F.R. Part 1314

DOMESTICEXPORTS

8 IMPORTS & Including its amides, its carbamates, its halides, and its salts 9 and its optical isomers 10 and its optical and geometric isomers 11 and its salts, optical and geometric iosmers and salts of optical and geometric isomers

KILOGRAMS

12 and its acetals, amides, carbamates, salts, and salts of acetals, amides, carbamates, and any combinaton thereof, whenever that existence of such is possible 13 and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible N/C = Not Controlled

Omvandlad till Markdown för tillgänglighetens skull; originalet är den gällande versionen. Figurerna finns i PDF:en.

Ladda ner som PDF